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ABSTRACT

Several lines of evidence link Alzheimer’s disease (AD) to atherosclerosis (CVD),
including that elevated low density lipoprotein (LDL)-cholesterol is a common risk
factor.

Development of genomic instability could also link the two diseases.

Previous fluorescence in situ hybridization (FISH) analyses revealed a clonal
expansion of aneuploid smooth muscle cells underlying atherosclerotic plaques.
Likewise, cellular and mouse models of AD revealed tau-dependent mitotic
defects and subsequent aneuploidy partly resulting from amyloid-beta (Aβ)
interference with microtubule (MT) stability, and specific MT motors function.
Moreover, AD patients develop aneuploid/hyperploid cells in brain and peripheral
tissues, implicating similar mechanism that may lead to apoptosis and
neurodegeneration.
This dissertation tested the hypothesis that elevated lipoproteins and
cholesterol may contribute to genomic instability in AD and CVD and showed
that: (1) treatment with oxidized LDL (OX-LDL), LDL and water soluble
cholesterol, but not high density lipoprotein (HDL), induced chromosome missegregation, including trisomy and tetrasomy 12, 21, and 7 in human epithelial

vii

cells (h-TERT-HME1), primary aortic smooth muscle cells, fibroblasts, mouse
splenocytes and neural precursors; (2) LDL-induced aneuploidy may depend on
a functional LDL receptor (LDLR), but not amyloid precursor protein (APP) gene;
(3) fibroblasts and brain cells of patient with the mutation in the Niemann-Pick C1
gene (NPC1) characterized by impaired intracellular cholesterol trafficking and
changed intracellular cholesterol distribution harbored trisomy 21 cells; (4) young
wild-type mice fed high and low cholesterol diets developed aneuploidy in spleen
but not in brain cells within 12 weeks; (5) like with the studies on Aβ-induced
aneuploidy, calcium (Ca2+) chelation reduced OX-LDL and LDL-mediated
chromosomal instability; and (6) altering plasma membrane fluidity with ethanol
attenuated OX-LDL and LDL-induced aneuploidy.
These results suggest a novel biological mechanism by which disrupted
cholesterol homeostasis may promote both atherosclerosis and AD by inducing
chromosome

mis-segregation

and

development

of

aneuploid

cells.

Understanding the cause and consequence of chromosomal instability as a
common pathological trait in AD and CVD may be beneficial to designing
therapies relevant for both diseases.

viii

CHAPTER ONE
INTRODUCTION 1

The accurate transmission of genetic material from a mother cell to the daughters
requires not only a faithful replication of the genome, but also a precise
segregation of chromosomes during the cell division.

To accomplish this

remarkable process, the cell has to disentangle replicated DNA molecules and
pull them accurately to the opposite poles of the mitotic spindle before
completing cytokinesis (Figure 1). In eukaryotic, including mammalian cells, the
cohesion between sister chromatids, a duplicated set of chromosomes, is
sustained long after DNA replication, which allows for successful completion of
mitosis (M). During the M phase of the cell cycle, microtubules (MT), highly
dynamic protein polymers of the mitotic spindle, attach the kinetochores of the
sisters chromatids to opposite spindle poles and drive chromosome movement
and traction (reviewed in Morgan, 2007). A tightly controlled interaction between
activating and inhibiting factors of the cell cycle assures chromosomal stability
and integrity (Draviam et al., 2004), whereas dysregulation of the genes that

1

Portions of the results in this chapter have been published (Granic et al., 2010) and are utilized with the permission from
the publisher. The contributions of the authors are: A. Granic, experimental designs and implementation, data collection
and analysis, and manuscript preparation; J. Padmanabhan, important scientific insights for the manuscript, M. Norden,
mice genotyping and assistance with the surgical procedures, and H. Potter experimental designs and manuscript
preparation.
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Figure 1. Metaphase to Anaphase Transition in hTERT-HME1 Cells
Immortalized human epithelial cells were stained for mitotic spindle (α-tubulin, red), centrosomes/spindle
poles (γ-tubulin; green) and nuclear DNA (DAPI, blue) to visualize the transition through the M phase of the
cell cycle. Granic and Potter, unpublished data.

govern the spindle checkpoints (Bharadwaj and Yu, 2004; Kinzler and Voglstein,
1997) and DNA repair result in various genomic alternations, including
mutations, chromosomal rearrangements, deletions, inversions and aneuploidy
(Draviam et al., 2004; Rao et al., 2009).

Despite numerous cytogenetic

pathways that ought to preserve this fundamental principle of life, spontaneous
and induced chromosome mis-segregation happens frequently in humans during
normal and pathological conditions (Cimini et al., 1999; Rasnik, 2000; Peterson
et al., 2008; Rao et al., 2009; Rehen et al., 2005; Shi et al., 2000; Wojda et al.,
2007).
Aneuploidy, a numerical abnormality of chromosomes compared to the
normal genome (King and Stansfiled, 1990) arises as a consequence of mitotic
errors (Kops et al., 2005; Rao et al., 2009) and has been linked to (1)

2

tumorigenesis of solid tumors (Boveri 1929; reviewed in Duesberg and Rasnik,
2000; Jefford and Irminger-Finger, 2006; Ried 2009); (2) spontaneous abortions
and embryonic lethality (Lebedev et al., 2004; Ljunger et al., 2011); (3) etiology of
genetic diseases with abnormal phenotype such as Down syndrome (DS)
(reviewed in Hassold and Sherman, 2000; Nižetić, 2008); (4) aging (Aviv et al.,
2001; Carere et al., 1999; Faggioli et al., 2011; Ly et al., 2000; Vijg and Dolle,
2007); (5) atherogenesis (Matturri et al., 1997; 2001); (6) neurogenesis (Peterson
et al., 2008; Rehen et al., 2005; Yang et al., 2003); and (7) neurodegeneration
and dementia (Arendt et al., 2010; Potter, 2004). Mitotic division of an aneuploid
cell is believed to be an evolutionary experiment resulting in cellular diversity and
constant genomic redistribution (Rasnick, 2000), but also a phenomenon
characterizing or contributing to the disease process.
This chapter will focus on genomic instability and chromosomal
aneuploidy in normal and diseased human brain, the functional consequence and
relevance thereof, the theoretical foundation for the role of altered gene dosage
and abnormal cell cycle in dementia of the Alzheimer’s type, cancer, and
cardiovascular disease (CVD).

GENOMIC INSTABILITY IN NORMAL HUMAN BRAIN

Ever since the numbers of human chromosomes have been determined (2n = 46;
Tjio and Levan, 1956), numerous molecular cytogenetic studies reported
genomic imbalance and the presence of euploid and aneuploid cells (i.e.,
3

mosaicism) in various pathogenic and nonpathogenic human conditions. The
cells from normal tissues have been assumed to contain identical genomes in
which aging, environmental and endogenously-induced insults may compromise
the accuracy of mitotic machinery, initiating or causing the diseased state (Aviv et
al., 2001; Beetstra et al., 2005; Benassi-Evans and Fenech, 2011; Mukherjee
and Thomas, 1997; Ried, 2009). In addition, higher cellular proliferation rates of
renewable tissues in a complex human organism during embryogenesis
(Biancotti et al., 2010; Mantzouratou and Delhanty, 2011), neurogenesis (Yurov
et al., 2005; 2007; Westra et al., 2008), tissue development

and cell

differentiation put at risk tightly regulated mitotic checkpoints, often resulting in
chromosome mis-segregation and aneuploidy (i.e., aneugenesis) (Draviam et al.,
2004).

Primary neurons in the normal human brain have been traditionally

viewed as post-mitotic and in G0 (Obrenovich et al., 2003), and thus genetically
stable. However, with advancements in cytogenetic techniques (Figure 2) from
the classic karyotype analysis of colcemid-arrested cells at metaphase (Barnicot
and Huxley, 1961) to more sophisticated examination of dividing and post-mitotic
cells via fluorescent DNA probes to target a part of a chromosome in interphase
cells (i.e., fluorescent in situ hybridization, FISH; Pinkel et al., 1986) or different
chromosome paints to visualize one or all chromosomes in dividing cells (i.e.,
spectral karyotyping, SKY; Schröck et al., 1996; Speicher et al., 1996), the
mosaic nature of developing and adult normal mammalian, including human
brain has been identified (Rehen 2001; 2005; Peterson et al., 2008; Yurov et al.,
2005; 2007).
4

Figure 2. Examples of Cytogenetic Methods for Analysis of Chromosome
Complements in Metaphase and Interphase Cells
Chromosomes in dividing cells can be visualized and analyzed via colcemid-arrested metaphase spread (left
panel), FISH with fluorescent DNA probe (middle panel), and chromosome paint (right panel). Granic and
Potter, unpublished data.

Mosaic Nature of Neurogenesis

For almost a century, a central dogma in neuroscience (Ramon y Cajal, 1913;
Rakic, 1985) viewed neurogenesis as a process confined to the embryonic stage
of mammalian development, and only recently a series of studies in various
animal models and human brain samples confirmed that new neurons are indeed
being born in distinct regions of the adult brain throughout life (reviewed in
Christie and Cameron, 2006; Gross, 2000; Kempermann and Gage, 2000; Ming
and Song, 2005; Zhao et al., 2008).

Adult neurogenesis, a continuous

generation of functional neurons in the dentate gyrus, olfactory bulb and
neocortex from the neural precursor cells (NPCs) occurs via mitosis (Eriksson et
al., 1998; Christi and Cameron, 2006) adding thousands of new neurons to the
brain per day (Cameron and McKey, 2001; Hastings et al., 2000), which become
an integral part of existing neuronal circuits (Carleton et al., 2003; Kingsbury et
al., 2005; Van Praag et al., 2002).
5

Methodological limitations of the techniques used to identify neurogenesis (e.g.
incorporation of the synthetic thymidine into mitotically active cells indicates DNA
synthesis and not necessarily cell division, and neuronal-specific markers crossreact with other brain cells or do not detect all types of neurons) (Cristie and
Cameron, 2006; Ming and Song, 2005; Rakic, 2002) suggest that the renewal of
the brain tissue may be happening at higher rates and in other brain regions than
has been reported. In addition, several modulators of adult neurogenesis have
been recognized (Ming and Song, 2005).

Unfavorable conditions such as

exposure to acute and chronic stress and aging may decrease (Kuhn et al.,
1996; Gould and Tanapat, 1999; Jin et al., 2003), whereas environmental
complexity (Brown et al., 2003) and learning of hippocampal-dependent tasks,
may increase the proliferation of neuronal cells in the dentate gyrus (Gould et al.,
1999; Leuner et al., 2004).

Accumulated evidence has shown that chronic

neurodegenerative diseases (e.g., Huntington’s and Alzheimer’s disease; Curtis
et al., 2003; Jin et al., 2004) and brain injury (Magavi et al., 2000) trigger a
significant increase in neuronal marker-positive cells, suggesting an induction of
brain’s self-repair mechanism under pathologic stimuli.
Advanced cytogenetic analyses by FISH and SKY have provided new
insights into the nature of the developing and adult mammalian brain. Numerous
chromosomal aberrations in the embryonic cerebral cortex, postnatal ventricular
zone (VZ) and other adult cortical regions of normal mouse and human brains
were observed among neuronal stem cells, NPCs and mature neurons (e.g.,
Kaushal et al., 2003; Kingsbury et al., 2006; Peterson et al., 2008; Rehen et al.,
6

2001; 2005; Yang et al., 2003; Yurov et al., 2005; 2007; Westra et al., 2008),
which were functionally active and had been incorporated into the present
neuronal circuitry (Kingsbury et al., 2005). Up to 33% metaphases cultured from
mouse embryonic neural cells exhibited both loss and gain of autosomal and sex
chromosomes (Rehen et al., 2001), and about one-third of postnatal NPCs that
give rise to neurons and glia were aneuploid for more than one chromosome
(Kaushal., et al., 2003).

Analyzing mitotic defects in prenatal cortical

hemispheres by co-immunolabeling for histone H3 to detect chromosomes and
for vimentin, a cytoplasmic marker of NPC, Yang et al. (2003) identified 4.6% of
NPCs with lagging chromosomes, 3.2% with multipolar cell division events, and
various aneuploidies by SKY. The rate of aneuploidy per mouse chromosome in
developing brain may be estimated as high as 1.65% assuming that every
chromosome has an equal chance to be gained or lost (Faggioli et al., 2011).
Similarly, application of multicolor interphase FISH with DNA probes for the
chromosomes exhibiting a frequent mosaic autosomal aneuploidy in humans
(i.e., chromosome 13, 18, and 21; Iourov et al., 2006) on isolated fetal brain
nuclei revealed between 30-35% of aneuploidy or estimated aneuploidy rate of
1.25-1.45% per chromosome (Yurov et al., 2005; 2007). Taken together, the
data indicates that genetic mosaicism or co-existence of euploid and aneuploid
cells is a universal feature of the developing mammalian brain.
Several hypotheses have been put forth to explain the susceptibility of the
central nervous system (CNS) to genomic instability, aneuploidy generation (i.e.,
aneugenesis) and the phenotypic benefits thereof (Dierssen et al., 2009).
7

Extreme brain complexity manifested by cellular diversity, lateral asymmetry,
regional interconnection of specialized microdomains, functional and structural
plasticity, and enhanced responsiveness to environmental stimuli and cues make
the brain more sensitive to genomic variations (Gericke, 2008) compared to other
organs.

Chromosome mis-segregation in neural precursors and consequent

genetic mosaicism could be a mechanism for biological variability and diversity in
neurons contributing to the functional complexity of the brain and differences in
intellectual abilities, personality, and psychiatric diseases in humans (Muotri and
Gage, 2006). Neuronal genomic heterogeneity as a universal organizational and
functional property of developing and adult brain may play a role in the late-onset
neurodegenerative diseases if the level of aneuploidy exceeds a physiologically
sustainable threshold and the mechanisms of aneuploidy clearance fail (Arendt
et al., 2009; Potter, 2004). Increased apoptosis of aneuploid neuroblasts during
cortical development (Rehen et al., 2001) suggests an inherent susceptibility to
the cell death and/or decreased proliferative potential (Blaschke et al., 1996; Kai
et al., 2009; Williams et al., 2008).
Advancements in neuroscience in the past couple of decades challenged
two scientific dogmas: (1) the adult brain is not capable of renewal, and (2)
normal

neural

cells

possess

identical

genomes.

However,

complete

understanding of the mechanism, extent, regional distribution and the role of both
neurogenesis and aneugenesis under normal and pathological conditions in
developing and mature human brain remains to be explored.

8

Mechanism of Aneuploidy Generation

Numerous tightly regulated processes and checkpoints throughout mitosis should
ensure equal chromosome segregation and accurate separation of synthetized
genetic material into two daughter cells (reviewed in Morgan, 2007). Molecular
biology and cytogenetic studies using mostly human cancer cells revealed

Figure 3. Mechanisms of Aneuploidy Generation
During the separation of sister chromatids, several pathways may lead to gain or loss of chromosomes such
as: (1) dysregulation in the spindle assembly checkpoints (SAC) genes in which one daughter cell gets both
chromosome copies after cell division; (2) improper attachment of microtubules and kinetochores to spindle
poles (e.g., one kinetochore attached to both spindle poles); (3) incorrect cleavage of cohesin; (4) multiple
spindle poles leading to asymmetric cell segregation; and (5) lagging chromosomes left after anaphase may
result in one or both daughter cells to be hypoploid.

9

several pathways that lead to aneugenesis: (1) dysregulation of spindle assembly
checkpoint (SAC) genes; (2) improper cross-linking of microtubules and
kinetochores; (3) sister chromatid cohesion defects; (4) supernumerary
centrosomes; and (5) incomplete cytokinesis (Chi and Jeang, 2007; Gisselsson,
2011; King, 2008; Yang et al., 2003).

These mechanisms of neoplastic

aneuploidy generation and persistence of chromosomal instability in tumors may
also explain chromosomal aberrations in the normal CNS (schematically
presented in Figure 3).
The SAC is a surveillance system responsible for delaying the separation
of the sister chromatids and progression into the anaphase until all chromosomes
are properly oriented across the mitotic plate and attached on the mitotic spindle
via kinetochores (Ito and Matsumoto, 2010; Straight, 1997). Dysfunction and
epigenetic modification of the signaling within the SAC (e.g., in the Mad and Bub
protein family) can result in a mother cell with mis-aligned or unattached
chromosomes proceeding with chromosome segregation towards opposite
spindle poles, producing a daughter cell with both chromosome copies.
Furthermore, inhibition of mitotic spindle motors such as kinesins, a group of
proteins that aid connecting antiparallel MT and segregation of spindle poles
resulted in massive aneuploidy in cultured cells (Borysov et al., 2011).
Proper cleavage of cohesin, a complex of four proteins that holds
duplicated DNA molecules together from the S phase through the metaphase is
the central event in chromosome segregation (Nasmyth, 2001; Uhlmann, 2003).
Experimental evidence in cellular and animal models has indicated that both
10

defects in expression of cohesin (Barbero, 2011) and cohesin protease separase
leads to mitotic errors, aneuploidy and tumor formation (Meyer et al., 2009;
Mukherjee et al., 2011; Zhang et al., 2008).
Additionally, erroneous number of spindle poles due to centrosome
replication defect (Godinho et al., 2009) may separate chromosomes to several
nuclei or give rise to asymmetric segregation and generation of laggards (Falck
et al., 2002; Norppa and Falck, 2003), which are chromosomes left at the mitotic
plate after anaphase and frequently captured into the micronuclei (Figure 3).
Studies on human neoplastic tumors have shown that despite bipolar
mitosis and accurate metaphase-anaphase transition, cytokinesis failure in
combination with spindle multipolarity may generate clones with high levels of
aneuploidy evident as trisomies and tetrasomies of multiple chromosomes, which
continue to propagate in similar fashion (Gisselsson et al., 2010), allowing for
long-term clonogenic survival of aneuploid cells (Gisselsson, 2011).
Chromosome gain and chromosome loss observed in human tissues
under normal and pathologic conditions may also arise through bipolar mitotic
nondisjunction in which chromosomes fail to separate, and both sister chromatids
move to one of the daughter cells (Kirsch-Volders et al., 2002; Torosantucci et
al., 2002; Weaver et al., 2006), resulting in trisomic and monosomic progeny.
Lastly, correct disassembly of both membrane layers, the nuclear pore
complexes and the nuclear lamina of the nuclear envelope (NE) at the onset of
mitosis requires the concerted action of duplicated centrosomes, microtubules
and mitotic motors (i.e., dynein complexes) to generate tension and
11

fragmentation of the NE (Burke and Ellenberg, 2002; Foisner, 2002; Gönczy,.
2002, Salina et al., 2003). Changes in the composition and dynamics of the
nuclear envelope prior to the M phase may affect the dismantling process of the
NE and its dynein-mediated attachment to MT and centrosomes, consequently
influencing the release and arrangement of the chromosomes.
In summary, several mechanisms may lead to the formation of trisomic
and monosomic cells during mitosis such as anaphase lagging, multipolar
centrosomes, sister chromatid nondisjunction (Yang et al., 2003), as well as
other pathways commonly observed in cancer cells, which allow for stable
propagation and persistence of aneuploid karyotype (Gisselsson, 2011).

Aneuploidy in Developing and Aging Brain

As mentioned previously, mitotic division of neuroblasts in embryonic human
brain is characterized by chromosomal instability in which nondisjunction is the
essential mechanisms of aneuploidy formation (Peterson et al., 2008; Yang et al.,
2003; Yurov et al., 2005). The invention of interphase FISH with DNA probes
(i.e., centromeric, locus-specific, and translocation) or chromosome paints
combined with immunocytochemistry allowed for analysis of low-level mosaicism
in non-dividing cells, and refuted the idea that mature neurons must possess
identical genomes to be functionally active.

Studies utilizing various FISH

approaches on isolated nuclei from normal adult brains revealed aneuploidy for
chromosome 1, 13, 21, 18, X and Y at a total aneuploidy rate of 2.3% (Yurov et
12

al, 2005), and 4% of monosomy and trisomy 21 (nondisjunction) in neurons and
glia which varied within the cell types and age of an individual (Rehen et al.,
2005).
In a more comprehensive study of aneuploidy incidence in normal brain
tissue, Iourov et al (2009) used interphase chromosome-specific multicolor
banding (Iourov et al., 2007) and multicolor FISH (mFISH) for chromosomes 1, 7,
11, 13, 14, 17, 18, 21, X and Y, and determined the average rate of aneuploidy
per chromosome as 0.5% and total aneuploidy as 10%, but noted wide variations
between the chromosomes and individuals. Constitutive or basal aneuploidy,
including trisomy 21 in normal human brains increased with advancing age
(Rehen et al., 2005; Yurov et al., 2007; Iourov et al., 2009), suggesting that
chromosomal instability may account not only for intrinsic genomic diversity but
also for susceptibility to aging and disease.
FISH analysis of the neurons prepared from several brain regions (i.e.,
cerebral cortex, hippocampus, and cerebellum) of normal human brains (aged
40-75) using the probes for chromosomes 1, 3, 6, 7, 8, 9 and 11 identified about
40% of total aneuploidy and 20% of loss of heterozygosity (LOH) and allelic
instability events in isolated subgroups of neurons (Pack et al., 2005).

The

authors speculated that constitutive neuronal aneuploidy may be necessary for
some neurons to preserve differentiated state and interconnectivity under
changing environmental conditions (Pack et al., 2005).
Furthermore, FISH analysis of non-telencephalic brain cells such as
cerebellar neurons and glia of both adult mice and humans with DNA probes for
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mouse chromosome X and 16, and human chromosome 6 and 21 revealed
chromosome gains and losses at the level of 1% per chromosome in both cell
populations (Westra et al. 2008). This study reported that mosaic aneuploidy in
both developing and adult cerebellum of mice and humans arises at a lower rate
than in, for example in cerebral cortex (~20% verses ~33%), suggesting that
aneuploid NPCs not only survive into adulthood as an integral part of brain
circuits, but that the level of genomic variation may be region specific and
contribute to overall CNS diversity.
Combining retrograde immunocytochemistry with the neuronal tracer
FluoroGold in vivo with immunolabeling to identify mature neurons in tissue
sections and FISH probes for chromosomes X and Y, Kingsbury et al. (2005)
showed that aneuploid neurons in the adult mouse brain possess axonal
connections, demonstrate functional activity, and are likely to be present in all
brain regions, and probably contain mis-segregated autosomal chromosomes.
Another study compared a slide-based cytometry (SBC) and PCR
amplification of alu-repeats with chromogenic in situ hybridization (CISH) for
chromosome 17 to quantify the DNA content of a single neuron on a fixed brain
slice (Mosch et al., 2007). About 12% of adult neurons isolated from the brains
without any known neurological or psychiatric disease (mean age ~72 years) had
hyperploid DNA content (here defined as more than diploid [2n] and less than
tetraploid [4n] karyotype), and included a subpopulation of cells expressing cyclin
B1, an early M phase marker (Darzynkiewicz, 1996). In addition, between 6-7%
brain cells showed three hybridization spots for chromosome 17 and about 0.414

0.7% cyclin B1-negative neurons were tetraploid, representing constitutional
tetraploidy.
Taken together, the results from all the studies suggest that: (1) the brain
genome is not constant—mosaic aneuploidy is a constitutive complement of the
developing and mature mammalian brain; (2) aneuploid neurons are functionally
active and incorporate into brain circuits; (3) aneuploidy levels may vary between
brain regions and change through the developmental stages; (4) basal
aneuploidy may be needed for brain diversification, cellular heterogeneity and
complexity of gene expression; (5) aberrant mitosis of neuroblasts in the
ventricular zone may not be the sole source of aneuploid neurons; and (6) overall
aneuploidy prevalence and incidence in human brain remains to be determined.
To date, comprehensive cytogenetic studies of chromosomal variations in normal
human brain compared to other somatic tissues throughout life are lacking, but it
is generally postulated that even a low level of aneuploidy may significantly
contribute to neuronal diversity, brain function and structure, and susceptibility to
aging, psychopathological and neurodegenerative conditions (Arendt. et al.,
2009; 2010; Muotri and Gage, 2006; Potter, 2004; Rehen et al., 2001).

Consequence of Genomic Instability in CNS

Gain or loss of at least one chromosome is associated with increased or
decreased expression of many genes in cancer cells (e.g., Sellmann et al., 2010)
and yeast strains (e.g., Pavelka et al., 2010), and exert a profound change at the
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transcriptome and proteome level, altering cell physiology and function (Torres et
al., 2007). Similarly, analysis of gene expression of aneuploid NPCs born in the
postnatal subventricular zone and olfactory bulb revealed loss of heterozygosity
and altered gene expression in cells missing one copy of chromosome 15
(Kaushal et al., 2003). Some aneuploid neurons survive into adulthood (Rehen
et al., 2001), escape ‘apoptotic pruning’ (Blaschke et al., 1996; Kai et al., 2009;
Harrison et al., 2000), and function aside mostly euploid cells (Kingsbury et al.,
2005).

This suggests that a mosaic brain network may produce a unique

variation in gene dosage and consequent gene expression profile with both
beneficial and detrimental consequences as observed in cancer cells (Shelzer
and Amon, 2011; Weaver et al., 2007;) and genetic diseases (Dowjat et al.,
2007; Gardiner et al., 2010). For example, Down syndrome (DS), a full trisomy
of chromosome 21 (HSA 21) is a genetic condition that provides some insights
into how constitutive aneuploidy (a change in one chromosome copy number)
may lead to altered gene expression, brain dysfunction and degeneration
(discussed below).
It is unclear how much aneuploidy a single brain cell can sustain under
normal developmental conditions (Kingsbury et al., 2006; Arendt at al., 2009),
and what overall ‘aneuploidy burden’ would prompt the susceptibility to disease
and consequent neurodegeneration.

It has been suggested that the neural

aneugenesis beyond the basal levels may represent an early or contributing
event in the brain disease process (Arendt et al., 2009; Potter, 2004), triggered
either by unfavorable genetic polymorphism and/or environmental stimulus.
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GENOMIC INSTABILITY IN DISEASED BRAIN

Recent cytogenetic studies have revealed an increase in genomic instability in
several human brain diseases compared to normal aging and development,
including Alzheimer’s disease (AD) (Arendt et al., 2010; Mosch et al., 2007;
Iourov et al., 2009; reviewed in Kingsbury et al., 2006; Thomas and Fenech,
2007),

mosaic

variegated

aneuploidy

(MVA)

(Matsuura

et

al.,

2000),

schizophrenia (Yurov et al., 2008), autism (Yurov et al., 2007b), ataxiatelangiectesia (AT) (Iourov et al., 2009; Iourov et al., 2009b), and frontotemporal
dementia (FTD) (Granic and Potter, unpublished data; Rossi et al., 2008). All
aforementioned diseases share chromosome mis-segregation and cell cycle
defects as an underlying pathological trait that may be associated with a gene
mutation, environmental insults or gene-phenotype interaction leading to brain
dysfunction and/or neuronal death.

Aneuploidy in Alzheimer’s Disease (AD)
Hypotheses of AD Neuropathology
Alzheimer’s disease is a multifactorial neurodegenerative disorder characterized
by the aberrant accumulation of two misfolded proteins—extracellular amyloid
beta

(Aβ),

a

main

constituent

of

senile

plaques,

and

intracellular

hyperphosphorylated tau protein (p-tau) assembled into neurofibrillary tangles
(NFTs) (reviewed in Selkoe 2004; Querfurth and LaFerla 2011).

Both early

diagnosis and successful treatment of AD will be greatly aided by a complete
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understanding of initiators of pathological processes that lead to formation of
neurotoxic

proteins,

inflammation,

oxidative

damage,

impaired

calcium

homeostasis, and neurodegeneration.
Over the past decades several hypotheses have been developed to
explain complex and heterogeneous nature of AD pathogenesis, which may not
be mutually exclusive. For example, a central hypothesis of AD, the Amyloid
Cascade Hypothesis, postulates that the imbalance between Aβ production,
aggregation and clearance from the brain is the major driver of the disease
process leading to synaptic loss, formation of senile plaques, inflammation,
oxidative stress, neurodegeneration, and dementia (Blennow et al., 2006; Hardy
2006; Potter et al, 2001). A highly neurotoxic isoform of the Aβ protein, Aβ42, is
produced by consecutive action of two cleaving enzymes, β- (BACE-1) and γsecretase, from a larger transmembrane protein, the amyloid precursor protein
(APP) (Haass and Selkoe, 1993; Wolfe, 2003) within cholesterol-rich membrane
domains (Wahrle et al., 2002).

A crucial step in AD pathogenesis is

oligomerization or polymerization of Aβ peptide driven by inflammatory proteins
(Potter et al., 2001; Hardy, 2006), coupled with Aβ-mediated phosphorylation of
tau that causes destabilization of microtubules (Small and Duff, 2008).

In

addition, intracellular Aβ accumulates in diseased neurons and contributes to
disease progression by affecting the function of mitochondria, calcium ion
channels and synapses (La Ferla et al., 2007).

NFTs clustering within the

neurons cause disruption in neuronal signaling, synaptic failure, and impaired
nutrient trafficking through the cell body and axons, and ultimately lead to
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neuronal death (Alonso et al., 2006). Because of their branched cell structure
and large surface, neurons are especially sensitive to depletion of oxygen and
nutrients, and impaired transport of key molecules and organelles essential for
the cell survival and communication (Mattson and Magnus, 2006; Stokin and
Goldstein, 2006).
The Vascular Hypothesis of AD (de la Torre and Mussivand, 1993) posits
that cardiovascular risk factors (CRF) play a substantial role in AD pathogenesis,
especially in the pre-clinical phase, by lowering cerebral blood flow (CBF) to a
critical point where the high metabolic demand of the brain for oxygen, glucose
and other nutrients cannot be sustained, leading to chronic cerebral brain
hypoperfusion (CBH) and a neuronal energy crisis (de la Torre, 2004). Reduced
ATP synthesis and depletion in affected neurons may promote oxidative stress,
dysfunction in ion pumps, neurotransmitter failure, abnormal APP metabolism
and increased production of Aβ, and microtubule damage (reviewed in de la
Torre, 2010).

While CBH can be present in cognitively intact older adults

decades before the appearance of first clinical symptoms and classic AD
markers (Vermeer et al., 2003), a combination of unfavorable vascular factors
(e.g., hypertension, hypercholesterolemia and atherosclerosis) and vascularrelated susceptibility genes (e.g., apolipoprotein (APOE) ε4 allele) can
exacerbate the disturbance in the cerebrovascular environment and weaken
brain hemodynamic function (Bell and Zlokovic, 2009; de la Torre, 2004).
The mechanisms that could lead to impaired cerebral perfusion in AD
include: (1) atherosclerotic changes in small and large vessel walls of both
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central and peripheral vascular systems (e.g., Hofman et al., 1997; Beach, et al.,
2007); (2) anatomical defects and atrophy of cerebral arterioles and capillaries
resulting in reduced microvascular density and injury to brain endothelium
(Farkas and Luiten, 2001; Grammas et al., 2002); (3) microvascular lesions; (4)
loss of cholinergic innervations in brain blood vessels (Farks and Luiten, 2001);
and (5) development of cerebral amyloid angiopathy (CAA) and Aβ deposits in
the smooth muscle cell (SMC) layers of cerebral microartheries (Olichney et al.,
1995), causing damage to the neurovascular unit (NVU) and decreased Aβ
clearance across the blood brain barrier (BBB) (Bell and Zlokovic, 2009). The
NVU at the BBB includes neurons and glia, vascular and perivascular brain cells
(e.g. vascular SMC, endothelial cells and perivascular macrophages), which are
responsible for cerebral homeostasis by regulating blood flow and molecular
exchange across the BBB, and by providing immune surveillance and trophic
support to the brain (Iadecola, 2010).
Both hypotheses try to answer several important questions regarding AD
initiation and treatment: (1) whether vascular or cerebral (i.e., Aβ-related) preclinical pathologies are the early markers of the disease process; (2) which
markers should be targeted therapeutically before progressive clinical symptoms
(i.e., cognitive decline) emerge, and (3) which preventive strategies should be
implemented so that neurovascular integrity and brain health remain at the
optimal level in old age.
The Down Syndrome Model/Chromosome Mis-segregation Hypothesis of
AD (Potter, 1991; 2008) suggests that genomic instability and a slow
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accumulation of aneuploid, including trisomy 21 cells through mitotic defects and
aberrant cell cycle events in peripheral organs and in the brain of an individual
over a lifetime could initiate or promote both familial (FAD; caused by mutations
in presenilin 1 and 2 [PS1 and PS2] and APP genes) and sporadic form of
Alzheimer’s.

The

universal

presence

of

AD-like

pathology

and

neurodegeneration in Down syndrome (Epstein, 1990; Glenner and Wong,
1984), the development of FAD in patients with a duplicated APP region on one
chromosome 21 (McNaughton et al., 2010; Rovelet-Lecrux et al., 2006; Sleegers
et al., 2006), and occurrence of ectopic cell cycle events and chromosome missegregation in the cells and mice expressing FAD genes (e.g., Boeras et al.,
2008; Granic et al., 2010; Nagy et al., 1997; Potter, 2004; Vincent et al., 1996;
Yang et al., 2006), and in fibroblasts, lymphocytes, buccal cells, and neurons of
AD patients (e.g., Arendt et al., 2010; Geller and Potter, 1999; Iourov et al., 2009;
Kingsbury et al., 2006; Migliore et al., 1999; Mosch et al., 2007; Thomas and
Fenech, 2008; Trippi et al., 2001) reinforced the hypothesis that chromosomal
instability and mosaic aneuploidy could be a ‘cytogenetic hallmark’ of AD
neurodegeneration, initiated by either genetic mutations, APP overexpression,
Aβ overproduction or by environmental insults (reviewed in Granic and Potter,
2011). Thus several molecules and processes associated with AD pathology
may act as aneugens and contribute to chromosome mis-segregation and
generation of aneuploid, apoptosis-prone neurons (Busciglio and Yankner, 1997)
and neural progenitors. Increase in surviving hyperploid and hypoploid brain
cells might contribute to other commonly observed features of AD, such as
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overexpression of inflammatory proteins, amyloidogenic processing of APP and
defective microtubule function and protein trafficking between and within the cells
(Potter, 2004).

The Level of Central Aneuploidy in AD
The advancements in DNA technologies and visualization of chromosomal
aberrations in mitotically active and dormant cells allowed for the establishment
of aneuploidy mosaicism in healthy and diseased tissues, including neuronal.
However, the hypothesis of unscheduled cell cycle re-activation in quiescent
neurons under pathological conditions of AD is not novel. Analyzing with the less
refined technique the brain tissue from Alzheimer’s patients, Ramon y Cajal and
Bouman suggested in the early twentieth century that the senile plaques may
arise from hyperproliferation and subsequent degeneration of diseased neurons
that re-enter a de novo cell cycle trying to self-repair (Bouman, 1934; Ramon y
Cajal, 1913). It would take another three-quarter of the century for the evidence
of the ectopic cell cycle events in fully differentiated neurons in AD brains to
emerge (e.g., McShea et al., 1997; Nagy et al., 1997; Vincent et al., 1996; Smith
and Lippa, 1995), which challenged the dogma of their post-mitotic nature.
Several studies have shown that mature neurons are capable of re-entering the
cell cycle in vitro and in vivo, and that, depending on the external cues, they are
either committed to finishing the M phase and divide, or abort the cell cycle via
apoptosis (Howard et al., 1993; reviewed McShea et al., 1999; Yang and Herrup,
2007).
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As discussed above, genomic instability in the normal adult and
developing fetal human brain in the form of mosaic aneuploidy (~10% or 0.5%
per chromosome, and 30-35% or 1.25-1.45% per chromosome, respectively)
with the gains and losses of whole chromosomes is part of neuronal complexity
and diversity (e.g., Iourov et al., 2009; Yurov et al., 2005; 2007; Arendt et al.,
2010), but could also play a pathogenic role if the level of aneuploidy exceeds
the sustainable physiological threshold, and the mechanisms responsible to
correct erroneous cells fail. To date, the evidence drawn from animal models of
AD and autopsy studies of human brains indicates that (1) reactivation of the cell
cycle and DNA duplication (Yang et al., 2001; Zhu et al., 2008) in the vulnerable
population of AD neurons may present a fundamental initiator of AD
pathogenesis (e.g., Heintz, 1993; McShea et al., 1999; Nagy, 2005; Obrenovic et
al., 2003; Varvel et al., 2008; Vincent et al., 1996; Yang et al., 2006) and occur
before fibrilar Aβ deposition and cell death; and (2) AD brains harbor up to 35%
of hyperploid, including trisomy 21 neurons, which are detectable at mild stages
of AD before neuronal loss (Arendt et al., 2010; Iourov et al., 2009). These
cycling or aneuploid mature neurons may arise during prenatal and/or adult
neurogenesis throughout an individual’s lifetime (Eriksson et al., 1998) and may
either die or be functionally active.
The above-mentioned study by Mosch et al. (2007) that used three
independent methods to compare single-cell DNA content in normal and AD
entorhinal cortices immunolabeled with the cell cycle markers, revealed about
20% cyclin B1-positive neurons with hyperploid DNA content (i.e., >2n and <4n),
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and about 12% neurons from early and 13% from advanced AD brains with
trisomy 17 compared to 6% in the age-matched control group. In addition, ~2%
of cyclin B1-positive neurons had tetraploid DNA content (4n karyotype)
compared to ~0.3-0.5% in the controls. The authors concluded that hyperploid
AD neurons undergo an incomplete DNA replication compared to a complete
replication observed in cyclinB1-positve tetraploid cells, and that these cells,
although committed to the cell cycle (i.e., progressing beyond the G1 restriction
checkpoint; Bybee and Thomas, 1991), would rather die than finish the cell
division. The majority of neurons with a more than diploid content which were
elevated in the early-stage of AD by 2-3 folds remained stable through the mildstage, but died off as the patients progressed to more severe dementia,
accounting for about 90% of total cell loss (Arendt et al., 2010). A shift from
physiologically sustainable levels of ~10% of hyperploidy to pathological ~3035% in the preclinical AD might trigger selective clearance of vulnerable,
genetically unstable neurons during AD development and progression. Thus,
mature neurons residing in the brain regions susceptible to AD pathology entered
a lethal cell cycle, but could survive in a hyperploid or diseased state for years or
decades (Morsch et al., 1999; Yang et al., 2001).
A recent study by Iourov et al. (2009) assessed aneuploidy in AD brains
using eight different FISH DNA probes and paints, and observed a 10-fold
increased level of trisomy and monosomy 21 (10.7% versus 1.7% in controls,
95% CI 6.5-14.7%) as the most predominant chromosome mis-segregation
event, and less than 0.04% tetrasomic (i.e., a chromosomal duplication of a
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single chromosome pair) and polyploid (4n) neuronal and glial cells. To date, this
is the latest and the most comprehensive analysis of neural genomic instability in
AD utilizing the FISH assay. Similarly, a study by Westra et al. (2009) that used
a combination of DNA fluorescence-activated cell sorting (FACS), FISH for
chromosomes 4, 6 and 21, and immunolabeling to analyze the level of tetraploidy
(4n karyotype) verses tetrasomy (2n+2) for a specific chromosome in AD and
normal brains determined that tetraploid cell are mostly non-neuronal, do not
occur explicitly in AD, and are present at extremely low level (0.003%).
The discrepancies among the described studies in the level and type of
aneugenesis and genomic instability, and the emphasis on either tetraploidization
(Arendt et al., 2010; Frade and Lόpez-Sánchez, 2010; Mosch et al., 2007; Yang
et al., 2001; Yang and Herrup, 2007) or aneuploidization of the brain cells
(Granic and Potter, 2011; Iourov et al., 2009; Iourov et al., 2011; Potter, 2004;
2008) as an important hallmark of AD pathology could be explained by the
differences in working hypotheses, methodology employed, and definition of
hyperploid state. Nonetheless, the accumulated evidence suggests that elevated
chromosome mis-segregation and aneuploidy in cycling neurons in AD may
represent a critical molecular event contributing to neurodegeneration (Potter,
2004; Arendt et al., 2009; Iourov et al., 2011; Yang and Herrup, 2007; McShea et
al., 1999).
It is generally accepted that (1) cell cycle dysregulation and aberrant cell
cycle re-entry in a subpopulation of susceptible neurons are early events in AD
pathogenesis that can ultimately lead to cell death (cycle-related neuronal death
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[CRND]; reviewed in Fiorelli and Padmanabhan, 2011); (2) how far into the cell
cycle postmitotic AD neurons progress and whether they complete the cell
division after DNA replication is unknown—an authentic mitotic event has yet to
be recorded; and (3) neurons with abnormal DNA content (>2n) are present at an
elevated level in AD brain regions prone to neuropathology and are capable of
surviving throughout early to mid-stage of AD and contributing to the brain
physiology.

The Level of Peripheral Aneuploidy in AD
Early cytogenetic studies have shown an increase in chromosomal abnormalities
in human lymphocytes with advancing age in which sex chromosomes and
chromosomes belonging to E, F and G group (i.e., short submetacentric and very
short acrocentric chromosomes; Robinson, 1960) were more readily lost or
gained than other autosomes (Jacobs et al., 1963; Galloway and Buckton, 1978).
The aging process has been recognized as the strongest risk factor for dementia
and AD; the risk of AD increases exponentially and doubles every 5-6 years after
about age of 60 (Jorm et al., 1987; Kawas et al., 2000; Ziegler-Graham et al.,
2008). The discovery that Down’s syndrome patients who live beyond the 4th
decade of life invariably develop AD-like neuropathology (Glenner and Wong,
1984; Olson and Shaw, 1969; Wisniewski et al., 1988), and the fact that APP
gene resides on chromosome 21 (HSA21) (Goldgaber et al., 1987; Neve et al.,
1988; Tanzi et al., 1987), a small acrocentric chromosome, instigated the
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research on nondisjunction in AD and on the common biological mechanisms
between AD and DS (Potter, 1991; 2008; Geller and Potter, 1999).
Initial cytogenetic studies investigating the rate and type of chromosomal
aberrations in patients with dementia used a classic karyotype analysis and Gbanding on blood cultures, and yielded inconclusive (e.g., Nordensen et al.,
1980) or negative results (e.g., Buckton et al., 1987; Kormann-Bortolotto et al.,
1993; Mark and Brun, 1973; Moorhead and Heyman, 1983) due to a small
sample size and technical limitations of the assay. The advent of FISH (Ried,
1998) allowed for analysis of chromosome mis-segregation in poorly dividing or
non-dividing cells or cells with a low-level aneuploidy such as human
lymphocytes, which in a mosaic living person are subjected to negative selection,
and may be ‘masked’ by diploid cells in the tissue culture and thus may not
represent the accurate level of chromosomal abnormality of an individual
(discussed in Potter, 2004).
Utilizing the advantages of FISH, Geller and Potter (1999) analyzed
primary fibroblasts from AD patients carrying familial mutations in the PS1, PS2
or APP gene and those of sporadic origin, and revealed twice the frequency of
trisomy 21 (~5%) compared to age-matched controls (~2.5%), which was not
associated with the age of the affected individual.

A parallel assessment of

trisomy 18 nondisjunction revealed an increase in aneuploidy, indicating that the
mitotic defects in AD likely affected other chromosomes. Both trisomy 21 and 18
are the most common trisomies in newborns linked to erroneous maternal
meiosis I or II, respectively and to 5-15% of postzygotic (mitotic) nondisjunction
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(reviewed in Nicolaidis and Petersen, 1998). In both trisomies, errors in maternal
meiosis I is associated with reduced genetic recombination between nondisjoined chromosomes and an increased recombination in meiosis II errors
(Lamb et al., 1996). The susceptibility of chiasmata, the points of crossing over
and genetic material exchange between to homologous chromosomes observed
in meiosis, and the fact that HSA21 is the smallest, gene-poor autosome in
humans (Gardiner and Davisson, 2000) might also explain a preferential
occurrence of HSA21 nondisjunction in genetic disorders and in AD.
Thomas and Fenech (2008) used FISH analysis and DNA probes for
chromosome 21 and 17 to compare aneuploidy levels in buccal cells (BC)
collected from young and older healthy adults, DS individuals, and clinically
diagnosed AD patients.

Young controls harbored 5% of trisomy 17 and 21,

whereas older adults had 13.8% trisomy 17 and 9.6% trisomy 21, confirming the
previous results that aneuploidy levels increase with advancing age. There was
a 1.5-fold increase in trisomy 21 and a 1.2-fold increase in trisomy 17 in AD
subjects compared to age-matched cognitively intact older adults. DS individuals
had 16% aneuploidy of chromosome 17 compared to 5% of young controls. The
use of BC in this study has several advantages: they are easy to collect and
share the same origin as a neural tube epithelium from which nervous system is
developed, and thus they may exhibit chromosomal defects similar to the brain
tissues.
Along with the studies described above, separate lines of investigation
provided evidence that other mitotic defects and mitosis-specific proteins may be
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present in the cells of AD patients (reviewed in Potter, 2004). For example, the
mitotic spindles in dividing AD cells exhibited abnormalities and susceptibility to
premature centromere division (PCD) and micronucleation (MN) upon chemically
induced (e.g., colchicines, griseofulvin) microtubule damage (e.g., Fitzgerald et
al., 1975; Spremo-Potparević et al., 2004; Trippi et al., 2001; Potter et al., 1995).
The PCD in which individual sister chromatids are separated by a clear gap and
not connected at the centromeres, has been observed in lymphocytes and
fibroblasts of AD patients and individuals prone to chromosome mis-segregation,
and recently confirmed in neurons of individuals with sporadic AD (SpremoPotparević et al., 2008).
In summary, the universal presence of genomic instability and increased
aneuploidy, including trisomy 21 in peripheral tissues (i.e., blood, skin, and
mucosa) from patients with both familial and sporadic AD indicates that mitotic
defects may not only be associated with FAD mutations but also with exogenous
risk factors, and possibly other susceptibility AD genes.

A larger scale

cytogenetic autopsy and biopsy study employing various FISH techniques at the
single-cell level is needed to establish the type and level of genomic instability in
AD and other neurodegenerative disorders.
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The Evidence for the Down Syndrome/Chromosome Mis-segregation
Hypothesis
Down Syndrome: Consequence of Altered Gene Dosage
As indicated previously, chromosomal instability and the resulting chromosomal
aneuploidy in somatic and germ-line cells have been implicated in the etiology of
genetic diseases and cancers in which the presence or absence of an entire
chromosome(s) alters the expression of the genes and gene products resulting in
a specific, abnormal phenotype (reviewed in Iarmarcovai et al., 2008; Ye et al.,
2007). Down syndrome, a phenotypic result of trisomy 21, is the most common
chromosomal instability in surviving humans.

Triplication of HSA21 is

responsible for about 95% of DS cases (reviewed in Sherman et al., 2005), and
arises as a direct result of meiotic error mostly of maternal origin (Ghosh et al.,
2008; Nicolaidis and Petersen, 1998; Warburton, 2005). The remaining cases
are due to mosaicism or translocations of parts of chromosome 21 with a heteroor homologous acrocentric chromosome (i.e., 13, 14, 15, 22) (Kim and Sheffer,
2002), and are usually associated with a less prominent DS phenotype (Devlin
and Morrison, 2004a). Overexpression of the critical genes in DS within the
Down syndrome critical region (DSCR; 21q22; Korenberg et al., 1990) has been
associated with several DS phenotypes, and instituted the research on genotypephenotype relationship. Besides intellectual disability, DS individuals share over
80 clinical traits including congenital heart disease, muscle hypotonia, leukemia,
deficits in vision and hearing, seizures, immune system deficiency, accelerated
aging and neurodegeneration of the Alzheimer’s type (Epstein, 1990;
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Antonarakis and Epstein, 2004; Patterson, 2009). There are two hypotheses that
explain the relationship between the DS specific phenotype and triplication of
HSA21.

Certain gene combinations might predispose DS individuals to a

disease (e.g., Alzheimer’s) while other gene groupings might be protective (e.g.,
lower incidence of atherosclerosis and solid tumors; Draheim et al., 2010; Hasle
et al., 2000) because of (1) gene dosage imbalance (Korenberg et al., 1990) or
(2) increased gene expression and altered genetic homeostasis (Shapiro, 1983).
For example, overexpression of APP gene may reflect the increased gene
dosage of 50% leading to overproduction of Aβ, increased ratio of more
amyloidogenic Aβ42 over Aβ40 (Teller et al., 1996) and neurodegeneration.

Trisomy 21: Links between DS and AD
Epidemiological evidence suggesting that chromosome mis-segregation and
trisomy 21 mosaicism might be associated with AD pathogenesis originated from
studies showing a significantly higher frequency of DS children in some families
with familial AD (Heston et al., 1981; Heyman et al., 1983). Another important
result that provided support for the Trisomy 21 Model of AD came from a
retrospective study of young mothers (aged <35) of Down syndrome children
who showed a 5-fold increased risk of developing AD later in life compared to
either older DS mothers or the general population (Schupf et al., 1994; 2001). In
the vein of the Trisomy 21 Model of AD, it could be postulated that the young DS
mothers most likely had HSA21 mosaicism and were predisposed for genomic
instability, which resulted in DS offspring and their own increased risk of AD later
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in life.

Recently, Migliore et al. (2006; 2009) confirmed the susceptibility to

aneuploidy and trisomy 21 nondisjunction in young mothers of DS children.
Furthermore, case studies of patients with HSA21 mosaicism and no mental
impairments of the DS type who developed AD by the age of 40, strongly
suggest that a small percentage of chromosomal instability sufficed to result in
early-onset AD (e.g., Ringman et al. 2008; Schapiro et al., 1989).
Therefore, a slow accumulation of a low number of trisomy 21 and other
aneuploid cells over the course of life may initiate and/or contribute to the
pathogenesis of both genetic and sporadic form of AD. Furthermore, a dose
response effect could be suggested in which full trisomy 21 in DS individuals
produces AD-like pathology by age 20 and by middle age in familial AD and even
later in sporadic Alzheimer’s patients, who also belonged to the trisomy 21
mosaic group with an increased frequency of DS children before the age of 35.
The recent discovery that an extra copy of APP gene on one HSA21 is sufficient
to cause early-onset AD (McNaughton et al., 2010; Rovelet-Lecrux et al., 2006;
Sleegers et al., 2006) suggests that APP overexpression and consequent
overproduction of Aβ peptide is the likely cause of AD in both DS and trisomy 21
mosaic individuals.

Experimental

Evidence

for

DS

Model/Chromosome

Mis-segregation

Hypothesis
Several predictions under the Down Syndrome Model/Chromosome Missegregation Hypothesis have been tested so far in the laboratory of Dr.
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Huntington Potter and others: (1) AD patient should harbor mis-segregated,
including trisomy 21 cells which could contribute to dementia onset and
neurodegeneration but at slower pace than in DS due to modulating effect of
normal cells in the body; (2) FAD mutations should occur in genes directly or
indirectly involved mitosis; and (3) AD cells should exhibit defect in microtubules,
mitotic spindle and mitosis-related proteins that could lead to aneuploidy and
trisomy 21 mosaicism.
As mentioned previously, the cytogenetic studies confirmed the first
prediction: the cells and tissues obtained from both familial and sporadic AD
patients are mosaic for several chromosomes, including HSA21.
Over the past two decades the lab of H. Potter investigated the role of
mutant PS1, PS2 and APP genes and their proteolytic product, the Aβ peptide in
the cell cycle, chromosome mis-segregation and induction of HSA21 aneuploidy.
All assays, tissues and cells from FAD transgenic mice and cells harboring FAD
genes or treated with Aβ peptide yielded comparable results: overexpression of
presenilin or APP in vivo and in vitro or exposure to Aβ peptide induced genomic
instability and trisomy 21 mosaicism through several defects in mitotic spindle,
dysfunction of microtubules and inhibition of mitotic motors (Boeras et al., 2008;
Borysov et al., 2011; Granic et al., 2010; Potter et al., 2008).
Additional experimental and epidemiological evidence has also suggested
the involvement of presenilins and APP in mitosis: (1) PS1/2 proteins localized to
the centromeres and nuclear envelope in dividing cells, and the kinetochores
during interphase (Li et al., 1997; Honda et al.,2000); (2) the PS1 gene inhibited
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the cell cycle (Janicki and Montero, 1999) and induced apoptosis in the cultured
cells (Wolozin et al., 1996); (3) APP was found to get increasingly
phosphorylated (Judge et al., 2011) and to localize to the centrosomes and
nuclear membrane during mitosis (Nizzari et al., 2007; Zitnik et al., 2006); and (4)
polymorphisms in the PS1 gene have been associated with an increased risk of
AD (e.g., Wragg et al., 1996; Higuchi et al., 1996) and with an increase of DS
offspring via a meiosis II defect (Lucarelli et al., 2004; Petersen et al., 2000) .
The possible mechanisms by which PS and APP mutations may induce
chromosome mis-segregation involves their inability to properly link the
chromosomes to the nuclear envelope and to release them at the appropriate
time during mitosis, which may lead to chromosome mis-segregation and other
cell cycle defects. Another possibility links PS1/PS2 and APP to the increased
production of neurotoxic Aβ42 as a likely effector molecule responsible for the
cell cycle dysfunction, including mitotic spindle abnormalities and chromosome
mis-segregation (Boeras et al., 2008; Borysov et al., 2011, Granic et al., 2010).
To determine whether genomic instability observed in fibroblasts and
lymphocytes from FAD and sporadic individuals could be mimicked in peripheral
and brain tissues of AD mice, we investigated the level of total and chromosomespecific aneuploidy in animals carrying PS1 and APP mutations. For instance,
quantitative FISH analysis with a mouse chromosome 16 BAC probe (Kulnane et
al., 2002) of neurons isolated from APP-V177F mutant mice showed about 6.5%
of trisomy 16 compared to 1.5% in nontransgenic littermates (Figure 4; Granic et
al., 2010). Similar levels of aneuploidy were observed in lymphocytes and brains
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Figure 4. Induction of Trisomy 16 in Neurons of APP-V177F Mice
(A-B) Quantitative FISH analysis with a mouse chromosome 16 BAC probe (orange) revealed significantly
higher levels of trisomy 16 NeuN-positive (green, neurons) cells in transgenic mice compared to controls but
no induction of tetrasomy in whole brain single-cell suspension (D).
(C) No induction of trisomy 16 was observed in NeuN-negative cell.
“Reprinted from Antoneta Granic, Jaya Padmanabhan, Michelle Norden, and Huntington Potter, “Alzheimer
Aβ Peptide Induces Chromosome Mis-Segregation and Aneuploidy, Including Trisomy 21: Requirement for
Tau and APP”, Molecular Biology of the Cell, Vol. 21, 511-520, February 15, 2010 with the permission of
The American Society for Cell Biology.”

of animals carrying either a mutant PS1 or APP human gene or in mutant PS1
knock in mice (Boeras et al., 2008; Granic et al., 2010).
To investigate whether FAD mutations or some other factors were
responsible for the chromosomal instability observed in mouse models of AD,
parallel cultures of human cells with a stable karyotype were transiently
transfected with plasmids carrying either PS1 or APP mutant genes (e.g., M146L
or Swedish mutation [K595N/M596L], respectively).

Overexpression of these

genes induced about 2-3% of trisomy 21 and/or trisomy 12, and up to 30% of
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total aneuploidy in metaphase cells (Granic et al., 2010; Boeras et al., 2008),
indicating that an aneugenic effect of FAD mutations likely affected all
chromosomes, and that chromosome mis-segregation was not restricted only to
transfected cells. We hypothesized that Aβ peptide itself found at increased
levels in both familial and sporadic AD might be the effector molecule interfering
with

the

cell

cycle

and

chromosome

segregation

(Potter,

2008).

Immunocytochemistry of PS1-expressing cells revealed several abnormalities in
the mitotic spindles, with disarrayed microtubules, multiple centrosomes and
lagging chromosomes as the most frequent spindle errors (Boeras et al., 2008).
Following the initial observation that more cells became aneuploid than
transfected, we examined the aneugenic effect of Aβ42 peptide in vitro. Human
epithelial cells treated with 1µM Aβ40 and Aβ42 for 48 hr develop more than 20%
total aneuploidy and 2% of trisomy 21 and 12 compared to 6% total and less than
1% chromosome 21 aneuploidy, respectively in the cells treated with various
control peptides (e.g., Aβ42-1) (Figure 5, Granic et al., 2010).
Further in vitro studies investigated the mechanism(s) by which Aβ exerts
its aneugenic activity on dividing cells, especially those related to microtubule
function, mitotic spindle integrity and tau. It has been shown that Aβ requires
downstream changes in tau protein and in microtubules to exert its toxic effect on
neurons—Aβ induces tau phosphorylation (Small and Duff, 2008) and Aβ
neurotoxicity depends on the presence of tau (Rappaport et al., 2002). Our data
indicated that (1) mouse splenocytes lacking one or both Tau genes developed
up to 5% aneuploidy; (2) Aβ aneugenic activity depended on tau, suggesting that
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Figure 5. Aβ Peptides-induced Trisomy 21 and 12 In Vitro
(A-C) Quantitative FISH analysis with a dual color probe (Abbott, Vysis) showed an increase in trisomy 21
(SpectrumOrange) and trisomy 12 (SpectrumGreen) in Aβ-treated cells. Adapted and used with permission
from Granic et al., 2010, Molecular Biology of the Cell, The American Society for Cell Biology.

the peptide interfered with the tau’s normal MT-stabilizing function; (3) Aβ
induced similar mitotic spindle defects observed in the cell expressing PS1
mutations, and inhibited three motor kinesins, the Eg5, KIF4A, and MCAK,
required for proper spindle formation and chromosome mis-segregation (Borysov
et al., 2011), and (4) a functional APP gene was necessary for aneugenic effect
of Aβ.

Additionally, we determined that chelation of extracellular Ca2+ with

BAPTA and thus inhibition of, for example, calpain, and inactivation of GSK-3β
by LiCl, reduced Aβ-induced aneuploidy. Previous studies have shown that both
BAPTA and LiCl inhibit Aβ toxicity (Sofola et al., 2010; Kuwako et al., 2002).
Future studies will determine if the interference with microtubule function
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by Aβ contributes to defective neuronal plasticity, neurotoxicity, as well as
impaired neurogenesis and generation of aneuploid neurons prone to Aβ
overproduction and neurodegeneration.

Chromosomal instability, including

trisomy 21 may be a cause and an effect of Aβ-induced microtubule dysfunction
creating a feed-forward loop that stimulates AD progression.

Aneuploidy in Other Neurodegenerative Diseases

Ataxia-telangiectasia (AT) and frontotemporal dementia (FTD) are examples of
neurodegenerative diseases in which mutations in genes involved in mitosis and
the cell cycle regulation may be associated with chromosomal instability and
neuronal death.
AT is an autosomal recessive genetic disorder caused by mutation in a
single gene, the ‘ataxia telangiectasia mutant’ (ATM) which encodes the ATM
protein, a kinase responsible for the G1 cell cycle checkpoint, maintenance of
genomic integrity and elimination of cells with damaged DNA (Abraham, 2001;
McKinnon, 2004; Shiloh, 2003). This single point mutation leads to a wide range
of

defects

including

neurodegeneration,

cognitive

impairment,

immune

dysfunction and high susceptibility to malignant tumors (McKinnon, 2004).
Because of the loss of function in ATM, one of the main pathological hallmark of
the disease is a significant increase in aneuploid cells, including neuronal cells
early in disease progression both in murine models of AT ( ~38%; McConnell et
al., 2004) and in humans (2-3 fold increase over normal human brain; Iourov et
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al., 2009). The data suggest that absence of ATM results in failed clearance of
mis-segregated cells, which in turn instigates increased incident of lymphatic
tumors, immunodeficiency because of accumulated oncogenic T and B cells, and
defective neurogenesis and progressive neurodegeneration (Iourov et al.,
2009b).
A recent study by Rossi et al. (2008) proposed another function for the
protein tau—protection of genomic stability and chromosomal integrity.
Cytogenetic analysis of lymphocytes and skin fibroblasts from individuals
harboring a P301L mutation in Tau gene showed several chromosomal
instabilities compared to non-demented controls (e.g., aneuploidy, chromosome
and chromatid breaks, translocations and de-condensed chromosomes). In the
Potter laboratory, we have been investigating the role of microtubule defects in
AD and FTD by determining the level of MT-based transport deficiency in mouse
models of FTD and human brains evidenced by aneuploidy and reduced
expression of neurotransmitters and neurotrophin receptors. Preliminary data
indicate an increased induction of trisomy 21 in human brains with FTD, and
elevated levels of trisomy 16 in spleens and brains of mice harboring P301S
mutation compared to non-transgenic controls.

GENOMIC INSTABILITY IN CARDIOVASCULAR DISEASE

Atherosclerosis is a leading cause of death in developed countries and a major
component

of

cardiovascular

disease
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(CVD).

The

pathogenesis

of

atherosclerosis is complex and involves multiple factors. It has been generally
accepted that three dominant pathways are implicated in atherogenesis:
disturbed cholesterol homeostasis, inflammatory response, and oxidative
damage.

Therefore, atherosclerosis has been described as an inflammatory

disorder that is induced and progresses within a high cholesterol environment
(Steinberg, 2002).

As with AD, several hypotheses have been proposed to

elucidate the initiating agent or process responsible for atherogenesis.
The Response to Injury Hypothesis postulates a tear in the endothelial
lining of an artery caused by e.g., mechanical injury or oxidized low density
lipoprotein (OX-LDL) (Ross, 1993; Carmena et al., 2004) as a first atherogenic
step followed by overexpression of adhesion molecules, infiltration of
inflammatory cells, an excessive migration and proliferation of smooth muscle
cells, accumulation of cholesterol, fats, and cellular debris, and consequent
plaque formation and calcification (Ross, 1993; Libby et al., 2002; Steinberg,
2002).
The Monoclonal Proliferation Theory posits a monoclonal expansion of
SMC and chromosomal instability as an initiating mechanism for the
development of atherosclerosis, similar to the development of aneuploid, benign
tumors (Benditt and Benditt, 1975; Casalone et al., 1991; Fernandez et al., 2000;
Lavezzi et al., 2005; Matturi et al. 1997; 2001; Murry et al., 1997; Vanni and
Licheri, 1991). Cytogenetic analysis of unstable atherosclerotic plaques revealed
clonal proliferation of SMC in artery intima and the presence of several
chromosomal instabilities, including trisomy and tetrasomy 7, trisomy 10, 18, and
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20, monosomy 11, and loss of Y, suggesting the involvement of genomic
alternations in atherosclerotic process.

THEORETICAL FRAMEWORK

Discovering the genetic origin of Aβ (Glenner and Wong, 1984) and the mapping
of the APP on chromosome 21 (e.g., Goldgaber et al., 1987), allowed for new
insights into pathogenic pathways of AD, and for the establishment of a unique
link between genomic instability in DS and Alzheimer’s (Potter, 1991).
Constitutive trisomy 21 has been associated with intellectual impairment, and
development of Alzheimer’s like neuropathology by the 4th decade of life
(Epstein, 1990). Overexpression of APP due to altered gene dosage, may lead
to overproduction of Aβ and neurodegeneration (Head and Lott, 2004). Similarly,
accumulated trisomy 21 and other aneuploid cells in AD patients both in the brain
(e.g., Arendt et al., 2010; Mosch et al., 2007; Iourov et al., 2009) and peripheral
tissues (Geller and Potter, 1999; Migliore et al., 1999; Thomas and Fenech,
2008) over the course of life may present an initiating event in AD pathogenesis
and/or promote neurodegeneration (Potter, 2008). Likewise, the evidence from
animal models of AD and autopsy studies of human brains suggests that
reactivation of the cell cycle and DNA duplication (e.g., Yang et al., 2001) in the
vulnerable population of AD neurons may present an important initiator of AD
(Nagy, 2005; Vincent et al., 1996; Varvel et al., 2008; Yang and Herrup, 2007;
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Yang et al., 2006) present before Aβ deposition and neuronal death, and could
also lead to chromosome mis-segregation and aneuploidy.
A

unifying

hypothesis

for

Alzheimer’s

and

Down

syndrome

neurodegeneration has been proposed (Potter, 1991)—development of a mosaic
population of aneuploid, including trisomy 21, cells and alternation in genomic
homeostasis may lead to classic AD neuropathology observed in both diseases.
The Trisomy 21 Hypothesis of familial and sporadic AD posits that slow
development and accumulation of a small number of trisomy 21 cells over a
lifetime could cause or help promote neurodegeneration (Potter, 1991; 2004;
2008). Trisomy 21 mosaicism could be the first step in AD pathogenesis, and
might lead to: (1) neurodegeneration and apoptosis; (2) higher expression of a
neurotoxic version of Aβ peptide; (3) induction of an inflammatory cascade; and
(4) defects in microtubule function and protein trafficking between and within the
neurons (Potter, 2008).
Genomic imbalance has been observed in other diseases of the brain
such as ataxia telangiectasia (Iourov et al., 2009; 2009b), schizophrenia (Yurov
et al., 2008), autism (Yurov et al., 2007b), and it has been recently implicated as
an early event in frontal temporal dementia (FTD) (Rossi et al., 2008). Taken
together, chromosome mis-segregation and aneuploidy in human brain may not
only represent neural complexity, cellular diversity, and a universal genetic state
of the human mind, but a mechanism for neurodegeneration if the level of
imbalance reaches a pathogenic threshold.
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Figure 6. Genomic Instability in AD and CVD as a Common Pathogenic Trait
High cholesterol as a common risk factor for AD and CVD (atherosclerosis) may initiate aneugenesis and
contribute to development of both diseases.

Cytogenetic analysis by FISH of the chromosome complement in
atherosclerotic plaques showed clonal expansion of aneuploid smooth muscle
cells in artery intima, with trisomy 7 and monosomy 11 as the most predominant
chromosomal instability (Matturri et al., 1997; 2001). Thus, the development of
atherosclerotic lesions may be initiated or promoted by clonal expansion of
aneuploid smooth muscle cells.
In line with the Down Syndrome/ Chromosome Mis-segregation
Hypothesis of AD and the Monoclonal Proliferation Theory of Atherosclerosis, it
could be inferred that elevated blood cholesterol lipoproteins, common risk
factors for AD and atherosclerosis, may act as atherogenic and aneugenic
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agents, and that AD and CVD (atherosclerosis) may share chromosomal
instability and development of aneuploidy as a unique cytogenetic and
pathogenic trait (Figure 6).
Therefore, the purpose of this dissertation was to investigate whether
disrupted cholesterol homeostasis (e.g., elevated lipoproteins/cholesterol and
modified intracellular cholesterol distribution) may contribute to genomic
instability observed in AD and CVD using in vitro and in vivo models.
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CHAPTER TWO
BIOLOGICAL LINKS BETWEEN AD AND CVD

Brain aging is characterized by the gradual and progressive biochemical and
physiological changes in the structure and function of brain cells, its subcellular
components, molecules and brain vasculature responsible for its optimal
functioning and integrity (Shankar, 2010). For example, alternation in dynamic
communication between the cells of the neurovascular unit at the BBB may lead
to decreased cerebral blood flow, impaired clearance of neurotoxic proteins, and
increased brain vulnerability to the changes and insults from peripheral systems
(Zlokovic, 2008; Iadecola, 2010). Furthermore, abnormal metabolism of the key
brain molecules like cholesterol and lipoproteins may promote several
pathophysiological processes observed in age-associated brain disorders such
as Alzheimer’s (e.g., reviewed in Canevari and Clark, 2007; Liu et al., 2010;
Panza et al., 2009; Pfrieger, 2003; Poirier et al., 2003; Wolozin, 2004).
Accumulated evidence from epidemiology, genetics, pharmacology, and
molecular, cell, and animal biology indicates that disturbance in central and
peripheral cholesterol homeostasis may play a role in AD initiation and
progression (Hartmann et al., 2007; Puglielli et al., 2003; Shobab et al., 2005;
Wellington et al., 2004). For instance, in line with the Vascular Hypothesis of AD
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(de la Torre, 2004), epidemiological studies propose a link between AD,
cardiovascular risk factors (e.g., high plasma cholesterol) and cardiovascular
disease (CVD) (e.g., atherosclerosis and coronary heart disease) (e.g., Alonso et
al. 2009; Anstey et al., 2008; Casserley and Topol, 2004; Dolan et al. 2010;
Hofman et al., 1997; Laitinen et al., 2006; Li et al., 2005; Kivipelto et al., 2001;
Solfrizzi et al., 2004; Solomon et al., 2007; 2008; Sparks et al., 1990; van Oijen
et al., 2007). Cerebral hypoperfusion and compromised neurovascular unit early
in pathology of AD may lead to decreased clearance of Aβ and cerebral amyloid
angiopathy (CAA), impaired cholesterol efflux across the BBB and atherosclerotic
buildup in cerebral blood vessels (Bell and Zlokovic, 2009; Iadecola, 2010). The
presence and severity of atherosclerotic lesions in systemic and intracranial
vasculature correlates with the extent of AD pathology (Beach et al., 2007;
Casserley and Topol, 2004; Honig et al., 2005; Li et al., 2003; Sparks et al.,
1997). Additionally, genetic and molecular studies identified ApoE as a major
cholesterol transporter in the brain (Mahley, 1988) that serves as a ligand for the
low density lipoprotein receptor (LDLR) family in neurons and glia, coordinating
cholesterol intake and distribution (Andersen and Willow, 2006; Brown and
Goldstein, 1976; 1986; May et al., 2007; Poirier, 2003). Likewise, the inheritance
of the ApoE ε4 allele has been recognized as the strongest genetic risk factor for
sporadic AD (Roses, 1996; Strittmatter et al., 1993a). ApoE, particularly apoE4
directly interacts with Aβ and catalyzes its polymerization into neurotoxic
assemblies (Ma et al., 1994; Wisniewski et al., 1994; Potter et al., 2001). Results
from several observational studies have also shown a reduced incidence of AD in
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older adults taking both lipophilic or lipophobic statins (e.g., Fassbender et al.,
2001; Jick et al., 2000; Wolozin et al., 2000; reviewed in Kandiah and Feldman,
2009; Wolozin, 2004b).
In line with the Amyloid Cascade Hypothesis (reviewed in Hardy, 2006), a
number of cellular and animal studies have indicated a reciprocal relationship
between cholesterol levels and APP processing and Aβ production.

The

evidence includes the following: (1) cholesterol depletion or inhibition reduces
cellular amyloid load and aggregation in vitro and in vivo (Fassbender et al.,
2001; Refolo et al., 2001; Schneider et al., 2006; Simons et al., 1998); (2) plasma
membrane cholesterol levels correlate with, and presumably influence the activity
and expression of APP secretases involved in Aβ generation (Bodovitz and Klein,
1996; Ehehalt et al., 2003; Kojro et al., 2001; Xiong et al., 2009); (3) APP
processing, γ-secretase and Aβ regulate cholesterol and other lipids (reviewed in
Grösgen et al., 2010); (4) Aβ aggregates preferentially bind to cholesterol
(Adulov et al., 1997; reviewed in Beel et al., 2010) and cause accumulation of
cholesterol in senile plaques and neuronal terminals in cortex and hippocampus
of human and mouse AD brains (Gylys et al., 2007; Mori et al., 2001; Panchal et
al., 2010); and (5) animals, especially FAD transgenic mice, fed a high
cholesterol diet increase Aβ production and develop greater amyloid burden,
possibly by increasing the expression of ApoE to accommodate the extra
cholesterol, and thus further catalyzing Aβ polymerization (Hooijmans et al.,
2007; Levin-Allerhand et al., 2002; Oksman et al., 2006; Refolo et al., 2001; Shie
et al., 2002; Sparks et al., 1994). Also, modification of membrane cholesterol
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content and accumulation of lipids in cytosolic compartments, and deregulation of
brain cholesterol metabolism has been implicated in other neurodegenerative
disorders such as Niemann-Pick, Huntington’s and Parkinson’s disease
(reviewed in Liu et al., 2009; Pfrieger, 2003).
Despite the plethora of aforementioned evidence that points to an intrinsic
role of cholesterol and CVD (atherosclerosis) in the etiology of AD, the nature of
the mechanistic connection between them is not completely explained, and
warrants further investigation.

This dissertation sought to explore a novel

pathological trait that may underlie both AD and CVD—chromosome missegregation and development of aneuploidy in which high cholesterol may act as
an environmental aneugen. To our knowledge, this would be the first study to
investigate the effect of elevated lipoproteins/cholesterol on chromosomal
integrity and the relevance thereof for AD and CVD.
The first part of this chapter will define the general hypothesis and three
specific research questions under the study, and the second part will focus on
underlying scientific background relevant for each by delineating some important
aspects of peripheral and central cholesterol homeostasis, and its role in AD
pathology, neurodegeneration and atherosclerosis.
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GENERAL HYPOTHESIS AND RESEARCH QUESTIONS

This dissertation sought to investigate the general hypothesis that disturbed
cholesterol homeostasis may lead to chromosome mis-segregation in vitro
and in vivo and therefore contribute to genomic instability observed in AD
and CVD.

Under this hypothesis, three specific research questions were

examined (Figure 7):
(1) Do elevated lipoproteins (i.e., oxidized low density lipoprotein [OXLDL], low density [LDL], and high density lipoprotein [HDL]) and
cholesterol induce chromosome mis-segregation and aneuploidy through
LDL receptor or APP-mediated pathways, and whether there is an
association between altered intracellular cholesterol distribution and
mitotic defects in vitro?
(2) Does peripheral hypercholesterolemia in nontransgenic mice fed a
high cholesterol diet affect chromosomal integrity in visceral and brain
cells?
(3) Is there a mechanistic link between calcium homeostasis (Mechanism
I)

and

membrane

dynamics

(i.e.,

fluidity)

(Mechanism

lipoproteins/cholesterol-induced cell cycle defects in vitro?
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II)

and

Figure 7. Research Questions under the General Hypothesis
Disturbed cholesterol homeostasis may lead to chromosome mis-segregation and aneuploidy in vitro and in
vivo, and this biological effect may initiate or contribute to AD pathogenesis similar to the development of
cell cycle defects observed in cellular, mouse models of AD and patients with dementia (path 1). Under the
general hypothesis, this dissertation investigated following research questions (path 1 and 2): Do elevated
lipids (in vitro and in vivo) and modifications in intracellular cholesterol lead to aneugenesis, and is this
biological process LDLR-mediated or independent of cholesterol-APP/Aβ interaction (referenced above); Is
there a mechanistic link between calcium homeostasis or plasma membrane dynamics and lipids-induced
mitotic defects?

CHOLESTEROL HOMEOSTASIS AND AD

Since its isolation from gallstones in late 18th century, cholesterol’s biosynthesis,
molecular structure and metabolism as well as its role in pathogenesis of
cardiovascular, brain and several genetic diseases has been extensively
investigated. Cholesterol is a molecule essential for life, yet excess or deficiency
and erroneous compartmentalization of cholesterol within the cells and body
organs can be detrimental. For instance, cholesterol is a main component of
eukaryotic cell membranes (Bloch, 1991) where it regulates membrane fluidity,
permeability and integrity, affects functioning of membrane-bound or membraneassociated proteins, and facilitates transmembrane signal transduction (reviewed
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in Maxfield and Tabas, 2005). In the brain, among other functions, cholesterol is
required for neurite formation, synaptogenesis, microtubule stability, and
myelination of axons (Björkhem and Meaney, 2004; Koudinov and Koudinova,
2001; Pfrieger, 2003). Excess of cholesterol and otherwise disturbed cholesterol
homeostasis has been implicated in the pathogenesis of several vascular,
metabolic, hepatic and brain disorders.
A renewed interest in the role of high blood cholesterol and CVD in
etiology of AD was spurred by several important discoveries, the main being the
identification of ApoE as key cholesterol transporter in the brain (e.g., Brown and
Goldstein, 1986), and the APOE ε4 allele as the strongest risk factor for sporadic
AD (e.g., Strittmatter et al., 1993a). Additionally, two groundbreaking studies by
Sparks and colleagues reported abundant amyloid plaque deposits in 75% of the
brains of cognitively intact older adults who died from coronary artery disease
(CAD) compared to 12% of control brains of individuals with a healthy heart
(Sparks et al., 1990), and an increase in Aβ immunoreactivity in the brains of
rabbits fed a high cholesterol diet (Sparks et al., 1994). A decreased prevalence
of AD was also shown in older adults using statins (Wolozin et al., 2000), and
reduced Aβ42 and Aβ40 production in neuronal culture and in a guinea pig
model treated with lovastatin and simvastatin (Fassbender et al., 2001). Despite
the sound criticisms of the Amyloid Cascade Hypothesis which emphasized the
inability to demonstrate causality (Neve and Robakis, 1998; Joseph et al., 2001),
and provide effective treatments (de la Torre, 2004), a body of research that
followed concentrated on the relationship between peripheral and central
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cholesterol

homeostasis

and

APP

processing/Aβ

production,

and

the

involvement of the genes associated with cholesterol metabolism in susceptibility
to AD (reviewed in Sagin and Sozmen, 2008). In parallel, increasing evidence
supporting a vascular etiology in AD (de la Torre, 2004) suggested the
involvement of other APP-independent pathways in disease initiation and
progression. However, the complete understanding of biological mechanism in
which combined influence of plasma cholesterol, related lipoproteins, protein
carriers (e.g., ApoE), brain hypoperfusion, cerebrovascular Aβ and the brain
cholesterol homeostasis contribute to neuropathology and cognitive dysfunction
is yet to be attained.

Cholesterol Metabolism, Function and Organization

Cholesterol homeostasis is a tightly regulated process that involves cholesterol
synthesis, transport, storage and removal. In periphery, cholesterol originates
from two sources: de novo synthesis in the liver and intestine and from diet. The
liver releases cholesterol into the circulation mainly in esterified form (i.e.,
cholesteryl esters) bound to ApoB, within LDL which is then taken up by
peripheral cells via receptor-mediated (e.g., LDL receptor family) endocytosis. In
endosomal and lysosomal compartments, internalized cholesterol is rapidly freed
from the lipoprotein particles and recycled back to the plasma membrane through
either the endoplasmic reticulum (ER) or Golgi network (reviewed in Maxfield and
van Meer, 2010; Soccio and Breslow, 2004). The studies of Niemann-Pick
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disease type C (NPC), which is characterized by abnormal accumulation of
cholesterol and other lipids in late endosomes and lysosomes have shown that
two proteins, the NPC1 and NPC2 are responsible for cholesterol egress from
these organelles to the ER (Karten et al., 2009; Mukherjee and Maxfield, 1999;
2004). Deletion or mutations in either of these two non-homologous genes leads
to altered trafficking of endogenous or LDL-derived cholesterol and its
sequestration into cytoplasmic organelles. Because of the delayed movement of
internalized LDL-cholesterol to the ER and back to plasma membrane, the
production of the endogenous cholesterol and LDL receptor is increased
(Wojtanik and Liscum, 2003).
The ER is the major regulatory site of cellular cholesterol homeostasis.
Cholesterol biosynthesis requires more than 20 steps for which the key enzymes
are localized in the ER, including the 3-hydroxy-3-methylglutaryl-CoA (HMGCoA) reductase, a rate-limiting enzyme and target of statins. An elaborate sterolsensing mechanism (e.g., SREBP, the sterol regulated element binding protein
and SCRAP, SREBP-cleavage activating protein; and INSIG) controls the
cholesterol synthesis and expression of lipoprotein receptors (e.g., LDLR) based
on the change in intracellular cholesterol levels. The surplus of cholesterol is
esterified in the ER by the Acyl-CoA acyltransferase (ACAT) and deposited in the
cytoplasm as lipid droplets or transported via nonvesicular pathways from the ER
to the plasma membrane through the ATP-binding cassette transporter family
(ABC) located at the membrane surface. Cholesterol efflux from the intra- to
extracellular pools is achieved via HDL that serves as extracellular cholesterol
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acceptor (with ApoA-I as a major apoprotein) taking cholesterol back to liver,
where it is excreted in the form of bile salts.

Furthermore, unesterified

cholesterol can be converted into oxysterols by cholesterol-metabolizing
enzymes localized in the ER such as cholesterol 7α-hydroxylase (CYP7A) and
cholesterol 24-hydroxylase (CYP46) and excreted from the cell via the ABCtransporters. Oxysterols also serve as ligands for the liver X receptor (LXR)
which in turn regulates the genes for APOE and ABC (reviewed in Huttunen and
Kovacs, 2007; summarized in Figure 8).

Figure 8. Elements of Cholesterol Homeostasis
Cholesterol homeostasis which includes cholesterol influx from the periphery, synthesis in the ER, storage
(esterification), trafficking to the plasma membrane and efflux (hydroxylation and export to extracellular
acceptors) is a tightly regulated process not fully explained. Several key proteins associated with the
endoplasmic reticulum regulate intracellular cholesterol levels. Plasma membrane is enriched with
cholesterol compartmentalized into lipid rafts, where APP and amyloidogenic APP-processing enzymes, βand γ-secretases reside. Schematic diagram was adapted from Martins, et al. (2006), Mol. Psychiatry.
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Thus, the ER as the central cholesterol sensing site regulates cholesterol
synthesis, esterification into lipid bodies, trafficking to intracellular and plasma
membranes and catabolism into oxysterols for excretion.
Cholesterol

distribution

between

the

organelles

and

intracellular

membranes is heterogeneous, the highest being in the plasma membrane (~40%
of lipid molecules; Maxfield and Wustner, 2002)—mostly packed into lipid raft
microdomains (Brown and London, 2000; Crane and Tamm, 2004; Simons and
Toomre, 2000), and the lowest in the ER (~1% of total cell cholesterol; Lange,
1991). Endocytic organelles and Golgi complex are also enriched in cholesterol
(Hao et al., 2002), but how this asymmetric compartmentalization is achieved,
and the mechanisms of cholesterol transport and movement within the cells is
not completely revealed (reviewed in Ikonen, 2008; Prinz, 2007). It is widely
accepted that cholesterol content and organization within the membrane affects
many cellular functions such as signal transduction and membrane trafficking
(Maxfield and Tabas, 2005). Cholesterol interacts with other membrane lipids
and proteins, and because of its biophysical properties (e.g., rigid ring structure),
it preferentially associates with hydrocarbon chains of saturated lipids causing
increased lateral ordering and decreased membrane fluidity (Demel and De
Kruyff, 1976; Mukherjee and Maxfield, 2004; Simons and Vaz, 2004). According
to the ‘fluid mosaic model’ of the plasma membrane, membrane lipids and
proteins are organized into bilayer leaflets (Ikonen, 2008) in either highly-ordered
(gel-like), liquid-ordered, or liquid-disordered (the most fluid) phases, which often
coexist with different types of microdomains. For example, the disordered lipid
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phases are characterized by poorly-organized and loosely-packed acyl chains,
which allow for easy diffusion of water and other molecules into the bilayer
structure (Mukherjee and Maxfield, 2004; Simons and Vaz, 2004), and is usually
cholesterol poor.

Cholesterol-rich plasma membrane, on the other hand, is

consistent with the ordered lipid phase—because of its rigid ring structure,
cholesterol has the ability to increase the order of more fluid membranes. The
lipid microdomains (e.g., lipid rafts) are involved in signal transduction and
segregation of the membrane-anchored proteins based on their preference for
different types of lipid ordering.
Cholesterol, as an important regulator of plasma membrane organization,
can be manipulated in culture, and the effect of changed biophysical membrane
properties on proteins and other cellular functions can be readily studied. In
mammals, dietary intake of cholesterol and saturated/unsaturated fats are
significant factors affecting membrane organization and therefore cell functioning
(e.g., Aoun et al., 2011; McMurray et al., 2011; Raza, 2010; Wang and Schreurs,
2010; Wassall and Stillwell, 2009).
In summary, intracellular cholesterol distribution and organization between
different organelles and membranes in eukaryotic cells is heterogeneous in
nature and characterized by differential lipid ordering which, if changed, may
affect the functioning of various proteins and lead to a diseased state.

The

mechanism by which cells maintain these differences, and keep in check the
sterol sensing response over a narrow range of cholesterol concentration, and
readily transport and distribute intracellular cholesterol is only partly understood.
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Brain Cholesterol Homeostasis and AD Pathology

Cholesterol is essential for normal brain development and function, including
formation of synapses and synaptic plasticity, neurotransmission, signaling
transduction, membrane biosynthesis and repair (Göritz et al., 2002; Koudinov
and Koudinova, 2001; Pfrieger, 2003).

Brain cholesterol homeostasis is a

complex, strictly regulated process not fully explained (Pfrieger and Ungerer,
2011). As in the periphery, this process includes cholesterol synthesis, shuttling,
storage and turnover, which are mostly independent of hepatic cholesterol pools,
and protected by the BBB (Björkhem and Meaney, 2004). The tight junctions
between cerebral endothelial cells that form the barrier prevent the brain to
compete for cholesterol from circulation (Ballabh et al., 2004). Alternations in
cholesterol/lipoprotein metabolism and brain cholesterol homeostasis have been
linked to several pathologic processes that, for example, lead to production of
neurotoxic proteins and changes in plasma membrane integrity (reviewed in Liu
et al., 2010). To understand the complexity of the role that cholesterol may play
in neurodegenerative diseases, one has to appreciate the unique aspects of
brain cholesterol homeostasis, the proteins and transporters involved in its
maintenance, and intermediary steps and enzymes interacting between
peripheral and central cholesterol pools.
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Figure 9. Brain Cholesterol Homeostasis
Brain cholesterol homeostasis is accomplished by a tight cooperation between the two main cell types of
CNS, astrocytes (left) and neurons (right). Astrocytes provide mature neurons with cholesterol, which is
synthetized in the ER from sterols and transported to Golgi apparatus and lipid rafts in the plasma
membrane (PM). Cholesterol with ApoE is exported to neurons via the ABC transporter family, internalized
via receptor-mediated endocytosis (e.g., LDLR), and further shuttled through the endosomes, lysosomes
and ER to the PM.
The excess cholesterol is converted by 24-hydrocylase (CYP46) to 24hydroxycholesterol (24-OH-Chol) which crosses the BBB.

The brain is the most cholesterol-rich organ in the human body: it contains 25%
of the total body cholesterol, but accounts only for 2% of total body weight
(Dietschy and Turley, 2004). Intracellular cholesterol is present mainly in the
myelin sheaths and cell membranes (e.g., lipid rafts), where it is essential for
membrane fluidity and elasticity, synaptogenesis, signal transmission, and
functioning of membrane-associated proteins (Pfrieger, 2003). Brain cholesterol
is synthesized de novo by neurons, astrocytes, and oligodendrocytes,
independently of peripheral production.

While oligodendrocytes supply

cholesterol for myelin formation, it is believed that astrocytes, the major neuronal
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supporting cells, produce cholesterol required to sustain the integrity of neuronal
membranes and synapse (Björkhem and Meaney, 2004; Pfrieger and Ungerer,
2011).

As the neurons mature, they reduce production of endogenous

cholesterol and become dependent on effective cholesterol synthesis and
transport from adjacent cells, primarily astrocytes (Figure 9; Liu et al., 2010).
Slowed rate of cholesterol biosynthesis in adult neurons may reflect the overall
reduced requirement for surplus cholesterol in the brain after maturation, and the
need for optimal energy efficiency. Furthermore, astrocytes not only synthesize,
but also recycle extracellular cholesterol released from dying neurons (Jurevics
and Morell, 1995).
Cholesterol exchange and uptake between the brain cells is a multifaceted
process not fully elucidated (reviewed in Liu et al., 2010; Pfrieger and Ungerer,
2011). As in peripheral cells, several key acceptors, receptors, transporters and
enzymes involved in regulation of the brain cholesterol homeostasis have been
recognized. For example, both ApoE (the main carrier protein) and lipoprotein
receptors are essential for cholesterol transport and clearance within the brain.
The ATP-binding cassette transporter (ABCA1) is responsible for cholesterol flux
from neurons to glia, preventing accumulation of excess cholesterol inside the
cells (Dietschy and Turley, 2004). The neurons also internalize cholesterol in
several intercellular compartments (e.g., endosomes, lysosomes, and Golgi
apparatus), where it is released from its lipoprotein complex in the form of free
cholesterol, or transformed into cholesterol esters for storage. Free intracellular
cholesterol serves as a negative feedback loop to HMGR to reduce cholesterol
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synthesis in the ER, while cholesterol esters have a role in dendritic and synaptic
remodeling (Pfrieger, 2003; Poirier, 2003). Because the brain has no mechanism
for cholesterol degradation, excess cholesterol is transformed into 24Shydroxycholesterol (24OH) by oxidation (encoded by CYP46 gene), a brainspecific lipophilic cholesterol metabolite that passes through the plasma
membranes and crosses the BBB (Björkhem et al, 1998). Another oxysterol, 27hydroxycholesterol (27OH) is produced in the periphery, and enters the brain at
an estimated rate of 1% a day.

The exchange between the two oxysterols

across the intact BBB has been proposed as a missing link between cerebral and
plasma cholesterol pools, suggesting that the brain cholesterol homeostasis is
not entirely independent of the periphery (Dietschy and Turley, 2004). Moreover,
vascular insults compromise the integrity of the BBB causing an increase in
exchange of oxysterols between the brain and circulation (Xie et al., 2003).
Any disturbance in the brain cholesterol homeostasis due to, for example,
presence of interfering molecules such as Aβ; and diminished efficiency of
transporting proteins (e.g., ApoE); or compromised BBB and injury to the
neurovascular unit could contribute to neurodegeneration.
Differential distribution of cholesterol in the cell membranes and
intracellular cell compartments makes the analysis of total cholesterol in aged
and diseased brain technically challenging. Studies involving aged mouse and
human brains have shown an increase of cholesterol in the membranes
(Igbavboa et al, 1996; Schroeder, 1984) and decreased synthesis in
hippocampus but stable levels of total cholesterol (Thelen et al., 2006).
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However, there is a little consensus about the change in bulk brain cholesterol in
AD (Panza et al., 2006). Some studies reported reduced levels of cholesterol in
the brain areas with extensive Aβ and tau pathology, especially in the patients
with APOE ε4 allele (Wood et al., 2002), but increased cholesterol flux in early
stages of AD (Dietschy and Turley, 2004).

Distribution of the membrane

cholesterol changes with the progression of disease severity—the levels of
cholesterol within the cell membrane increase, altering membrane fluidity.
Higher membrane cholesterol content is associated with the increased Aβinduced toxicity both in neurons and astrocytes (Abramov et al, 2011). Also,
excess cholesterol accumulates in the form of ester droplets within senile
plaques (Gómez-Ramos and Asunción Morán, 2007; Mori et al., 2001; Panchal
et al, 2010) and in Aβ-positive neuronal terminals (Gylys et al., 2007), whereas
tangle-bearing neurons in AD brains contain more free cholesterol compared to
phospho-tau free cells (Distl et al., 2001). These findings fit with the hypothesis
that change in intracellular cholesterol and not in total cholesterol may be the
major force behind AD progression that alters APP processing and Aβ dynamics
(Eckert et al., 2000).
Another measure of cholesterol turnover and neurodegeneration in AD
may be the disruption in oxysterol homeostasis.

Several studies reported a

change in oxysterol levels during disease progression. At early stages of the
disease, the amount of 24OH cholesterol increases in the brain and periphery,
suggesting increased cholesterol turnover from destroyed synapses and dying
neurons (e.g., Papassotiropoulos et al., 2002; Lütjohann et al., 2000). In the later
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stages, concentrations of 24OH fall, indicating lower brain cholesterol
metabolism and the loss of neurons expressing CYP46 gene proportionally to the
degree of brain atrophy. The ratio between brain and circulatory oxysterols has
been suggested as a biochemical biomarker for AD progression (Leoni et al.,
2004; Leoni and Caccia, 2011).
Supposedly a bidirectional relationship between cholesterol and Aβ has
been observed in cellular and animal studies that manipulated the levels of
cholesterol by depletion or synthesis inhibition, or by dietary interventions. At
least a part of cell’s APP and APP-cleaving enzymes that generate
amyloidogenic Aβ peptide, the β- and γ-secretases are localized in lipid rafts
(Chen et al., 2006; Wahrle et al., 2002), whereas the non-amyloidogenic αsecretase activity favors more fluid, non-lipid raft environment (Kojro et al., 2001;
reviewed in Wolozin, 2004). Alternations of the membrane lipid content may
therefore shift the activity of the key enzymes involved in APP processing from
harmful (Ehehalt et al., 2003; Xiong et al., 2008) to neuroprotective (Bodovitz and
Klein, 1996; Kojro et al., 2001). For example, cholesterol depletion/inhibition with
different drugs (e.g., statins, cyclodextrins) reduced Aβ production and cellular
amyloid load in cultured neurons and in brains of treated animals (e.g., Burns et
al., 2006; Fassbender, et al., 2001; Refolo et al., 2001; Schneider et al., 2006;
Simons et al., 1998), whereas increased membrane cholesterol in mature
neurons led to Aβ-induced calpain (a calcium-dependent cysteine protease)
activation and generation of neurotoxic tau fragments (Nicholson and Ferreira,
2009; reviewed in Wray and Noble, 2009).
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Small rodents, especially FAD

transgenic mice fed a high cholesterol diet increased production Aβ and develop
greater amyloid burden (e.g., Hooijmans et al., 2007; Levin-Allerhand et al.,
2002; Oksman et al., 2006; Refolo et al., 2001; Shie et al., 2002; Sparks et al.,
1994) compared to animals on regular diet.
It could be postulated that an altered ratio between the more
amyloidogenic Aβ42 and less harmful Aβ40 affects membrane lipid content, and,
in turn, membrane fluidity could affect activity of the enzymes involved in the
amyloidogenic pathway, causing a vicious circle.

The data suggest that

intracellular and not total cholesterol regulates APP processing and Aβ
production (Burns et al, 2006), but the interconnection between all proteins
involved in APP proteolysis and cholesterol homeostasis is not fully elucidated.
Similarly, the mechanism linking the increase in extracerebral cholesterol content
and intracerebral Aβ load is not completely clear, but it points to disrupted
oxysterol homeostasis, vascular insults and compromised BBB (reviewed in
Martins et al., 2006).
In summary, disturbance in cholesterol homeostasis and specific changes
in cholesterol distribution in plasma membrane may be involved in AD
pathogenesis by: (1) overproduction of toxic Aβ that affects membrane
properties; (2) altered plasma membrane fluidity and elasticity due to improper
cholesterol trafficking or/and receptor mediated uptake; (3) increased calcium
influx and calpain activity leading to generation of neurotoxic tau species; (4)
change in cholesterol flux and recycling; and (5) inability to maintain cholesterol
steady-state levels for synaptogenesis and repair. The research on cholesterol
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involvement in neurodegenerative diseases and the role it plays in health of
central nervous system is fairly new with a plethora of ‘brain secrets’ to be
discovered.
Hypercholesterolemia and AD Risk

A positive association between high blood cholesterol and dementia has been
reported in some but not all epidemiological studies (Panza et al., 2009). The
studies differed depending on: (1) the ‘time period at exposure’ (late vs. mid-life
blood cholesterol); (2) the length of follow up; (3) number of cholesterol
measurements; (4) dementia ascertainment method; (5) availability of ApoE ε4
genotype; (6) choice of covariates; and (7) population under study. All of the
above may bias the results and account for inconsistencies. Dementia has a
long latency period and the concepts of time at exposure and follow up period
may be of essence to detect a true relationship between exposure and disease.
Proponents of a ‘life-course perspective’ seek to understand at which stage of life
an exposure (total cholesterol) might have the most effect on the outcome
(cognitive impairment), and if the effect of exposure is additive or synergistic
(Fratiglioni et al., 2010).
For example, some of the recent prospective studies reported positive,
negative or no association between blood cholesterol and AD and/or vascular
dementia (VaD). The Seven Countries Study of 10,211 men and 40 years followup reported a positive association between total cholesterol (TC) and dementia
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mortality (HR = 1.73, [95% CI 1.05-2.84]) in individuals with >250 mg/dl of blood
cholesterol compared to men with <200 mg/dl (Alonso et al., 2009).

In the

Honolulu Asia Aging Study of 1027 men, the serum TC declined significantly 15
years before AD diagnosis, the strongest in those with ApoE ε4 allele (Stewart et
al., 2007). A recent meta-analysis of 12 prospective studies of AD and VaD
(Anstey et al., 2008) that included about 23,800 subjects over, on average, 13
years of follow-up revealed no association between late-life TC, LDL or HDL and
any type of dementia, but positive association between mid-life TC and AD and
VaD which was not dependent on ApoE genotype.

Similarly, in the Kaiser

Permanente Study with 21 years of follow-up, Solomon et al. (2009) reported a
positive association between high mid-life TC (>240 mg/dl) and AD and VaD (HR
= 1.57, [95% CI 1.23-2.01; and HR = 1.26, [95% CI 0.82-1.9], respectively).
Current research suggests that cholesterol and the risk of dementia may
have a nonlinear association with age; at mid-life, high blood cholesterol may
pose a risk for cognitive decline 30-40 years later, while higher cholesterol levels
may be protective later in life (Duron and Hanon, 2008; Panza et al., 2006).
Protective effects of higher cholesterol on cognition may be due to cholesterol
involvement in neuronal plasticity (Koudinov and Koudinova, 2001), while the
decrease in cholesterol from mid to late life may result from pathological process
associated with neurodegeneration (Solomon et al., 2007).

65

The Role of Atherosclerosis in AD

As mentioned previously, a number of epidemiological and pathological studies
provided evidence for a pronounced vascular pathology in AD, and the
importance of vascular risk factors and CVD in AD development (reviewed in de
la Torre, 2004; 2010).

Autopsy studies revealed that white matter lesions,

ischemic infarcts, lacunes, microvessel hemorrhages, CAA and atherosclerotic
plaques as the most frequent types of vascular pathology in AD (Honig et al.,
2005; Jellinger, 2008), that contribute to steeper cognitive decline especially in
the early stages of the disease (Esiri et al., 1999). For instance, a comparative
pathological study showed a higher incidence of vascular lesions in 48% of AD
patients compared to 32.8% age-matched controls (Jellinger and Mitter-Ferstl,
2003), whereas in the autopsy study of elderly Japanese-American males, these
lesions were as common as classic AD markers (White et al., 2002).
A number of epidemiological and autopsy studies provided important, yet
inconsistent evidence regarding the etiologic role of systemic and central
atherosclerosis in AD onset and development.

In a cross-sectional study,

Hofman et al. (1997) showed that indicators of atherosclerosis in carotid arteries
and large vessels of the legs were associated with an increased risk of AD and
VaD especially in ApoE ε4 carriers (OR = 3.9 [95% CI 1.6-9.6], and OR = 19.8
[95% CI 4.1-95.0], respectively). In a recent autopsy study, atherosclerosis of
coronary arteries associated strongly with the density of neuropathological
lesions of AD in older adults with at least one ApoE ε4 allele (Beeri et al., 2006).
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No association between coronary atherosclerosis and VaD was found. In a large
prospective study of 6,647 participants, two noninvasive measures of carotid
atherosclerosis (i.e., the intima media thickness and carotid plaques) were
associated with AD regardless of ApoE genotype (HR = 2.4 [95% CI 1.25-4.60],
and HR = 2.53 [95% CI 1.21-5.32], respectively) after controlling for vascular
covariates (van Oijen et al., 2007). The Baltimore Longitudinal Study of Aging
(BLSA) utilized a series of 200 brain and 175 full body autopsies from
prospectively followed participants to examine the relationship between systemic
and central atherosclerosis, AD pathology and the risk of dementia (Dolan et al.,
2010). The results indicated that the presence of intracranial but not cardiac or
aortic atherosclerosis significantly increased the odds for dementia (OR = 2.0
[95% CI 1.4-2.9] per unit increase in atherosclerotic grade), independently of AD
pathology and cerebral infarcts.

Quantitative analysis of atherosclerosis in

systemic and central vessels showed no association between the degree of
atherosclerotic burden and AD pathology, suggesting that there is an additional
association between intracranial atherosclerosis and dementia that is not related
to cerebral infarcts and AD lesions.

Furthermore, recent retrospective

histopathological studies confirmed the association between the intracranial
atherosclerosis in the circle of Willis of AD subjects compared to age-matched
controls, and a strong correlation between the density of senile plaques and
NFTs and the degree of the atherosclerotic narrowing independently of
possession of ε4 allele (Beach et al., 2007; Honig et al., 2005; Roher et al.,
2003).

For example, in a study of 397 older adults with confirmed
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neuropathological diagnoses, Beach et al. (2007) showed that the circle of Willis
atherosclerosis score was a significant predictor of AD (OR = 1.31 [95% CI: 1.041.69]) and VaD (OR = 2.50 [95% CI: 1.52-4.10]) but not for non-AD dementia for
each unit of increase in atherosclerotic grade, independently of the ApoE ε4
genotype.
In line with the aforementioned evidence, several hypotheses have been
proposed to explain the relationship between AD and CVD: (1) atherosclerosis
may

exacerbate

AD

pathogenesis

and

act

synergistically

with

neurodegeneration; (2) atherosclerosis may present a parallel pathology that
adds to cognitive burden independently of classic AD markers and susceptibility
genes (e.g., ApoE ε4); and (3) both diseases may share a common biological
mechanism linking the two pathologies (e.g., cell-cycle defects). While larger
scale prospective and autopsy studies are needed to address the validity of
association between systemic and central atherosclerosis and AD risk, the
proponents of the Vascular Hypothesis argue that scientific evidence supporting
vascular origins of AD outweighs that supporting the Amyloid Hypothesis (de la
Torre, 2004; Casserly and Topol, 2004).
Thus, atherosclerosis and AD may be independent but converging
diseases that share several common genetic and environmental risk factors (i.e.,
ApoE ε4 polymorphism, hypercholesterolemia, hypertension, diabetes, systemic
inflammation, obesity, smoking, and high fat diet) [Casserly and Toppol, 2004]. A
better understanding of one disease could aid in providing better therapies and
prevention strategies for the other. Because most of the vascular risk factors are
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preventable, skillful and timely prevention and/or treatment of vascular disease
preferably at middle age could help preserve both cardiovascular and cognitive
health (de la Torre, 2004; 2010). For instance, several non-invasive techniques
have been developed to detect systemic vascular pathology such as the
narrowing of carotid artery (e.g., carotid artery ultrasound [CAUS]) caused by
intima-media thickness [C-IMT]; the velocity and direction of the blood flow from
the heart to brain [e.g., pulse-wave Doppler scanning]; changes in the structure
and function of the heart muscle [e.g., echocardiography]; and the extent of
peripheral arterial disease (e.g., ankle-brachial index [ABI]). All the above may
be valuable screening tools that could aid in designing strategies to prevent
ongoing or future cognitive decline (de la Torre, 2010). Similarly, CVD-related
clinical trials could routinely include measures of cognitive function to investigate
the therapeutic potentials of anti-inflammatory, anti-angiogenic, and antihypercholesterolemic agents on dementia development.

In sum, additional

epidemiological and clinical studies looking at the benefits of either lifestyle
changes or therapies for CVD (e.g., atherosclerosis) at middle age would provide
valuable insights for prevention strategies aimed to stall cognitive decline later in
life.

CONCLUSIONS: DISRUPTED CHOLESTEROL HOMEOSTASIS AND AD

Taken together, the cellular, animal and epidemiological studies referenced
above implicate cholesterol as an important component of neurodegenerative
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process in AD. While hypercholesterolemia may contribute to AD pathology via
systemic and cerebral atherosclerosis by causing diminished cerebral perfusion
and neuronal energy crisis, other mechanisms may also take place. First, altered
cholesterol homeostasis within the brain and plasma membrane may promote Aβ
production and increase both amyloid and tau-related pathologies.

Second,

similar to atherogenesis in peripheral vessels, high cholesterol may disrupt
communication between neurons and vascular cells within the neurovascular unit
resulting in increased inflammation, impaired cerebral Aβ clearance and
consequent CAA within vessel walls, endothelial injury and compromised BBB
(e.g., Farks and Luiten, 2001; Bell and Zlokovic, 2009).

Third, a unique

cytogenetic mechanism may underlie both AD and atherosclerosis contributing to
pathogenesis—disrupted cholesterol homeostasis may interfere with the
cytogenetic properties of mitotic cells (peripheral and central) by affecting the
process of proper chromosome segregation.
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CHAPTER THREE
EXPERIMENTAL PROCEDURES

To assess the effect of lipoproteins and cholesterol on chromosome segregation
in vitro and in vivo, this study utilized various human cell lines and primary cells
derived from human and mouse peripheral tissues and brains, dietary
intervention on wild-type mice, and karyotype and fluorescence in situ
hybridization (FISH) analyses as the main methods for the quantification of
chromosomal aberrations in a single cell. This chapter describes in detail the cell
lines, cell sources, reagents, experimental procedures, and data acquisition and
analysis used to address the research questions under the general hypothesis
(Figure 7).

CELL LINES

hTERT-HME1 Cell Line

The hTERT-HME1 cell line (Clontech) is a primary human mammary epithelial
cell line that permanently expresses the telomerase reverse transcriptase
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(Clontech). Stable expression of this enzyme preserves telomere length and
allows the cells to divide indefinitely while retaining normal function, phenotype,
and karyotype (Jiang et al., 1999; Morales et al., 1999).
cultured

in

the

mammary

epithelium

basal

medium

The cell line was
(MEBM,

Lonza)

supplemented with 52 µg/ml bovine pituitary extract (BPE), 0.5 µg/ml
hydrocortisone, 10 ng/ml hEGF, 5 µg/ml insulin, 50 µg/ml gentamicine, and 50
µg/ml amphotericine-B, and subcultured every 2-3 days. The cells were
maintained for no more than 6 population doublings (PD) from the PDinitial.

HASM Cell Line

The Human Primary Aortic Smooth Muscle Cells (HASMC) (ScienCell Research
Laboratories) were isolated from the human aorta and cryopreserved at
secondary culture at the density > 5 x 104 cells per vial.

The cells were

maintained in smooth muscle cell medium (SMCM; ScienCell Research
Laboratories) consisting of 500 ml basal media, 2% fetal bovine serum (FBS), 5
ml smooth muscle cell supplement, and 5 ml 1x penicillin/streptomycin (PS;
5,000 I.U/ml each; Cellgro) solution according to manufacturer’s specifications.
The cells were propagated when they were 90% confluent in 2 µg/ml poly-Llysine (Sigma)-coated cell culture dishes, and the growth media was changed
every other day.
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Human Fibroblasts

LDL receptor-deficient human skin fibroblasts harboring two mutations, C240-F
and Y160-ter, that cause a severe form of familial hypercholesterolemia (FH),
and human fibroblasts with a functional LDL receptor from an unaffected age and
race matched donor were purchased from Coriell Cell Repositories. Both cell
lines were cultured following company’s protocol in Minimum Essential Medium
(MEM;

with

Eagle-Earle

salts

and

non-essential

AA)

(Gibco/Invitogen)

supplemented with 2 mM L-glutamine (Gibco), 5 ml MEM essential AA 50x
(Gibco), 2.5 ml MEM Vitamins 100x (Gibco) and 15% heat inactivated FBS
(Cellgro).
Four different human fibroblasts harboring a Niemann-Pick C1 (NPC1)
mutation (Coriell, NIGMS Human Genetic Cell Repository) and four age-matched
controls (Coriell, NIA Aging Cell Culture Repository) (Table 1) were maintained in
Dulbecco’s

modified

MEM

(with

2

mM

L-glutamine;

Gibco/Invitrogen),

supplemented with 15% FBS (Atlanta Biological), and 5 ml of 1x PS solution
(5,000 I.U/ml each; Cellgro). All fibroblasts and HASMC were grown in 37˚C, 5%
CO2 incubator and subcultured every 3-5 days.
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Table 1. Characteristics of the Niemann-Pick Type C (NPC) and Control Samples

NK = not known. Human fibroblasts were purchased from Corielle and brains from NICHD Brain and Tissue
Bank for Developmental Disorders. Independent t-test revealed no age difference between NPC and control
brain donors (data not shown).

PRIMARY CELLS

Generation and Maintenance of mNPC

Neurosphere cultures containing mouse neuronal precursor cells, mNPC) were
established from non-transgenic prenatal brains (E17-E18) following a modified
protocol by Pacey et al. (2006) and maintained according to the procedure
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developed by Marchenko and Flanagan (2007).

Specifically, timed-pregnant

C57BL/6J mice (Jackson Labs) were anesthetized with sodium pentobarbital (50
mg/kg) by intraperitoneal (i.p.) injection and the fetuses retrieved through the
transabdominal incision. Six to eight pups were removed from the amniotic sack,
decapitated with a sterile blade and their brains cleaned of skulls, meningeal
tissue and cerebella and pooled into a 60 mm culture dish in cold 1x PBS
(Cellgro). The remaining cortical tissues were enzymatically and mechanically
processed to obtain a single-cell suspension and grown in the presence of
mitogens (i.e., growth factors). First, the cortices were minced and incubated in
5 ml of pre-warmed 0.25% trypsin (Gibco/Invitrogen) for 4 min at room
temperature followed by a gentle trituration with a fire polished Pasteur pipette.
After a centrifugation at 1500 rpm for 5 min, the majority of the trypsin was
removed with the supernatant and the rest neutralized in 5 ml of Trypsin
Neutralization Buffer (Lonza) for 4 min at 37˚C. The tissue aggregates were
triturated with a fire-polished pipette for at least 10 times. Following the second
centrifugation (1500 rpm for 5 min), the cell pellet was further resuspended and
triturated in 1 ml of mouse neural precursor cell media (mNPC media, described
below) (Schwartz et al., 2003; Marchenko and Flanagan, 2007) with fire polished
pipettes of two different pore sizes (each 60-70 times) to yield a single-cell
suspension. Lastly, after the viability and the cell concentration was established
by Trypan Blue (Invitrogen) dye exclusion, the cells were plated in 24 multi-well
tissue culture plates (Falcon) at a density of 50-100 cells/µl (Pacey et al., 2006)
in 0.5 ml of mNPC media and grown in 37˚C, 5% CO2 incubator. The mNPC
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media consisted of DMEM:F12 growth media (Gibco) supplemented with 20%
BIT-9500 (5x) serum substrate (Stem Cell Technologies), 1x PS (Cellgro), and
the following growth factors at the concentration of 40 ng/ml: human epithelial
growth factor (EGF), fibroblast growth factor (FGF)-basic, and platelet-derived
growth factor (PDGF-AB) (PeproTech).
After 5-7 days, developed neurosphere clones were dissociated in 2 ml of
Cell Dissociation Buffer (Invitrogen) for 5 min at 37˚C, centrifuged, resuspended
and triturated in 0.5 ml of NPC media, and plated in 6-well plates (Fisher

Figure 10. Development of Mouse Neural Precursor Cells
The cells were isolated from the mouse fetal cortices (E17-E18) and were mechanically and enzymatically
processed to yield a single-cell suspension. The development of neurospheres clones was achieved by
culturing dissociated clusters in growth factors-containing media, which resulted in newly formed spheres.
Adapted and re-drawn from Chojnacki et al. (2009).
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Scientific). Mature neurospheres (~100 µm in diameter, Pacey et al., 2006) were
passaged once a week and grown in 25 cm2 tissue culture flasks (Falcon) in
conditioned mNPC media (½ supernatant of old and ½ fresh growth media) to
assure optimal cell growth. Similarly, only half of the media was changed every
other day in between the passaging (Figure 10).

Mouse Splenocytes and Brain Cells

Mouse spleens and brains were harvested and processed to yield a single-cell
suspension and prepared for karyotype and FISH analysis according to
procedures described elsewhere (Boeras et al., 2008; Granic et al., 2010).
Briefly, mouse spleens were removed, washed in sterile 1x PBS and triturated in
RPMI 1640 medium (Gibco/Invitrogen) using the ends of two sterile Superfrost
Plus slides (Fisher) to dissociate single cells. The cell suspension was grown for
44 hr in RPMI 1640 medium supplemented with 10% FBS, 2 mM L-Glutamine,
5% PSA, 50 µM β-mercaptoethanol, and 5 µg/ml Concanavalin-A (Sigma) which
was used as a mitogen.
Mouse brains were cleaned of meninges and mechanically dissociated in
ice-cold 1x PBS using 5 ml and 2 ml pipettes and fire polished Pasteur pipettes
of three different pore sizes (10-15 times each). The brain cells prepared as a
single-cell suspension were centrifuged at 1500 rpm for 5 min, and then
immediately resuspended and fixed in cold 3:1 anhydrous methanol (Fisher
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Scientific):acetic acid (Fisher Scientific) (fixative) and incubated on ice for at least
30 min prior to any downstream assays being performed.

Human Brain Cells

Frontal cortices from the patients with the Niemann-Pick type C disease (aged
17.26 ± 11.07) and age, gender and race matched control brain tissues (age
20.88 ± 8.64) were obtained from the NICHD Brain and Tissue Bank for
Developmental Disorders at the University of Maryland (Baltimore, MD) (Table
1).

To generate a single-cell suspension, we used a technique established

previously in the laboratory of H. Potter with fresh and frozen mouse brains
(Granic et al., 2010). Briefly, 2 g of frozen brain tissue was triturated with fire
polished Pasteur pipettes of different pore sizes in ice-cold 1x PBS. The cells
and cell aggregates were centrifuged at 1500 rpm, the supernatant removed, and
the cell pellet resuspended and fixed in either ice-cold fixative (3:1 anhydrous
methanol and acetic acid) and incubated on ice for at least half an hour, or in 4%
paraformaldehyde (PFA, Electron Microscopy Science) in 1x PBS and incubated
in 37˚C water bath for 30 min.
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MICE

APPKO Mice

Six transgenic mice lacking an APP gene and their non-transgenic littermates
were 3-4 months of age (Jackson Labs) and had C57BL/6J background strain.
The genotype was confirmed using QPCR Bio-Rad iCycler (Bio-Rad).

Mice

spleens were used for primary cell culture and lipoprotein/cholesterol treatments.

Wild-type Mice

Twelve one month old non-transgenic C57BL/6J mice (6 males and 6 females)
(Jackson Lab) were caged in standard housing in pairs, and were fed ad libitum
for 12 weeks with either regular rodent chow, low cholesterol or high cholesterol
diet (Harlan Laboratories) with free access to fresh water.

Food intake and

weight gain were monitored and recorded weekly for each mouse.

After 12

weeks, the mice were anesthetized with i.p. injection of sodium pentobarbital (50
mg/kg weight), and transcardially perfused with 0.9% saline before any internal
organs of interest were removed.

Livers, spleens and brains were visually

inspected for pathological changes. All animals, including the two time-pregnant
C57BL/6J mice were housed at the animal housing facility at the University of
South Florida (USF) in a 12-hours light and dark cycle room at 22˚C. All animal
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studies were approved and conducted in accordance with the guidelines stated
by the USF Institutional Animal Care and Use Committee.

DIETS

Regular mouse chow (2018 Teklad Global 18% Protein Rodent Diet, Harlan
Laboratories) consisted of 5% crude plant-based oil (fat), 0% cholesterol, and
supplied 3.3 Kcal/g of Digestible Energy (DE). Low cholesterol diet (7001 Teklad
4% Mouse/Rat Diet, Harlan) contained 4.2% crude oil, 0.02% cholesterol, and
3.23 Kcal/g of DE. The custom made high cholesterol diet (TD.95286, Harlan)
consisted of 21% milk fat (fat), 1% of cholesterol, and provides 4.5 Kcal/g of DE.

REAGENTS

Lipoproteins

Human oxidized LDL (protein concentration 2 mg/ml), human LDL (protein
concentration 5 mg/ml) and human HDL (protein concentration 10 mg/ml) were
purchased from Biomedical Technologies Inc. The content of protein in each
lipoprotein complex was assayed by the supplier using the Lowry method (Lowry
et al., 1951), and the lipid concentration calculated according to chemical
composition established by Fellin et al. (1974) and Barclay et al. (1972). For
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example, chemical composition of human LDL is 22% protein and 78% lipid
which brought the lipid content of the sample to 17.7 mg/ml.

Water-soluble

cholesterol (WsCh) was obtained from Sigma (31.8 mg of pure cholesterol in 0.6
g total weight of solid, balanced in methyl-β-cyclodextrin) and resuspended in
sterile water.

Salts

For the calcium ions chelation, two different Ca2+ blockers were used. Chelator
BAPTA (Calbiochem) served as an intracellular Ca2+ buffering reagent at the
concentration of 1 mM. Four carboxylic functioning groups in BAPTA molecule
bind to two calcium ions.

EGTA chelator was added to the cells at the

concentration of 1.5 mM. The reagent is selective for Ca2+, and binds one cation
per molecule (soluble in 1 M NaOH). hTERT-HME1 cells are cultured in the
medium that contains 294 mg/L of calcium (or 2.65 mM).

OTHER REAGENTS, KITS, AND DNA PROBES

Absolute (without benzene) ethyl alcohol (Sigma-Aldrich) was prepared as a
sterile aqueous 1 M solution and aliquoted.

Filipin complex (Sigma) was

dissolved in dimethyl sulfoxide (DMSO, Sigma) and stored at -20˚C in small
aliquots protected from light. Giemsa stain (Gibco/Invitrogen) was diluted freshly
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in the 1x GURR buffer (GibcoBRL Life Technologies) to stain metaphase
spreads according to standardized cytogenetic protocol. Trypan blue (0.4%, BD
Biosciences) exclusion assay was used to determine the viability of the hTERT
cells grown in the closed chamber system with and without ethanol. Mouse antineuronal nuclei (NeuN) Alexa Fluor® antibody (Millipore) and VectaShield with
4’,6-diamino-2-phenylindole (DAPI) (Vector Laboratories) was used to label
neurons and nuclei, respectively. Nick Translation Kit (Abbott Molecular Inc.)
and SpectrumGreen™ or SpectrumOrange™ dUTPs (Abbot, Vysis) were used to
generate BAC probe following an established protocol (Kulnane et al., 2002;
Boeras et al., 2008). Ethanol Assay Kit (BioVision) and BioTek Synergy HT
micro-plate reader (BioTek Instruments) for colorimetric assay (optical density
570 nm; OD570) and Gen5™ (BioTek Instruments) data analysis software were
used to measure ethanol concentration in the media at the baseline, after 24 and
48 hr of exposure following manufacturer’s instructions. Oil-Red-O staining kit
(American MasterTech) was used to detect fatty deposits in hepatocytes of mice
fed a high cholesterol diet.

LSI® ETV6(TEL)/RUNX1(AML1) ES Dual Color

Translocation Probe, LSI® IGH (14q32)/MALT1(18q21) Dual Color Dual Fusion
Probe, and LSI® D7S522 (7q31) SpectrumOrange™/CEP® 7 SpectrumGreen™
were purchased from Abbott, Vysis.
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IN VITRO INCUBATION WITH LIPOPROTEINS/CHOLESTEROL

Two days prior to treatment/incubation, freshly passaged hTERT cells (1-3 x 105
cells/2 ml) were plated in 100 mm tissue culture dishes (56 cm2/dish) with
supplemented Mammary Epithelium Basal Medium (MEBM, Lonza) to assure
60%-70% confluency on the day of the treatment. The cells were incubated for
48 hr at the concentration of 20 µg/ml of lipoproteins and 2 and 4 µg/ml of WsCh.
Higher concentrations of WsCh were cytotoxic (data not shown).
First, 7 parallel experiments were conducted to assess the effect of
lipoproteins

on

chromosome

segregation

(i.e.,

karyotype

analysis

and

chromosome specific aneuploidy) and 6 separate experiments to test the
aneugenic effect of cholesterol. Second, the same cell passages were used for
the set of parallel experiments involving Ca2+ chelating reagents, BAPTA or
EGTA.

The cells were pretreated with the 1 mM and 1.5 mM of chelators,

respectively for 3 min before lipoproteins were added. Prior to the harvest, the
cells were treated with 33 ng/ml colcemid for 10 hr, fixed according to the
standardized cytogenetic procedure, and prepared for metaphase chromosome
and FISH analysis. Third, two sets of triplicate experiments involving lipoproteins
and ethanol co-incubations were conducted separately with the same low cell
passage (described below).
Similarly, two days before the treatment with lipids, freshly passaged
HASMC were seeded onto pre-coated (2 µg/ml of poly-L-lysine, Sigma) single
well glass chamber slides (8.6cm² growth surface/well) (BD Bioscience) at the
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density of 105 cells per slide. After 48 hr of lipids/cholesterol incubation, the cells
were rinsed twice with 1x PBS without Ca and Mg (Cellgro) and immediately
fixed with cold 3:1 anhydrous methanol and acetic acid fixative and put at -20°C
for 30 min. Fresh fix was added to the cells before storage at -20°C.
Human fibroblasts with and without functional LDL receptor were seeded
at a density of ~2 x 105 cells per single chamber slide pre-coated with 2µg/ml of
poly-L-lysine. The same procedure involving incubation with lipids and fixation
was followed as with the HASMC.
Mouse non-transgenic and APPKO spleen cells were incubated with the
lipoproteins at the same concentration mentioned above for 48 hr, harvested and
fixed for FISH analysis using a BAC probe for mouse chromosome 16 according
to established protocol (Kulnane et al., 2002; Boeras et al., 2008).

CLOSED CHAMBER FOR ETHANOL AND LIPIDS INCUBATION

To assure an exact and consistent ethanol (EtOH) concentration in treated cells,
a modified closed chamber system protocol by Adickes et al. (1988) was used
(described below). Prior to ethanol and lipoproteins co-treatments, several pilot
experiments were conducted to examine the viability of hTERT-HME cells in the
closed chamber, and to establish cytotoxicity of the two EtOH concentrations
using the Trypan Blue dye exclusion assay and hemocytometry. First, the effect
of 25 and 50 mM of EtOH for 6, 12 and 24 hr on cell morphology, proliferation
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and survival was assessed (data not shown). Second, based on these results,
triplicate experiments were conducted with 25 mM EtOH for 24 hours followed by
lipoproteins/cholesterol and EtOH co-incubation for 48 hr.
Specifically, a day before pretreatment with EtOH in the closed chamber
(a 27 x 16.5 x 11 cm tightly sealed polystyrene container), hTERT cells were
seeded in 6-well plates at the density of 6 x 104/well and grown in 37˚C, 5% CO2
incubator. Next, established cultures were incubated in 25 mM EtOH containing
media for 24 hr and cultured in the sealed chamber alongside with an open dish
(10 x 7 x 6 cm) filled with 300 ml 25 mM EtOH aqueous solution, which was
changed daily to counteract alcohol evaporation. The next day, lipoproteins (20
µg/ml) and water soluble cholesterol (4 µg/ml) were added to the fresh culture
media with EtOH, and the cells were grown for 48 hr. A small aliquot of EtOHcontaining media from two samples was collected at the baseline, 24 and 48 hr
later to measure alcohol concentration using a colorimetric assay (Ethanol Assay
Kit, BioVision). Lastly, the cells were harvested and fixed for FISH analysis.

METAPHASE CHROMOSME ANALYSIS

After colcemid treatment, hTERT-HME1 cells were harvested according to the
standard cytogenetic procedure described previously (Boeras et al., 2008).
Briefly, the cells were hypotonically treated in 75 mM KCl for 15 min in a 37°C
water bath, fixed in 3:1 anhydrous methanol: acetic acid fixative for a minimum of
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30 min on ice, followed by two fixative washes and resuspension in fresh fix.
Metaphase

spreads

were

stained

with

Giemsa

stain

(Gibco/Invitrogen

Corporation) diluted in the 1x GURR buffer (GibcoBRL Life Technologies) and
the chromosomes counted (Figure 11A, B). Genus 2.81® software was used for
chromosome analysis (Applied Imaging).

At least 40-45 metaphases were

analyzed per each sample.

FLUORESCENCE IN SITU HYBRIDIZATION (FISH)

Fluorescence in situ hybridization (FISH) is a cytogenetic technique that allows
one to detect the number of copies of a particular chromosome in both
metaphase and interphase cells at the single-cell level (Ried, 1998; Tibiletti et al.,
1999; Speicher and Carter, 2005) with great sensitivity and specificity (Tibiletti,
2004). This method is especially suitable for poorly and non-dividing cells, or for
cells with a very low level of aneuploidy (e.g., lymphocytes). The basic principle
of FISH consists in hybridization of fluorophore containing DNA probe with a
unique genomic sequence to its complimentary DNA in cytological samples
prepared on slides (Figure 11C).

Annealed probe and target-DNA is then

visualized in situ using fluorescent microscope filters that should match the
wavelength of the selected fluorophore for proper detection and analysis
(reviewed in Jiang and Katz, 2002; Tibiletti, 2007). In the present studies, for
human samples commercially available single or dual-labeled locus specific
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chromosome probes (Abbott, Vysis) were used, and for mouse samples, a ~300
kb unique mouse DNA sequence cloned into the bacterial artificial chromosome
(BAC) cloning vector and labeled by Nick translation (Zhu et al., 1994) was
utilized.
Prior to hybridization, all slides were aged at room temperature followed
by hybridization procedures recommended by Abbott, Vysis and by protocols
described elsewhere (Boeras et al., 2008; Granic et al., 2010; Kulnane et al.,
2002). Briefly, aged slides were placed in 37˚C 2x SSC buffer for 45 min and
dehydrated in serial ethanol washes (70%, 80%, and 90% for 2 minutes each),
and targeted with a DNA probe mixture (7 µl hybridization buffer, 1 µl
fluoroprobe,

and

2

µl

DNase-free

water).

Interphase

FISH

of

all

lipoprotein/cholesterol and reagents-treated human cell lines and primary cells
was performed with either the LSI® ETV6(TEL)/RUNX1/(AML1) ES Dual Color
Translocation Probe, LSI® D7S522 (7q31) SpectrumOrange ™/CEP® 7
SpectrumGreen™ or LSI IGH/MALT1 Dual Color Dual Fusion probe (Abbott,
Vysis) in a HyBrite hybridization chamber (Vysis) according to manufacturer’s
specifications for a selected probe for at least 16 hr at 37˚C.

A dual color

detection protocol allows one to simultaneously assess two chromosomes under
appropriate dual-band pass fluorescence microscope filters. The next day, slides
were washed with 0.4x SSC and 2x SSC containing NP-40 detergent to remove
nonspecifically-bound probe, and mounted with DAPI II (Abbott, Vysis) or
Vectashield with DAPI (Vector Laboratories) counterstain.
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Figure 11. Metaphase Chromosome Spreads and FISH Procedure
(A-B) Human aneuploid metaphase (A) (>46 chromosomes) and mouse (B) euploid metaphases (40
chromosomes) were prepared following standardized cytogenetic protocol (Barnicot and Huxley, 1961) and
stained with Giemsa.
(C) In the FISH procedure, DNA probe is labeled with fluorophore-containing nucleotides followed by the codenaturing of the target and probe DNA and annealing of the complimentary DNA sequences.
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A bacterial artificial chromosome (BAC) containing a mouse chromosome
16-specific sequence (a gift from Dr. Bruce Lamb at Case Western Reserve of
University) was labeled by Nick translation and fluorophore-containing dUTP as
described previously (Kulnane et al., 2002; Boeras et al., 2008; Granic et al.,
2010).

Briefly, 1 mM of either SpectrumGreen™ dUTP (2’-Deoxyuridine, 5’-

Triphosphate; Abbott, Vysis) or SpectrumOrange™ dUTP (Enzio Life Sciences)
was used to label 1 µg of BAC DNA in Nick translation enzymatic
reaction/incubation (Nick Translation kit, Abbott) at 15˚C for 8-16 hr. Precipitated
and pre-incubated (37˚C overnight) BAC probe was co-denatured with mouse
spleen or brain cells at 74˚C for 4 min and hybridized at 37˚C in HyBrite chamber
for either 22 or 48 hours, respectively, followed by two or three consecutive
washes in SSC detergent-containing buffers of various stringencies (0.4x SSC,
2x SSC, and 4x SSC) and counterstained with DAPI II (Abbott, Vysis) or
Vectashield (Vector) nuclear DNA stain.

FISH FOLLOWED BY IMMUNOCYTOCHEMISTRY

Studying the effect of PS1 mutation and overexpression on the cell cycle and
chromosome mis-segregation in mouse models of FAD, this laboratory
previously used a modification of the protocol by Liesi et al (2001) to develop
primary mouse neuronal cultures followed by FISH analysis, therefore depending
on availability of live animals and successful isolation of neuronal cells. Other
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researchers that examined the levels and distribution of aneuploidy in normal and
AD

brains

in

humans

and

mice

utilized

either

brain

slices

and

immunofluorescence staining and cytometry to measure the DNA content in
single neurons (e.g., Arendt et al., 2010), and mechanically isolated nuclei from
different brain regions and FISH (e.g., Iourov et al., 2009), or FACS analysis of
PFA-fixed brain cells labeled with a neuronal specific marker followed by FISH
assay (e.g., Westra et al., 2008).
To circumvent the technical complexity of each method (e.g., a single-cell
DNA quantification on the brain slices requires specialized instruments and
multistep immunocytochemistry protocol), the lab developed a relatively simple
technique which combines FISH and immunostaining performed in two
consecutive steps on a single slide (Granic et al., 2010). To assess neuronal
versus glial cell aneuploidy in the cells derived from either fresh or frozen brain
tissue utilizing only fluorescence microscopy, mechanically dissociated single
cells (nuclei) were first subjected to FISH assay with a single or dual labeled
DNA probe followed by immunocytochemistry using a conjugated primary
antibody against the neuronal nuclear antigen, NeuN labeled with AlexaFluor 488
or with other fluorophore. With this method, both neurons and glial cells from any
brain region could be assessed for aneuploidy for any chromosome of interest.
Thus, a single-cell suspension of NPC and control frontal cortices (Table
1) were hybridized with a DNA probe for chromosome 21, and immediately after
FISH, incubated in 1x PBS for 10 min, blocked in 10% goat serum/0.1% Triton X100 PBS solution for 1 hr followed by overnight incubation in conjugated Ms X
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Neuronal Nuclei AlexaFluor 488 (Millipore) 1:100 antibody prepared in 1%
BSA/0.1% TritonX-100 1x PBS. After final washes in 1x PBS, the cells were
stained with DAPI II counterstain and coverslipped.

IMMUNOCYTOCHEMISTRY, FILIPIN AND OIL-RED-O STAINING

Filipin is a cholesterol-specific fluorescent dye (Norman et al., 1972) used to
quantify plasma membrane and intracellular free cholesterol and to demonstrate
a correlation between decreases in membrane cholesterol and increased
membrane fluidity (Coxey et al. 1993). To co-stain NPC brain cells with neuronal
marker and filipin, a modification of the protocol described by Millard et al. (2000)
was used.

A single-cell suspension of 4 NPC and 5 control frontal cortices

(Table 1) were fixed in 4% PFA in 1x PBS for 30 min at 37˚C. The cells were
dropped onto pre-wetted slides (Fisher) that were marked around the edges with
the ImmEdge pen (Vector Laboratories) to create a single chamber, and allowed
to age overnight. After the three consecutive washes with 1x PBS for 10 min, the
slides were stained/permeabilized with 50 µg/ml filipin in PBS/10% normal goat
serum overnight at 4˚C, and then incubated in conjugated Ms X Neuronal Nuclei
AlexaFluor 488 (Millipore) 1:100 antibody prepared in filipin/1x PBS/10%goat
serum for 60 min in 37˚C hybridization oven on a shaker. Following final washes
in 1x PBS, the cells were mounted with Fluoro-gel with Tris Buffer (Electron
Microscopy Sciences) and coverslipped.
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Oil-Red-O stain is used to detect intracellular neutral lipids in hepatocytes
and adipogenic cultures (e.g., De Gottardi et al., 2007), and for detection of
hepatic steatosis in liver cryosections (e.g., Zhao et al., 2011). Visual
accumulation of cytosolic lipids in more than 5% of hepatocytes in human liver is
considered as diagnostic of steatosis (Klein et al., 2005) as a consequence of an
increased efflux of free fatty acids and triglycerides formation (Bradbury, 2006).
A single-cell suspension of 4% PFA/1x PBS-fixed livers were dropped onto slides
and stained with the Oil-Red-O staining kit following manufacturer’s procedures
(American MasterTech).

Hematoxylin stained single cells (blue) and cell

aggregates were evaluated under phase microscopy for the presence of lipid
droplets (red).

IMAGE AQUISITION AND ANALYSIS

FISH Visualization and Scoring

Hybridization signals were visualized using a Nikon Eclipse E1000 fluorescence
microscope with a 4912 CCIR high performance COHU CCD Camera and Genus
2.81® software (Applied Imaging) or a Zeiss Imager.M1 microscope with a CVM4+CL high resolution camera and Axiovision 4.6 software (Zeiss).

The

corresponding optical filters and their spectral bandwidths were: DAPI (peak
excitation/emission (ex/em) 350 and 470 nm), Fluorescein Isothiocyanate (FITC)
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(ex/em 490/525 nm), and Tetramethyl Rhodamine Isothiocyanate (TRITC)
(ex/em 557/576 nm) for the Nikon Eclipse scope, and Zeiss filter sets 49
DAPI/Hoechst 33258 (ex/em 365/445[450] nm), 38 HE eGFP/FITC/Alexa488
(ex/em 470[40]/525[550] nm) and 43 HE Cy3/DsRed/Rhodamine (ex/em
550[525]/605[670] nm) from Chroma.
Only intact nuclei (DAPI) and compact and bright signals were scored for
aneuploidy separately for each probe/fluorophore following the Abbott/Vysis
(http://www.abbottmolecular.com/contactus/fishtechsupport/techtipsandinfo/fishlab-quality-control.html) guidelines.

For example, overlapping cells were not

analyzed and closely adjacent spots or spots connected with a fluorescent strand
were evaluated as a split signal and counted as one chromosome.
During the course of our studies, this laboratory experienced high
hybridization efficiency (> 98%) with both commercially available (Vysis) and
homemade BAC probes (data not shown) on cell lines and primary cells as a
source of target-DNA.

The evaluation of chromosomal abnormalities in the

samples lacking more than 10% of fluorescent spots is not recommended
because it leads to underestimation of trisomies and overestimation of
monosomies and miscalculation of aneuploidy (Tibiletti, 2007). A similar problem
arises when the nuclei are processed from paraffin sections (slices) or isolated
from paraffin-embedded tissue blocks if the architecture of analyzed cells is not
correctly assessed (Tibiletti, 2007). To avoid any biases in scoring of euploid
and aneuploid cells in the study samples, only non-overlapping single nuclei
derived from a single-cell suspension were evaluated.
93

A portion of the

hybridization area was routinely recounted for reliability. On average, between
700 and 1,000 interphases per each sample/treatment were scored for
aneuploidy, and about 400 NeuN-positive and NeuN-negative NPC brain cells
were analyzed for DNA hybridization spots.

Filipin Semi-quantitative Analysis

First 50 NeuN-positive NPC and control brain cells were semi-quantitatively
assessed for the most intense filipin stain and cholesterol localization and
categorized into three following groups: membrane staining, intracellular staining
and both.

For filipin visualization and image acquisition, a Zeiss Imager.M1

microscope with a CV-M4+CL high-resolution camera and 49 DAPI/Hoechst
33258 filter set (Chroma) was used, along with the Axiovision 4.6 software
(Zeiss). Also, a Zeiss Imager.M1 and phase contrast was used to assess the
presence of Oil-Red-O staining in mouse hepatocytes.

STATISTICAL ANALYSIS

To establish whether lipoprotein/cholesterol induce chromosome mis-segregation
in various human and mouse cells (i.e., hTERT-HME, HASMC, human
fibroblasts, mouse splenocytes, and mouse neural precursors), a Paired
Student’s t-test was used to compare the aneuploidy levels (mean ± SEM)
between treated cells and controls.

Similarly, to answer the question if a
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functional LDLR or APP gene is required to observe aneugenic effect of lipids in
vitro, a Paired t-test was employed to contrast the levels of aneuploidy in
lipoproteins-treated fibroblast harboring malfunctional LDLR compared to
controls, and in lipid-treated mouse splenocytes lacking APP gene compared to
untreated cells (Research Question 1).
To investigate the role of intracellular cholesterol homeostasis in
chromosome mis-segregation in a neurodegenerative disease model, an
Independent t-test was used to compare the aneuploidy levels between the
NPC1 fibroblasts and the NPC brain cells and corresponding age, gender and
race matched controls. The same statistical analysis was utilized to contrast
filipin staining between the NeuN-positive NPC cells and normal neurons
(Research Question 1).
To establish the effect of a dietary-induced hypercholesterolemia on
chromosome segregation in peripheral tissues in a mouse model, a Paired t-test
was used to compare the levels of aneuploidy in spleens of the mice (littermates)
fed a high cholesterol to mice consuming regular diet, and the mice fed a low
cholesterol diet to mice on regular chow (Research Question 2).
To explore the mechanism of aneuploidy induction in vitro, and to
establish whether Ca2+ chelation and plasma membrane fluidization by ethanol
may attenuate lipoproteins/cholesterol-induced aneuploidy, a Paired Student ttest was used to compare aneuploidy levels between the lipids-treated cells with
and without chelator, and the cells co-incubated with lipids and ethanol compared
to appropriate controls (Research Question 3).
95

Three to 7 treatments with lipids for each cell line, and triplicate
experiments with the chelator and ethanol were conducted and scored for
aneuploidy. Four to 5 primary NPC cells sources and controls (Table 1) and at
least 6-12 mice were analyzed for each graph. All data were presented as mean
± SEM of treatments and controls with p < 0.05 considered as statistically
significant.

SUMMARY

To summarize, the following materials and methods were used to answer the
research questions. For the Research Question 1 (Do lipids induce aneugenesis
in vitro and is the induction dependent on a functional LDL receptor and APP
gene?), hTERT-HME1, HASM cells, human fibroblasts with and without
functional LDLR, mouse APPKO splenocytes and neural precursors, human
NPC1 fibroblasts and brain cells where treated either with lipoproteins/cholesterol
and/or assessed for aneuploidy utilizing the FISH assay, and for the intracellular
cholesterol distribution using filipin staining. For the Research Question 2 (Does
diet-induced hypercholesterolemia affect chromosome mis-segregation in
visceral and brain tissues of wild-type mice?), young nontransgenic animals were
fed three different diets, and the spleen and brain cells analyzed for chromosome
16 aneuploidy using a BAC probe and FISH. For the Research Question 3 (Is
there a mechanistic link between calcium homeostasis (Mechanism I) and
plasma membrane dynamics (Mechanism II) and lipid-induced chromosome mis96

segregation in vitro?), hTERT cells were treated with lipoproteins in the presence
or absence of calcium chelators (BAPTA and EGTA) and EtOH, respectively, and
analyzed for aneuploidy using FISH.
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CHAPTER FOUR
RESULTS

To investigate

the role of lipoproteins and cholesterol in chromosome

segregation in vitro and in vivo, and to establish the effect of disrupted
cholesterol homeostasis on the cell cycle, we used: (1) human and mouse
primary cells with a functional LDL receptor; (2) mouse primary cells lacking APP
gene; (3) human primary cells with defective LDLR and Niemann-Pick Type C1
(NPC1) genes responsible for lipoprotein uptake and intracellular cholesterol
trafficking, respectively; (4) young wild-type mice fed high (1.05%) and low
(0.02%) cholesterol diet for 12 weeks to induce hypercholesterolemia; and (5)
metaphase chromosome analysis and FISH to examine the levels of total and
chromosome specific aneuploidy, respectively.

Specifically, we assessed the

level and distribution of trisomy and tetrasomy of human chromosomes 7, 12, 14,
18, 21, and mouse chromosome 16 in various peripheral and brain cells. Missegregation of these chromosomes has been implicated in AD (e.g., Boeras et
al., 2008; Geller and Potter, 1999; Granic et al., 2010; Migliore et al., 1999;
Thomas and Fenech, 2008) and in development of atherosclerotic lesions (e.g.,
Casalone et al., 1991; Fernandez et al., 2000; Matturri et al., 1997; 2001).
Lastly, (6) we examined the mechanisms by which lipoproteins and cholesterol
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may cause chromosome mis-segregation, and asked whether (a) alternation in
extracellular Ca2+ homeostasis by either EGTA or BAPTA, and (b) a change in
membrane

fluidity

and

elasticity

by

ethanol,

may

decrease

lipoproteins/cholesterol-induced chromosome mis-segregation in the cell culture.
This chapter describes individual research questions, scientific rationale
and study results in three sections: (1) lipoproteins/cholesterol-induced
chromosome mis-segregation in vitro (Research Question 1); (2) diet-induced
peripheral genomic instability in vivo (Research Question 2), (3) mechanistic link
between calcium homeostasis and plasma membrane fluidity and lipids-induced
aneuploidy in vitro (Research Question 3).

LIPOPROTEINS/CHOLESTEROL-INDUCED ANEUPLOIDY IN VITRO

hTERT-HME1 Cells Treated with Lipoproteins Developed Aneuploidy within
48 Hours

Recently, this laboratory has shown that overexpression or mutation in the PS1
or APP genes causes chromosome aneuploidy, including trisomy 21 in cellular
and animal models of AD (Boeras et al., 2008; Granic et al., 2010) partly via Aβ
peptide by disrupting the microtubule integrity and the function of mitotic spindle
motors (Borysov et al., 2011). To broaden the knowledge that cell cycle defects
and accumulation of aneuploid/hyperploid cells, including neurons may contribute
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to neurodegeneration and dementia (e.g., Arendt et al., 2010; Iourov et al., 2009;
Obrenovich et al., 2003; Potter, 2004), this dissertation sought to investigate the
aneugenic effect of other effector molecules implicated in pathology of AD and
AD-related risk factors (i.e., atherosclerosis), such as LDL and OX-LDL.

To

answer the question whether lipoproteins at physiologically elevated levels
induce mitotic defects and chromosome mis-segregation in dividing cells with low
aneuploidy background and a functional LDL receptor, human primary epithelial
cells with a stable karyotype (i.e., permanently expressing a telomerase reverse
transcriptase gene; Jiang et al., 1999; Morales et al., 1999), the hTERT-HME1
cells were exposed to OX-LDL, LDL and HDL for 48 hr at the concentration of 20
µg/ml and assessed for aneuploidy by metaphase chromosome analysis and
FISH. First, seven parallel cultures of hTERT-HME1 cells were incubated with
lipoproteins, then arrested at metaphase by colcemid and assessed for
aneuploidy (metaphase spreads both of < and > of 46 chromosomes).

The

results showed a significant increase in chromosome mis-segregation, especially
in OX-LDL and LDL-treated cells compared to controls (p = 0.0001, and p =
0.005, respectively; Paired t-test; Figure 12A).

LDL-cholesterol induced

significantly more mis-segregated cells compared to less aneugenic HDL (p =
0.005) and OX-LDL (p = 0.01). Second, the induction of chromosome specific
aneuploidy was analyzed by quantitative FISH analysis (Figure 12B-G), and
revealed the induction of: (1) trisomy 21 (p = 0.02) and 12 by OX-LDL (p = 0.02;
Paired t-test) and a borderline significant induction of trisomy 21 and 12 by LDL
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Figure 12. Chromosome Aneuploidy, Including Trisomy and Tetrasomy 21, 12 and
7 Induced in Lipoproteins-treated hTERT-HME1 Cells
(A) hTERT-HME1 cells were treated with 20 µg/ml of OX-LDL, LDL and HDL for 48 hr and arrested in
metaphase by incubation in 33 ng/ml of colcemid for 10-12 hr. Hypotonic treatment in 0.075 M KCl was
followed by a cell fixation in 3:1 methanol:acetic acid. Fixed cells were Giemsa stained for karyotype
analysis. All lipid-treated cells harbored significantly higher levels of aneuploidy compared to controls,
especially those treated with LDL-cholesterol.
(B-G) FISH analysis of the same lipoproteins-treated cells revealed OX-LDL-induced trisomy 21 (B) and
trisomy 12 (C), and OX-LDL and LDL-induced tetrasomy 21 (E), tetrasomy 12 (F), and tetrasomy 7 (G).
continued>
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LSI® ETV6(TEL)/RUNX1(AML1) ES Dual Color Translocation Probe (SpectrumOrange™
21/SpectrumGreen™ 12) was used to detect complimentary DNA sequence on chromosome 21 and 12 in
interphase cells (D), whereas LSI® D7S522 (7q31) SpectrumOrange™/CEP 7 SpectrumGreen™ probe was
used to detect LDL-induced tetrasomy 7 (G). Atherogenic OX-LDL induced significantly higher levels of
trisomy 21 and 12 compared to HDL-cholesterol. No induction of trisomy 7 in any lipid-treated sample was
observed (data not shown).
(H) Karyotype analysis of an aliquot of the cells from the same treatments showed low number of polyploidy
cells, suggesting that the tetrasomies observed were due to chromosome mis-segregation of chromosomes
21, 12 and 7, and not a result of chromosome duplication without cell division.
A Paired t-test was used to compare aneuploidy levels (percentages) between lipids-treated and control
cells with p < 0.05 considered to be statistically significant.

(not significant; Figure 12B-D); and (2) tetrasomy 21, 12, and 7 induced by OXLDL and/or LDL (p = 0.03, Paired t-test; Figure 12D-G). Compared to HDL, OXLDL-cholesterol induced significantly more trisomic 21 and 12 cells within 48 hr
(p = 0.03 and p = 0.01, respectively; paired t-test).
Taken together, the data suggest that OX-LDL and LDL-induced
tetrasomy in interphase cells happed possibly due to either cell reduplication with
incomplete cell division or due to chromosome mis-segregation for a particular
chromosome. The presence of tetraploid neurons has been observed in AD
brains of humans and mice, and explained by some researchers as due to
aberrant cell cycle activation and DNA duplication without the cell cycle
completion (e.g., Arendt et al., 2009; Obrenovich et al., 2003; Yang et al., 2001;
2006; Yang and Herrup, 2007; Zhu et al., 2008). In order to determine why there
is more than diploid content of DNA in interphases of lipid-treated hTERT cells, a
total number of metaphase hyperploid/polyploid and diploid cells were scored in
the portion of the slide initially analyzed for karyotypes. There was no elevation
of polyploid (>4n) within diploid (2n) cells in OX-LDL and LDL-treated samples
indicating that the increases in interphase tetrasomies were most likely due to
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chromosome mis-segregation for the particular chromosome of interest (p = 0.4
and p = 0.3, respectively; Figure 12H).

LDL Induced Trisomy 7 in HASM Cells

Cytogenetic analyses of atherosclerotic plaques from diseased human arteries
and isolated primary smooth muscle cells (SMC) from these plaques have shown
a variety of chromosomal instabilities, including trisomy and tetrasomy 7,
monosomy 11, trisomy 10, 18, 20, and loss of the Y chromosome (Casalone et
al., 1991; Fernandez et al., 2000; Lavezzi et al., 2005; Matturri et al., 1997;
2001).

According to the Monoclonal Proliferation Theory of atherogenesis,

individual SMCs occasionally undergo a somatic mutation and chromosomal
alternations resulting in increased proliferative activity and consequent clonal
expansion to yield atherosclerotic lesions (Benditt and Benditt, 1975; Casalone et
al., 1991; Murry et al., 1997; Vanni and Licheri, 1991) similar to development of
aneuploid benign tumors. Therefore, the effect of lipoproteins (OX-LDL, LDL and
HDL) on chromosome segregation in primary human aortic smooth muscle cells
(HASMC) was assessed, and the cells treated with lipoproteins (20 μg/ml) for 48
hr, fixed, and analyzed by FISH with fluorescent DNA probe for chromosome 7.
Quantitative FISH analysis showed a statistically significant 3-fold increase in
trisomy 7 (p = 0.0007, Paired t-test; Figure 13A, B) in LDL-treated cells, and a
borderline significant increase in tetrasomy 7 over the background (6.2% over
3.4%, respectively; data not shown).

Compared to HDL, atherogenic and
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aneugenic LDL-cholesterol induced significantly more trisomy 7 (p = 0.01, Paired
t-test) within 48 hr.

Figure 13. LDL-induced Trisomy 7 in HASM Cells
(A) Quantitative FISH analysis of HASM cells showed an increase in trisomy 7 when incubated with 20 µg/ml
of LDL for 48 hours. Atherogenic LDL-cholesterol induced significantly more trisomy 7 compared to HDLtreated cells. A Paired t-test was used to compare aneuploidy induction between treated and untreated cells,
and between LDL and HDL-treated cells.
(B) LSI® D7S522 SpectrumOrange™ probe was used to detect a region on chromosome 7 in interphase
cells.

LDL-induced Trisomy 7 may be Dependent on a Functional LDL Receptor

To establish whether lipoprotein-induced chromosome mis-segregation may be
mediated through the LDLR and thus dependent on intracellular signaling,
human

primary

cells

from

the

patients

diagnosed

with

familial

hypercholesterolemia (FH) were obtained, and the aneuploidy levels were
compared to control cells with a functional LDLR after exposing them to various
lipids under the same conditions.
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LDL receptor belongs to a large family of structurally and functionally
homologous cell-surface receptors, the LDLR receptor family (Brown and
Goldstein, 1976; 1986; Herz and Bock, 2002; Hussain et al., 1999) which are
involved in diverse cellular functions implicated in AD pathogenesis (Jaeger and
Pietrzik, 2008; Andersen and Willow, 2006), from cholesterol metabolism and
Apolipoprotein E (ApoE) binding (Herz and Beffert, 2000) to APP trafficking and
processing (Abisambra et al., 2010; Marzolo and Bu, 2009). The LDLR is a
ubiquitously expressed transmembrane protein that mediates clearance of
cholesterol rich LDL particles circulating in the blood and facilitates LDL
internalization into cells (Brown and Goldstein, 1976; 1986; Goldstein and Brown,
1976; 1987), and is, therefore, essential for cholesterol homeostasis. To date,
there are more than 1066 unique LDLR genetic alternations that lead to FH
(Leigh et al., 2008) causing three to four times higher levels of LDL cholesterol
than normal (Khachadurian, 1964) and premature CVD events, including severe
atherosclerosis (reviewed in Fahed and Nemer, 2011).
To investigate whether lipoprotein-induced chromosome mis-segregation
requires a functional LDLR, FH primary human fibroblasts (Coriell repository
number GM01915) harboring two mutations in the LDLR gene and normal
human fibroblasts (NHF, repository number GM01661) were treated with 20
µg/ml of lipoproteins for 48 hr and assessed for aneuploidy. Quantitative FISH
analysis revealed that LDL treated NHF develop significantly higher levels of
trisomy 7 compared to FH fibroblasts exposed to the same concentration of LDL
(p = 0.03, Paired t-test; Figure 14A, B).
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Compared to HDL-cholesterol,

atherogenic LDL induced more aneuploidy cells which reached a borderline
significance (p = 0.07). The data indicates that a functional LDLR is necessary to
observe LDL-induced chromosome mis-segregation and aneuploidy generation
in vitro.

Figure 14. LDL-induced Trisomy 7 in Primary Human Fibroblasts may be LDLR
Dependent
(A) Normal human fibroblasts (NHF, light gray bars) developed significantly higher levels of trisomy 7 when
treated with 20 µg/ml of LDL within 48 hr compared to LDL receptor deficient human fibroblasts obtained
from the patient diagnosed with familial hypercholesterolemia (FH, black bars). Compared to HDL-treated
NHF, LDL-cholesterol induced a 2-fold increase in trisomy 7 that reached a borderline significance (p = 0.07,
Paired t-test). The data suggest that a functional LDLR may be required for aneugenic effect of LDL in vitro.
(B) FISH analysis and LSI® D7S522 SpectrumOrange™ probe was used to detect chromosome 7 in
interphase cells.

Lipoprotein-induced Aneuploidy is Independent of APP

As discussed previously, accumulated evidence from experimental, animal and
human studies points to the role of cholesterol in APP processing and Aβ
generation and clearance (e.g., Eckert et al., 2000; Panza et al., 2009; Pfrieger,
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2003; Schneider et al., 2006; Solomon et al., 2008). High lipoprotein/cholesterol
within the plasma membrane promotes (Ehehalt et al., 2003; Hooijmans et al.,
2007; Refolo et al., 2001; Sparks et al., 1994; Xiong et al., 2008), and low
cholesterol reduces, the production of Aβ (Fassbender, et al., 2001; Refolo et al.,
2001; Simons et al., 1998), partly by changing the activity of the key membranebound secretases involved in APP proteolysis (e.g., Bodovitz and Klein, 1996;
Kojro et al., 2001; Schneider et al., 2006; Wahrle et al., 2002) within lipid rafts
microdomains (Lee et al., 1998; Parkin et al., 1999; Refolo et al., 1991; Simons
and

Toomre,

2000).

Furthermore,

Aβ

and

presenilin

(PS1/2)

affect

lipid/cholesterol metabolism (Cutler et al., 2004; Grimm et al., 2005) and
cholesterol content of the plasma membranes, influencing in turn their fluidity and
function (Grimm et al., 2006).
As mentioned previously, this lab reported that familial AD-causing (FAD)
mutations in the PS1 and APP gene and their pathogenic product, the Aβ peptide
induced aneuploidy in transgenic mice and transfected cells in culture (Boeras et
al., 2008; Granic et al., 2010) by disrupting the formation and stability of mitotic
spindle and by interfering with normal microtubule function (Borysov et al., 2011).
Moreover, Aβ-induced aneuploidy is dependent on a functional Tau gene and
tau-stabilized microtubules, and on interaction with endogenous APP (Granic et
al., 2010). Similarly, Aβ-induced cytotoxicity requires a full-length APP possibly
as a cell-surface receptor to aid endocytosis and generation of intracellular or for
the uptake of extracellular Aβ (Lorenzo et al., 2000; Shaked et al., 2006).
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To test the hypothesis that observed lipoprotein/cholesterol induced
chromosome mis-segregation in vitro may be independent of APP, APP
processing and consequent Aβ production, primary splenocytes from APPKO
mice and nontransgenic littermates were isolated and exposed to lipoproteins for
48 hr. The cells were fixed and hybridized with the mouse chromosome 16 BAC

Figure 15. Primary Mouse Splenocytes Lacking the APP Gene Expression Develop
Aneuploidy Upon Lipoproteins Treatment
(A) In situ DNA FISH with a BAC plasmid containing mouse chromosome 16 labeled with the
SpectrumOrange™ dUTP was used to detect the levels of aneuploidy in lipoprotein-treated primary
splenocytes derived from non-transgenic (NON) and APP gene deficient mice (APPKO).
(B) Quantitative FISH analysis revealed comparable levels of trisomy 16 in both cell types upon incubation
with 20 µg/ml of OX-LDL and LDL within 48 hours. The data suggest that aneugenic activity of lipoproteins
may be independent of a functional APP gene and thus probably independent of Aβ. Paired t-test was used
to compare the levels of aneuploidy in lipid-treated and untreated cells.
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probe (Kulnane et al., 2002) labeled with SpectrumOrange™ dUTPs by Nick
translation (Enzio Life Sciences) and scored for aneuploidy (Figure 15A). OXLDL and LDL induced significant increases in trisomy 16 in both cells types
compared to controls (p = 0.04 and p = 0.02 in OX-LDL-treated normal and
APPKO splenocytes, and p = 0.03 and p = 0.05 in LDL-treated cells,
respectively, Paired t-test; Figure 4B), suggesting that aneugenic effect of
lipoproteins may be independent of APP expression and Aβ production. Thus,
endogenous APP may not be required for lipoproteins-induced aneuploidy,
though it is needed for aneugenic activity of Aβ (Granic et al., 2010), Aβ-induced
tau phosphorylation (Pigno et al., 2001; Small and Duff, 2008) and Aβ cytotoxicity
(Rapoport et al., 2002; Roberson et al., 2007).

Water-soluble Cholesterol Induced Aneuploidy In Vitro

Cholesterol is the most abundant lipid in eukaryotic cell membranes (Bloch,
1991) and is compartmentalized into microdomains (e.g., lipid rafts; Brown and
London, 2000; Crane and Tamm, 2004; Pike, 2003), where it is required for
essential cellular functions and membrane structure, such as signaling
transduction and plasma membrane dynamics (Mukherjee and Maxfield, 2004;
Simons and Toomre, 2000; Weber et al., 2006).

It is well established that

membrane cholesterol content affects membrane stiffness and fluidity (Demel
and De Kruyff, 1976), which can be changed by either cholesterol enrichment or
depletion,

respectively

(e.g.,

Abramov
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et

al.,

2011;

Mukherjee

and

Chattopadhyay, 2005; Weber et al., 2006). Also, cyclodextrins as cholesterol
acceptors (e.g., methyl-β-cyclodextrin, MβCD) have been effectively used to
manipulate intracellular cholesterol levels (Christian et al., 1997; Yancey, et al.,
1996) and to aid the delivery of hydrophobic cholesterol into the plasma
membrane and cytosolic compartments (Härtel et al., 1998; Ohvo et al., 1997).
To examine the effect of MβCD-delivered exogenous cholesterol on
chromosome

segregation

in

vitro,

water-soluble

cholesterol (WsCh),

a

MβCD:cholesterol complex, and karyotype and FISH analysis was used to
assess the levels of overall and chromosome specific aneuploidy. First, hTERTHME cells were incubated with either 4 μg/ml or 2 μg/ml of WsCh for 48 hr, and
the metaphases analyzed for chromosome mis-segregation. The cells treated
with 4 μg/ml of cholesterol showed a 2-fold increase in total aneuploidy
compared to untreated cells (p = 0.01, Paired t-test) but no induction of
chromosome mis-segregation at the concentration of 2 μg/ml of WsCh was
observed (not significant; Figure 16A).

Second, FISH analysis for a specific

chromosome revealed a significant increase in trisomy 21 and trisomy 12 in 4
μg/ml WsCh treated cells (p = 0.01 and p = 0.03, respectively, Paired t-test;
Figure 16B) and no induction of tetrasomy 21 or 12 (data not shown). Taken
together, the data suggest that aneugenic effect of cholesterol is likely to affect
all chromosomes, and that this biological effect may be related to the changed
membrane fluidity in which cholesterol-enriched, more rigid membranes of the
nuclear envelope fail to properly attach chromosomes during mitosis, leading to
generation of aneuploid cells.
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Figure 16. Cholesterol: MβCD Complex-induced Aneuploidy in hTERT Cells
(A) Karyotype analysis of hTERT cells treated with 4 µg/ml water-soluble cholesterol (WsCh) showed the
induction of aneuploidy within 48 hr. Cell death was observed at the concentration of 10 and 20 µg/ml (data
not shown). A Paired t-test was used to evaluate the difference in aneuploidy between treated and
untreated cells.
(B) Quantitative FISH analysis with dual-labeled DNA probe revealed an increase in trisomy 21 and trisomy
12 but no induction of tetrasomy 21 or 12 (data not shown). The data suggests that exogenously derived
cholesterol balanced in MβCD is disturbing an important aspect of mitotic machinery probably by changing
plasma membrane fluidity, which in turn may affect chromosome segregation in general.
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Water-soluble Cholesterol Induced Trisomy 16 in mNPCs

Recently, this lab reported that Aβ-induced cell cycle abnormalities and
chromosome mis-segregation (Granic et al., 2010) may involve selective
inhibition of mitotic spindle motors and microtubule defects (Borysov et al., 2011),
which would especially be detrimental during neurogenesis and regeneration
upon neuronal injury (Ming and Song, 2005; Zhao et al., 2008), resulting in
malfunctional, apoptosis-prone neural progenitors and neurons. Trisomy 21 cells
that accumulate in the brains of AD patients (e.g., Iourov et al., 2009) and in FAD
transgenic mice (Boeras et al., 2008; Granic et al., 2010), over-express APP and
Aβ the imbalance of which may contribute to disease onset and progression, as
evident

in individuals harboring trisomy 21 mosaicism (Migliore et al., 2006;

Schupf et al., 1994) or an APP gene duplication (McNaughton et al., 2010;
Rovelet-Lecrux et al., 2006; Sleegers et al., 2006). Like Aβ, cholesterol-induced
mitotic defects in neural progenitors may lead to the development of aneuploid,
genetically-imbalanced neuronal and glial cells susceptible to apoptosis and
degeneration in vivo.
To test this hypothesis and to investigate the effect of cholesterol on the
development of aneuploidy, including trisomy 21 in mouse neural precursor cells
(mNPCs), neurospheres derived and cultured from prenatal brains of
nontransgenic mice (described in Chapter Three) were utilized, and subjected to
FISH with a fluorescently labeled BAC probe for chromosome 16 (Kulnane et al.,
2002), a mouse analog for human chromosome 21. Parallel mNPCs cultures
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were incubated with 4 µg/ml of WsCh for 7 days (equivalent to two cell divisions),
and fresh cholesterol-containing media replenished every other day to allow for
expansion of the spheres, a sign of mNPCs proliferation (Pacey et al., 2006).
More than 4% trisomy 16 was detected in untreated cells (Figure 17A), which
represents a constitutional genomic imbalance that has been previously reported

Figure 17. Cholesterol-induced Trisomy 16 in Mouse Neural Precursor Cells
(mNPC)
(A) Fluorescently labeled BAC DNA probe containing a sequence of mouse chromosome 16 was used to
detect aneuploidy levels in mouse neural precursor cells (mNPC) derived from prenatal brains of wild-type
mice (E17-18). Established neurospheres were treated with 4 µg/ml of WsCh for 7 days.
(B) Quantitative FISH analysis showed a 2-fold increase in trisomy 16 in WsCh-treated cells compared to
controls (Paired t-test). mNPC harbor up to 4.6% endogenous aneuploidy reported previously in developing
mouse and human brains (Peterson et al., 2008; Rehen et al., 2001; 2005).
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in developing and adult healthy human and mouse brains (Peterson et al., 2008;
Rehen et al., 2001; 2005; Westra et al., 2008; Yang et al., 2003; Yurov et al.,
2007). Therefore, to detect measurable levels of cholesterol-induced aneuploidy
over the background, mouse NPCs were incubated with the aneugenic
concentration of cholesterol for longer time, and revealed 2-fold increases in
trisomy 16 compared to untreated cells (p = 0.01, Paired t-test; Figure 17B).

Differential Distribution of Cholesterol and Trisomy 21 in NPC1 Neurons,
Glia, and Fibroblasts

To investigate the role of disrupted central and peripheral cholesterol
homeostasis in chromosome segregation in a human neurodegenerative disease
model, primary cells derived from the patients diagnosed with Niemann-Pick
Type C (NPC) disease (Table 1 in Chapter Three) were utilized. All patients
donors were clinically diagnosed with NPC, and the presence of disorder
assessed with either filipin staining or the cholesterol esterification assay (Park et
al., 2003), and by DNA analysis to confirm the mutation in NPC1 gene.
Mutations and deletions in the NPC1 and NPC2 genes cause impaired trafficking
of

unesterified

cholesterol

(both

LDLR-internalized

and

endogenously

synthesized) and other lipids (e.g., glycosphingolipids) that accumulate in late
endosomes and lysosomes and fail to travel to the plasma membrane and ER
(reviewed in Karten et al., 2009; Mukherjee and Maxfield, 2004; Peake and
Vance, 2010). Like with exogenously delivered cholesterol that changes plasma
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membrane stiffness, the ‘lipid traffic jam’ (Mukherjee and Maxfield, 1999) and
differential redistribution of intracellular cholesterol in NPC1/2 cells, including
neurons and glia away from plasma membrane (Karten et al., 2002; 2003;
Mukherjee and Maxfield, 2002) may affect membrane fluidity and elasticity
(Mukherjee and Maxfield, 1999), and proper chromosome segregation during
mitosis, which may lead to the development of aneuploid cells susceptible to
other cellular insults (e.g., oxidative stress) and apoptosis (Brusciglio and
Yankner, 1997).

Thus, intracellular cholesterol imbalance as a pathological

process that causes neurodegeneration in NPC disease may affect plasma
membrane structure of dividing cells and neural precursors, making them prone
to mitotic errors.
To test the association between cholesterol redistribution and genomic
instability in NPC disease, following assays were used: (1) immunofluorescence
labeling and fluorescence microscopy to compare the localization of unesterified
cholesterol between the neurons in NPC and age-matched normal brains; and
(2) FISH analysis to detect the level of chromosome mis-segregation in NPC
neurons, glia, and fibroblasts.

First, to visualize cholesterol distribution in

neurons from the sample (Table 1), a single-cell suspension derived from frontal
cortices of NPC cases and controls was fixed in PFA and co-stained with
neuronal marker (Neu-N Alexa Fluor® 488 antibody) and filipin (Figure 18A) as
described (Millard et al., 2000), and quantified into three distinct categories
based on filipin stain intensity (i.e., plasma membrane, intracellular and both).
Pronounced filipin-positive staining in endocytic organelles as indicative of
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intracellular cholesterol sequestration has been reported previously in cellular
(Jin et al., 2004; Millard et al., 2005), mouse models (Hawes et al., 2010; Kodam
et al., 2010; Treiber-Held et al., 2003) of NPC, and in fibroblasts and neurons
from NPC patients (Karten et al., 2002; reviewed in Morris and Carstea, 1998;
Vanier, 2010). Semi-quantitative analysis of cholesterol localization of the first 50
NeuN/filipin-positive cells revealed significantly more cholesterol staining in
intracellular compartments of NPC neurons (18%) compared to controls (2%, p =
0.02, Independent t-test) in which cholesterol was associated mostly with the
plasma membrane (85% verses 37%) (p = 0.02, Independent t-test; Figure 18B).
Second, a separate single-cell suspension of NPC and control brain cells
was fixed in methanol:acetic acid fixative and hybridized with the chromosome 21
probe or dual-color DNA probes for chromosome 21 and 12 (Figure 18C), and
chromosome 18 and 14 followed by immunocytochemistry with the NeuN
antibody to distinguish between neuronal and glial cell.

Quantitative FISH

analysis of Neu-N-negative and Neu-N-positive cells showed 4 to 6-fold
increases in trisomy 21 in both neurons and glia with the NPC mutation,
respectively compared to the cells from control brains (p = 0.02 and p = 0.0003,
Independent t-test; Figure 7C middle and right panel and Figure 18D). However,
there was no increase in aneuploidy of chromosomes 12, 14 and 18 in the mixed
brain cells population in NPC cases compared to controls (0.55% vs. 0.24%, p =
0.11; 1.61% vs. 1.46%, p = 0.41; and 0.75% vs. 0.78%, p = 0.45, respectively).
Third, primary fibroblasts from the patients harboring NPC1 mutations and
fibroblasts from controls were subjected to FISH analysis with DNA probes for
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Figure 18. Neurons, Glia, and Fibroblasts Derived from Niemann-Pick Type C1
(NPC1) Patients Harbored Aneuploidy and Altered Cholesterol Distribution
(A) NPC and control brain cells were co-stained with the NeuN antibody (green) and filipin (blue) to detect
continued>
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the localization of the intracellular cholesterol in neurons.
(B) Semi-quantitative analysis and comparison of cholesterol distribution between NPC and control neurons
revealed mostly perinuclear/cytoplasmic filipin staining in NPC and membrane staining in control cells.
(C) NPC1 fibroblasts were analyzed by FISH with the DNA probe for chromosome 21 (red) and 12 (green),
and counterstained with DAPI (blue) (first left panel). NPC brain cells from frontal cortices were subjected to
FISH analysis with DNA probe for chromosome 21 (red) followed by co-staining with NeuN antibody (green)
and DAPI (blue) nuclear stain, which revealed mostly disomic NeuN-positive (neurons) and NeuN-negative
(glia) cells (middle panels) but significantly higher levels of trisomy 21 in NPC neurons (right panel) and glia
compared to controls.
(D) FISH analysis of NeuN-positive and NeuN-negative cells derived from patients harboring NPC mutations
showed an increase in trisomy 21 cells compared to age-matched normal brain cells.
(E) Likewise, human fibroblasts from NPC1 individuals showed an increase in trisomy 21 compared to agematched controls. Independent t-test was used to compare cholesterol localization and the levels of trisomy
21 between cases and controls.

chromosome 21 and 12 and compared for chromosome mis-segregation. We
observed a 4-fold increase in trisomy 21 in NPC1 cells (p = 0.03, Independent ttest; Figure 18C left panel and Figure 18E) and an induction of aneuploidy 12
that did not reach statistical significance compared to normal fibroblasts (2.1%
vs. 0.4%, p = 0.12).

LIPOPROTEINS/CHOLESTEROL-INDUCED ANEUPLOIDY IN VIVO

Low and High Cholesterol Diets Induced Trisomy 16 in Splenocytes

An increasing body of evidence from observational and experimental studies
suggests that the disruption in systemic cholesterol homeostasis plays a role in
AD onset and progression (reviewed in Canevari and Clark, 2007; Panza et al.,
2009; Puglielli et al., 2003; Wolozin, 2004). For example, recent epidemiological
studies suggested a positive association between hypercholesterolemia at midlife
and the risk of AD decades later (Anstey et al., 2008; Kivipelto et al., 2001;
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2002a;

Solomon et al., 2007; 2009), and an increased risk of dementia/AD

among individuals consuming high cholesterol and/or saturated fats diet
(Engelhart et al., 2002; Kalmijn et al., 1997; Laitinen et al., 2006; Luchsinger and
Mayeux, 2004; Morris et al., 2003; Parrot and Greenwood, 2007).

Likewise,

murine and other animal models, including FAD transgenic mice fed a high
cholesterol diet (1-1.3% w/w) developed pronounced amyloid burden and
increased Aβ production (both central and peripheral), cerebrovascular
disturbance, inflammation and steeper cognitive decline and learning impairment
compared to animals on regular diets (Galloway et al., 2007; 2008; Hooijmans et
al., 2007; 2009; Li et al., 2003; Levin-Allerhand et al., 2002; Oksman et al, 2006;
Refolo et al., 2000; Shie et al., 2002; Sparks et al., 1994; Thirumangalakudi et
al., 2008; Tibola et al., 2010) within 5-12 weeks. Wild-type mice on long-term
cholesterol enriched regimens (e.g., Typical Western, Atherogenic, ThomasHartroft Diet) developed dyslipidemia (i.e., high total plasma cholesterol), altered
VLDL,

LDL

and

HDL

metabolism,

cerebrovascular

disturbances,

neuroinflammation, increased hepatic steatosis, atherosclerosis, and aerobic
and/or cognitive dysfunction (Li et al., 2003; Maxwell et al., 2009; Paigen et al.,
1990; Sullivan et al., 1997; Thirumangalakudi et al., 2008).

Furthermore,

inhibition of endogenous cholesterol synthesis with statins has been associated
with a reduced risk of AD and decreased amyloid deposits in several human
(Dufouil et al., 2005; Haag et al., 2009; Jick et al., 2000; Li et al., 2007; Sparks et
al., 2005; Wolozin et al., 2000) and animal studies (Fassbender et al., 2001;
Refolo et al., 2000).

The mechanistic link between increased extracerebral
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cholesterol content and intracerebral Aβ load is not fully understood (Puglielli et
al., 2003), but it points to disrupted oxysterol homeostasis (Papassotiropoulos et
al., 2002; Xie et al., 2003), vascular insults (reviewed in Bell and Zlokovic, 2009;
Casserly and Topol, 2004; de la Torre, 2010; Iadecola, 2010) and compromised
blood-brain-barrier (Takeshi et al., 2010; Zlokovic et al., 2008).
In the following in vivo experiment, it was investigated whether dietinduced hypercholesterolemia in atherosclerosis-susceptible wild-type mice, the
C57BL/6J strain (Li et al., 2003; Paigen et al., 1990) has an effect on
chromosome-segregation in peripheral (splenocytes) and brain cells.

Twelve

one month old nontransgenic mice (6 males and 6 females), the offspring from
the same breeding pair were randomly assigned to three dietary regiments (two
mouse pairs per group) for 12 weeks: (1) a regular rodent diet (18% protein, 5%
crude fat from oil and 0% cholesterol w/w; Harlan Laboratories); (2) a low (25%
protein, 4.2% crude fat and 0.02% cholesterol w/w, Harlan Laboratories); and (3)
a high cholesterol diet (17% protein, 21% milk fat, and 1% cholesterol w/w, total
cholesterol of 1.05%, Harlan Laboratories).

The characteristics of the mice

throughout the study are summarized in Table 2.

120

Table 2. Characteristics of the Mice Fed Three Different Diets for 12 Weeks

Compared to other diets, mice fed a low cholesterol diet consumed more food per mouse pair/week (p <
0.001, Paired t-test). Also, in each dietary group except for a low cholesterol diet, female pairs consumed
more food/g/mouse pair/week (p < 0.05). Correspondingly, mice fed a low and high cholesterol diet digested
significantly more DE compared to mice fed a regular diet (p < 0.001; Paired t-test). All female pairs except
in a low cholesterol diet group consumed more DE than male pairs (p < 0.05). Thus, mice fed high
cholesterol diet gained significantly more weight within 60 days compared to mice on a regular and low
cholesterol diet (p < 0.05, Paired t-test).
Digestible Energy (DE) is the total amount of energy in the diet minus the energy in indigestible portion of
the food.
All values are presented as M ± SD. Paired Student t-test was used to compare the differences in food and
caloric intake and weight gain between dietary groups. *p<0.05, **p<0.01, ***p<0.001

Compared to other diets, the mice fed a low cholesterol diet consumed more
food per mouse pair/week (p < 0.001, Paired t-test), and the mice on either a low
and high cholesterol diet digested significantly more Digestible Energy per week
compared to the mice fed a regular chow (p < 0.001, Paired t-test). Because of
the difference in caloric value between the diets, the mice on a high cholesterol
diet gained on average 2 ½ times more weight than the mice fed either a regular
chow or low cholesterol diet within 60 days of intervention (p < 0.05; Paired ttest). All four mice in the high cholesterol group developed hepatic steatosis, a
sign of dyslipidemia while mice in the two other dietary groups showed no
indication of fatty deposits in the livers (observational data). Oil-Red-O staining
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of isolated hepatocytes revealed pronounced Oil-Red-O staining in mice fed a
high cholesterol diet compared to mice consuming regular chow (Figure 19A)
Primary splenocytes cultures were grown according to established
protocol (Boeras et al., 2008) for 44 hours in Con A containing media, fixed and
prepared for FISH analysis with fluorescently labeled BAC probe for
chromosome 16. Brains were processed to yield a single-cell suspension as
described elsewhere and analyzed for aneuploidy (Granic et al., 2010). FISH
analysis of spleen cells from mice fed a low and high cholesterol diet showed a
significant increase in trisomy 16 compared to splenocytes of mice fed a regular
diet (p = 0.005 and p = 0.02, respectively, Paired t-test; Figure 19B), and no
induction of aneuploidy in the brain cells (data not shown). While there are no
animal studies to date demonstrating that diet-induced hypercholesterolemia in
nontransgenic mice affects brain cholesterol homeostasis, the data suggest that
development of aneuploidy cells in peripheral (visceral) tissues of animals fed
high cholesterol may be an initiating event that precedes the induction and
accumulation of aneuploidy in the brain resulting from, for example,
compromised BBB (Zlokovic, 2008). Lipoproteins and Aβ complexes from the
periphery may pass across weakened BBB as demonstrated by co-localization of
plasma ApoB and Aβ close to the cerebral vasculature (Takechi et al., 2010) and
thus contribute to genomic instability in the brain.
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Figure 19. Young Wild-type Mice Fed Low (0.02%) and High (1.05%) Cholesterol
Diets for 12 Weeks Developed Higher Levels of Trisomy 16 in Spleen Cells
Compared to Mice Fed Regular Diet
(A) Mouse hepatocytes (hematoxylin; light gray in micrograph) were stained with Oil-Red-O stain (dark gray
in micrograph) to detect accumulation of lipid droplets, a sign of liver steatosis and consequence of
dyslipidemia.
(B) Quantitative FISH analysis of primary splenocytes revealed a 2 to 3-fold induction of trisomy 16 in a low
and high cholesterol diet fed mice compared to the animals on a regular diet (Paired t-test). No induction of
aneuploidy in the brain cells was observed in either low or high cholesterol diet fed mice (data not shown).
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MECHANISM OF LIPIDS-INDUCED CHROMOSOME MIS-SEGREGATION

Alterations in Extracellular Ca2+ may Attenuate OX-LDL and LDL-induced
Aneuploidy In Vitro

It has been postulated that perturbed calcium homeostasis plays an important
role during aging and in AD pathogenesis (Eckert et al., 1994; Khachaturian,
1994; LaFerla, 2002).

Aβ peptide neurotoxicity is partly explained by Ca2+

dysregulation in synapses early in AD (Green and LaFerla, 2008). Increased
production of a longer, more toxic version of Aβ peptide, Aβ42, by mutations in
PS1 and PS2 gene leads to overload of intracellular calcium stores and deficits in
Ca2+ refilling mechanism, and reductions in γ-secretase/PS1-dependent Ca2+
levels in the ER (Mattson and Chan, 2003). Recently, it has been shown that
oligomeric Aβ incorporates into neuronal membranes forming ‘amyloid channels’
that contribute to Ca2+ disturbances prior to the accumulation of Aβ deposits and
classic senile plaque burden (Kawahara et al., 2011).

Furthermore, calcium

augments Aβ formation and tau phosphorylation (reviewed in LaFerla, 2002; Yu
et al., 2009), and it is required for Aβ-induced inactivation and cleavage of tau
(Park and Ferreira, 2005), as well as for the proper function of kinesin-like MT
motors important for spindle formation and mitosis (Vinogradova et al., 2009;
Wang and Schwarz, 2009).

In the study of Aβ-induced aneuploidy, this

laboratory has shown that chelation of extracellular Ca2+ with BAPTA prevented
chromosome mis-segregation in vitro (Granic et al., 2010), possibly by
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inactivation of calpain-mediated tau cleavage and consequent destabilization of
microtubules.
To

elucidate

the

role

of

Ca2+

in

lipoproteins/cholesterol-induced

aneuploidy and to investigate whether the blockage of Ca2+ influx may normalize
chromosome mis-segregation, several experiments with hTERT-HME cells using
two different chelating reagents, EGTA and BAPTA were conducted. First, the
cells were pre-treated with 1.5 mM of EGTA for 3 minutes before the incubation
with 20 µg/ml of lipoproteins for 48 hr, then fixed by standard cytogenetic
procedures and analyzed by FISH. Karyotype and FISH analysis revealed a
slight increase in total aneuploidy and lower mitotic index in EGTA-treated cells,
but similar levels of trisomy 21 and 12 compared to controls (data not shown).
Contrasting the aneuploidy levels of the cells treated with EGTA and lipoproteins
to cells incubated only with lipids, we observed a 3-fold decrease in OX-LDL
induced trisomy 21 (p = 0.04, Paired t-test; Figure 20A), tetrasomy 21 (p = 0.01,
Paired t-test), and tetrasomy 12 (p = 0.03, Paired t-test; Figure 20B). Second, to
confirm these results, the hTERT-HME1 cells were pre-incubated with 1 mM of
extracellular Ca2+ chelator BAPTA for 3 minutes, and treated with lipids for 48 hr.
The results showed a statistically significant BAPTA-dependent reduction in OXLDL-induced trisomy 21 (p = 0.02; Paired t-test), trisomy 12 (p = 0.01; Paired ttest; Figure 20C) and a borderline decrease in trisomy 21 in LDL-treated samples
(p = 0.065; Paired t-test; Figure 20C).
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Figure 20. Alternations in Extracellular Ca2+ with Chelators may Attenuate OX-LDLinduced Aneuploidy In Vitro
(A-C) Quantitative FISH analysis with dual-labeled DNA probe for chromosomes 21 and 12 showed a
significant reduction in trisomy 21 (A), tetrasomy 21 (light gray bars, B) and tetrasomy 12 (black bars, B) in
2+
hTERT cells pretreated with 1.5 mM of Ca chelator EGTA compared to the cells treated only with OX-LDL.
continued>
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(C) Also, cells pretreated with 1 mM BAPTA had significantly lower levels of OX-LDL-induced trisomy 21
(light gray bars, C) and trisomy 12 (black bars, C) compared to the cells grown without chelator. Paired ttest was use to compare aneuploidy levels between the lipids-treated cells with and without chelators.

Changing Membrane Fluidity by Ethanol Decreased Lipids-induced
Chromosome Mis-segregation In Vitro

The membrane fluidizing property of ethanol (EtOH) and its effect on the
biophysiology of different mammalian cell including neuronal membranes, has
been recognized (Alling, 1983; Goldstein, 1983; Rubin and Rottenberg, 1982)
and actively investigated (e.g., Bae et al. 2005; Marques et al., 2011; Serget et
al., 2004).

The membrane disordering effect of acute and chronic ethanol

exposure has been attributed to several processes, including (1) perturbation of
acyl chains’ ordering within the membrane (Holte and Gawrisch, 1997; Marques
et al., 2011); (2) altered binding to the lipid-water surface (Barry and Garwrisch,
1994); (3) changed membrane cholesterol content compared to other lipids
(Yamada and Lieber, 1984), and (4) oxidative stress induced by ethanol
metabolism (Sergent et al., 2004). As mentioned before, both lipoprotein- and
MβCD-delivered cholesterol increase the membrane cholesterol content in vitro
(Abramov et al. 2011), decreasing membrane fluidity and elasticity (Demel and
De

Kruyff,

1976).

It

could

be

hypothesized

that

the

cells

with

lipoprotein/cholesterol-enriched membranes may be prone to mitotic errors, and
that this biological effect may be counteracted by membrane-fluidizing actions of
ethanol.
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To determine whether enhancing membrane fluidity with ethanol prior to
lipoproteins/cholesterol treatment may reduce aneugenic effect of lipids, the
hTERT cells were pretreated with 25 mM of EtOH for 24 hr and further coincubated with lipids in EtOH-containing media. The rationales for using this
concentration of EtOH were: (1) 25 mM or 0.115% correspond to the bloodalcohol levels of moderate drinkers (1-3drinks a day, 15-45 g), which has been
associated with a decrease in CVD (Rimm et al., 1999) and AD (Luchsinger et
al., 2004) risk; 2) increased cholesterol efflux and cholesterol transport but
unchanged cholesterol synthesis have been observed in human astrocytes in
vitro at the concentration of 25 mM of EtOH in the presence and absence of
cholesterol acceptors (Guizzetti et al., 2007); (3) preincubation of hepatic cells
with 0.5% EtOH did not have an effect on LDLR or LDL (Dashti et al., 1996); (4)
25mM EtOH fluidized the exofacial leaflet of the synaptic membranes (Schroeder
et al., 1988; Wood et al., 1989); and (5) pilot experiments showed low cytotoxicity
and up to ~95% of cell viability within 48 hr of EtOH exposure and non-significant
induction of aneuploidy (data not shown).

To avoid evaporation and assure

consistent concentration of EtOH in the culture (Eysseric et al., 1997), a modified
closed chamber system was used (i.e. ‘compensating system’, described below;
Adickes et al., 1988; Rodriguez et al., 1992) with EtOH replenished every 24 hr.
A colorimetric assay (OD570; Ethanol Assay Kit, BioVision) was used to measure
the ethanol concentrations in two random EtOH-containing samples at the
baseline, 24 and 48 hr later and calculated according to manufacturer’s
specifications (mean ± standard deviation of three dilutions; M ± SD; 22.32 ±
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0.36, 20.39 ± 0.58, and 18.29 ± 0.59 mM, respectively). A slight decrease in
EtOH levels within 24 hr of each time point was not statistically significant (Paired
t-test, data not shown).
Quantitative FISH analysis with dual-labeled translocation DNA probe of
lipoproteins/EtOH-treated cells showed a significant decrease in OX-LDL and
LDL-induced trisomy 21 (p = 0.015, Paired t-test; Figure 21A), and OX-LDL and
LDL-induced trisomy 12 (p = 0.012, Paired t-test; Figure 21B), suggesting that
fluidization of the membranes by EtOH may stabilize chromosome segregation
upon lipid treatment. In this experiment, a statistically significant LDL-induced
aneuploidy for chromosomes 21 and 12 was observed (p = 0.02 and p = 0.03,
respectively, Paired t-test), which separately reached a borderline significance in
previous experiments (Figure 12B, C), a variation that may be contributed to the
clonal change in hTERT aneuploidy background (Granic and Potter, unpublished
data) and to a difference in LDL-cholesterol composition between different
lipoprotein batches.
It has been reported previously that ethanol can affect cell proliferation
(Guizzetti et al., 1997; Luo and Miller, 1998) by affecting the length of G1 and S
phase (Hicks et al., 2010), and by delaying the progression though M phase of
the cell cycle (Mashimo et al., 1999).

Also, recent in vitro studies showed

ethanol-induced chromosomal instability and chromosomal damage in human
cell lines, including neurons (Benassi-Evans and Fenech, 2011, Kayani and
Parry, 2010; Lamarche et al., 2004). Here, a non-significant increase in trisomy
21 (Figure 21A), tetraploidy 21 and 12 in 25 mM EtOH-treated cells was
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observed within 72 hours, and no reduction in OX-LDL and LDL-induced
tetraploidy in EtOH pre-incubated samples (data not shown). An opposing effect
of lipoproteins and ethanol on chromosomal stability in vitro could be postulated
in which EtOH-induced fluidization of the membrane may attenuate or normalize
its rigidity caused by exogenous lipoproteins/cholesterol delivery and increased
membrane lipid content.

Figure 21. Altering Membrane Fluidity with Ethanol Decreased Lipoproteinsinduced Aneuploidy In Vitro
(A-B) Quantitative FISH analysis of hTERT cells pre-treated with 25 mM of ethanol (EtOH) for 24 hr and coincubated with lipoproteins and EtOH for next 48 hr revealed a decrease in OX-LDL and LDL-induced
continued>
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trisomy 21 (A) and trisomy 12 (B) (Paired t-test). No change in tetraploidy 21 or 12 was observed (data not
shown). This experiment was conducted in the closed chamber system to counteract EtOH evaporation and
to assure consistent EtOH concentration. Colorimetric assay (OD570) was used to measure EtOH levels in
two random samples at the baseline, 24, and 48 hr later. A slight decrease in EtOH concentration within 48
hr was observed, but stayed at 82% of the baseline.

To summarize, this study reported several novel findings investigating the
cytogenic link between CVD and AD: (1) atherogenic lipoproteins (i.e., LDL, OXLDL) and cholesterol induced chromosome mis-segregation, including trisomy
and tetrasomy 12 and 21, and trisomy 7 in primary human and mouse cells in
vitro, and apparently require a functional LDL receptor but not the presence of
APP gene to exert their aneugenic effect; (2) disturbance in intracellular
cholesterol homeostasis and obstructed cholesterol trafficking to the plasma
membrane may be associated with an increase in trisomy 21 in NPC1 fibroblasts,
neurons and glial cells; (3) long-term exposure to dietary cholesterol may induce
chromosome mis-segregation in peripheral tissues of young wild-type mice; and
(4) alternation in either extracellular Ca2+ homeostasis or plasma membrane
fluidity may decrease lipoproteins/cholesterol-induced aneuploidy in vitro.
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CHAPTER FIVE
DISCUSSION

The

main

premise

of

this

dissertation

was

that

atherogenic

lipoproteins/cholesterol disrupt genomic stability in vitro and in vivo and thereby
contribute to the etiology of Alzheimer’s disease. Several important ideas and
discoveries prompted the research described here, including that (1) the cell
cycle defects and chromosome mis-segregation as a pathological trait of
Alzheimer’s disease are associated with overexpression or mutations in FAD
genes, PS1/2 and APP, and its proteolytic product, the amyloid-beta peptide,
which acts as a mitotic spindle toxin leading to accumulation of aneuploid and
hyperploid, apoptosis prone neurons and neural progenitors (e.g., Arendt et al.,
2010; Boeras et al., 2008; Borysov et al., 2010; Granic et al., 2010; Iourov et al.,
2009; Obrenovic et al., 2003; Potter, 1991, 2008); (2) atherosclerotic plaques are
characterized by a monoclonal expansion of smooth muscle cells in arterial walls
under high LDL (OX-LDL)-cholesterol stimuli (e.g., Matturri et al., 1997; 2001),
which trigger chromosomal aberrations; (3) disturbed cholesterol homeostasis as
a risk factor for AD is associated with enhanced amyloidogenesis and
atherogenesis in the brain and blood vessels, changed plasma membrane
dynamics, and compromised integrity of the BBB (e.g., Casserly and Topol,
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2004; Dolan et al., 2010; Solomon et al., 2007; Xiong et al., 2009; Zlokovic,
2008), leading to decreased clearance of neurotoxins, inflammation and neuronal
death.

Despite a body of molecular, cellular and epidemiological evidence

pointing to the central role of lipoproteins/cholesterol in AD initiation and
progression, the mechanistic connections between cardiovascular and brain
disease risk factors (e.g., hypercholesterolemia) are only partly understood. One
challenge has been that there is a separation and limited exchange between
peripheral and central cholesterol pools, suggestive of independent pathological
pathways.
Cholesterol is a molecule essential for life, involved for example in brain
development and function—yet excess, shortage or erroneous distribution of
extracellular or intracellular cholesterol could be detrimental and lead to
neurodegeneration. Investigating further the event of chromosomal instability as
a ‘cytogenetic hallmark’ of AD and the involvement of other dementia-associated
molecules in aneugenesis, this study revealed that the cell lines with a functional
LDL receptor developed mitotic defects and aneuploidy of several chromosomes,
including HSA21 upon treatment with elevated levels of lipoproteins (OX-LDL
and LDL) and cholesterol, the common risk factors for AD and CVD
(atherosclerosis), independently of Aβ-mediated genomic instability. The cells
exposed to cardioprotective HDL-cholesterol (Assmann and Gotto, 2004) were
less prone to genomic errors. Furthermore, disrupted intracellular cholesterol
homeostasis in Niemann-Pick skin and brain cells was associated with HSA21
mosaicism, possibly due to the changed distribution of the cellular cholesterol
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between the cytosolic compartments and plasma membrane.

In the animal

model of diet-induced hypercholesterolemia, atherosclerosis susceptible wildtype mice fed a high cholesterol diet soon developed aneuploidy in peripheral
cells.

Attenuation of the extracellular calcium levels and therefore the

inactivation of, for example calpain-mediated tau cleavage, decreased the lipidinduced chromosome mis-segregation in cultured cells.

Also, changing the

plasma membrane property with ethanol prior to and during lipoproteins and
cyclodextrin-derived cholesterol incubation reduced aneugenesis by 2-3-fold in
vitro. Taken together, the data suggest a common pathological trait and a unique
cytogenetic mechanistic link between AD and atherosclerosis in which elevated
cholesterol acts as environmental aneugen.
This chapter will explore (1) the relevance of lipid-mediated aneuploidy in
AD with regards to the recent findings involving membrane cholesterol-Aβ-tau
and calcium homeostasis connections (2) the possible role of plasma membrane
fluidity in cholesterol-induced genomic instability; (3) the limitations of employed
experimental designs; (4) future experiments to further address the research
questions; and (5) diagnostic and therapeutic implications of the chromosome
mis-segregation in AD and CVD.

LIPOPROTEINS/CHOLESTEROL-INDUCED ANEUPLOIDY IN VITRO

Several human cell lines (mostly derived from primary cultures) used in this study
developed

a

rapid

chromosome

mis-segregation
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and

aneuploidy

of

chromosomes 7, 12 and 21 upon treatment with atherogenic lipoproteins, OXLDL and LDL, compared to HDL-treated cells or untreated controls (Figures 12BG; 13A; 14A). The studies of atherogenesis have shown that smaller and denser
LDL particles are prone to oxidation and easily penetrate into subendothelial
arterial space, initiating the atherosclerotic process (Berliner and Haberland,
1991; reviewed in Ross, 1993; Tsimikas and Miller, 2011). The data presented
here suggest another biological role of atherogenic lipoproteins—induction of cell
cycle defects and aneuploidy that is likely to affect other chromosomes besides
7,12, and 21.
Mis-segregation of chromosomes 7, 12 and 21 has been reported in
previous studies in the brains and peripheral tissues of AD patients (e.g., Geller
and Potter, 1999; Iourov et al., 2009), as well as in the mouse and cellular
models of AD (e.g., Boeras et al., 2008), and in atherosclerotic plaques (e.g.,
Matturri et al., 1997; 2001).

To date, it is not known whether or how the

relationship between the AD candidate genes and mis-segregation of carrier
chromosomes, and thus altered gene (gene product) expression, bears on the
etiology of AD. Whereas aneuploidy of HSA21 fits well with the Down Syndrome
Model of AD (Potter, 1991), altered genomic homeostasis (i.e., APP
overexpression) and the Amyloid Cascade Hypothesis (e.g., overproduction of
Aβ) (Hardy, 2006), other chromosomes susceptible to mitotic errors may carry
the genes involved in other pathways significant to AD, such as cholesterol
metabolism and de novo lipogenesis. For example, recent genome scan and
association studies reported at least three late-onset AD candidate genes located
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on chromosome 12 (e.g., Scott et al., 2000); of which oxidized LDL (lectine-like)
receptor 1(OLR1), a gene implicated in lipid metabolism, has been proposed as a
risk factor for AD in some French and American families (Lambert et al., 2003),
and has been associated with increased Aβ40 levels and pronounced CAA in
frontal cortices of AD patients (Shi et al., 2006). Moreover, OLR1 has been
linked to tumorigenesis (Hirsch et al., 2010), upregulation of NF-κB and its target
oncogenes responsible for inhibition of apoptosis (Khaidakov et al., 2011) and to
development of atherosclerotic lesions (Chen et al., 2000), suggesting a
mechanistic overlap between atherogenic and oncogenic pathways.
A future study utilizing SKY or mFISH techniques could determine, for
example, the frequency and type of chromosomal aberrations for each
chromosome in mitotically active cells upon lipoprotein treatments, and establish
whether, under certain aneugenic stimuli, some chromosomes are lost or gained
more than others.
It is well established that ApoE and LDL receptors are key players in the
etiology of AD (e.g., reviewed in Gopalraj et al., 2005; Jaeger and Pietrzik, 2008;
Kim et al., 2009) and are involved in ‘lipid’ and ‘amyloid cascade’ pathways. Both
candidate genes reside on chromosome 19 (19q13.2 and 19p13.2, respectively)
(Francke et al., 1984; Lin-Lee et al., 1985; Smit et al., 1988) within the A-T rich
and gene poor chromosome bands as revealed by G-banding (Rønne, 1990;
Ushiki et al., 2002), but the loss or gain of this chromosome has not been
reported in relation to AD. Early molecular studies in the laboratory of H. Potter
that investigated the role of ApoE allelic variants in Aβ polymerization (Ma et al.,
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1994; 1996) and their possible involvement is the cell cycle defects in AD,
determined that apoprotein alone had no aneugenic properties in vitro, but rather
the lipid cholesterol bound to it could be the candidate effector molecule that
triggered

erroneous

chromosome

segregation

(Lee

and

Potter,

1995;

unpublished data). This dissertation confirmed the initial hypothesis. However, it
is not known whether the absence of ApoE or presence of its different allelic
variants (i.e., ε2, ε3, and ε4; Strittmater et al., 1993a) would result in a more or
less pronounced aneugenic karyotype upon lipoprotein treatment.

Similarly,

whether AD transgenic mouse models harboring mutant APP or PS1 genes in
combination with different APOE alleles develop variable aneuploidy profiles may
be worthwhile to investigate.
As mentioned above, ApoE, a major cholesterol transporting molecule in
the brain and a ligand for LDLR in neurons and glia, is produced de novo by
astrocytes (reviewed in de Chaves and Narayanaswami, 2008), and performs
several functions that are isoform-specific. ApoE coordinates cholesterol intake
and redistribution during development or after neuronal injury (May et al., 2007;
Poirier, 2003); it associates with Aβ, promoting its aggregation in an isoformspecific manner (e.g.,Ma et al., 1994; Wisniewski et al., 1994), and is involved in
inflammation, tau aggregation, signaling transduction, and brain cells survival
(Gee and Keller, 2005; Kim et al., 2008). To date, APOE ε4 gene is the most
investigated and best established risk factor for late-onset of AD. There is no
consensus among the researchers about the relationship between cholesterol
homeostasis, ApoE and AD (Kivipelto et al., 2002a). One of the hypotheses
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reviewed by de Chaves and Narayanaswami (2008) emphasizes the isoformspecific effect of ApoE in AD pathogenesis. Animal and cellular studies revealed
several pathology-promoting features of APOE ε4 gene, which include: (1) less
efficient cholesterol delivery to neurons for regeneration and repair; (2) impaired
antioxidant mechanism; (3) promotion of tau and Aβ aggregation; (4) reduced Aβ
clearance; (5) dysregulation of neuronal signaling; (6) altered LDL receptor
binding; (7) greater susceptibility to proteolytic degradation and aggregation; (8)
and

lesser

cellular

cholesterol

release

(reviewed

in

de

Caves

and

Narayanaswami, 2008). It is believed that compared to ε4, other isoforms of the
APOE gene are neuroprotective (Ma et al., 1994; Wisniewski et al 1994; Rebeck
et al., 2002), and are less involved in AD-promoting pathways. Taken together, it
could be hypothesized that the carriers of APOE ε4 genotype in combination with
unfavorable AD genes and environmental risk factors may be more at risk for AD
and neurodegeneration than non-carriers, but whether they are more susceptible
to chromosome instability is currently not determined.

The role of APP and LDLR in Lipid-induced Aneuploidy

This study provided in vitro evidence that aneugenic effect of lipoproteins may be
independent of APP expression and Aβ production, and that both aneugens may
act separately, at least in their early steps. On the other hand, a functional LDL
receptor was required for aneugenic activity of LDL.
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Accumulated evidence from molecular and animal studies indicates that
cholesterol is involved in APP processing and Aβ generation (e.g., Eckert et al.,
2000; Refolo et al., 2001; Solomon et al., 2009), partly by affecting the activity of
membrane-associated APP-secretases (e.g., Ehehalt et al., 2003; Kojro et al.,
2001). Aβ toxicity includes the interference with a proper mitotic spindle function
(Borysov et al., 2011) and consequent aneuploidy that is dependent on a
functional Tau gene and on the presence of endogenous APP (Granic et al.,
2010).

To determine whether lipids and Aβ-induced chromosome mis-

segregation are mechanically related, mouse spleen cells lacking the APP gene
were exposed to lipoproteins, and the aneuploidy levels compared to lipid-treated
cells with a functional gene (Figure 15B) under the same experimental
conditions. Comparable levels of OX-LDL and LDL-induced trisomy 16 (up to
~5.5%) were observed in both cell lines, suggesting that neither endogenous
APP or Aβ, nor Aβ-induced Tau phosphorylation was required for lipoproteininduced aneuploidy.
To confirm these results in other cell models, the following experiments
could be conducted. To determine the role of APP in lipid-induced aneugenesis
in the brain cells, neural precursor cells (Pacey et al., 2006) derived from young
APPKO mice with the established genotype could be treated with isolated lipids
prepared with ApoE as a protein carrier.

Human monocyte-derived

macrophages exposed to OX-LDL exhibit increased production of lipid-free ApoE
(Cader et al., 1997), which could be immunoprecipitated from the culture
supernatant, and, coupled with purified lipids, extracted and isolated by the
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method described by Bligh and Dayer (1959) to generate ApoE containing LDL
particles. In addition, siRNA gene silencing technology (Elbashir et al., 2001)
could be employed to transiently block the expression of APP in a human cell line
followed by the treatment with lipoproteins.
As discussed previously, the LDL receptor family has been implicated in
several processes relevant to AD pathogenesis, which include isoform-specific
ApoE binding (Hertz and Beffert, 2000), APP trafficking and processing
(Abisambra et al., 2010; Marzolo and Bu, 2010), decreased amyloid deposition
and increased Aβ clearance upon overexpression (Kim et al., 2009), and
synaptic plasticity (Herz, 2009). In the periphery, the main function of LDLR is to
mediate the removal of cholesterol from the bloodstream (Brown and Goldstein,
1986), and to reduce the risk of atherogenesis and coronary heart disease
(CHD). The number of LDL receptors in liver, and thus the efficiency of LDL
removal are regulated by the cholesterol content in hepatocytes (Goldstein and
Brown, 1987). The data reported here suggest another potential role of LDLR—
mediation of LDL-induced aneuploidy in vitro (Figure 14A). Future studies could
determine the relationship between downregulation and upregulation of LDL
receptor and lipid-induced aneuploidy in vitro by manipulating the expression of
the receptor prior to LDL-cholesterol treatment.
Genetic defects in the LDLR gene result in impaired clearance of
lipoproteins from the circulation and severe atherosclerosis and the risk of CHD.
Mutations in LDLR are classified into several classes based on the
characteristics of the mutant receptor (e.g., class 1 mutations lead to absence of
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the protein; class 2 (50% of the mutations) affect the intracellular transport of the
receptor; in class 3, mutant receptors can reach the cell membrane but are
defective in binding to lipoprotein; class 4 mutations prevent the ligand-receptor
internalization) (Gent and Braakman, 2004). The class of the mutant FH cell line
used in this study is not known, but it could be hypothesized that similar results
would be obtained with cell lines harboring a different class of LDLR mutation.
Alternatively, gene silencing technology could be used to completely block the
receptor in hTERT-HME1 cells prior to lipid treatment to confirm the results
obtained with the primary fibroblasts.
In summary, it could be suggested that the presence of LDLR and
absence of APP play a complex, interdependent role in lipoprotein-induced
chromosome mis-segregation in vitro, which could be further explored by utilizing
different cell models and methods.

HIGH CHOLESTEROL DIET-INDUCED ANEUPLOIDY

Epidemiological evidence suggests an association between high consumption of
cholesterol and saturated fats and dementia (e.g., Engelhart et al., 2002; Kalmij
et al., 1997; Luchsinger and Mayeux, 2004; Morris et al., 2003; Solfrizzi et al.,
2005). Similarly, familial AD (FAD) and nontransgenic animals on a long-term
high cholesterol regimen develop dyslipidemia, neuroinflammation, increased
amyloid burden, atherosclerosis, hepatic steatosis, and cognitive dysfunction
(e.g., Levin-Allerhand et al., 2002; Li et al., 2003; Maxwell et al., 2008; Oksman
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et al., 2006; Refolo et al., 2000) compared to animals on regular diets.
Compromised BBB and vascular insults (Iadecola, 2010; Zlokovic, 2008) due to
altered peripheral cholesterol homeostasis may affect the integrity of the central
cholesterol metabolism and exacerbate AD pathology.
In this study, diet-induced hypercholesterolemia in nontransgenic young
mice (1 month) was associated with mitotic defects and the accumulation of
aneuploid cell in the periphery (splenocytes) (Figure 19) at a higher levels than in
mice fed a low cholesterol diet or regular (non-animal fat containing) chow,
suggesting that change in systemic cholesterol homeostasis may compromise
genomic stability in dividing cells. As discussed previously, patients diagnosed
with sporadic AD harbor aneuploidy in various peripheral cells (lymphocytes, skin
fibroblasts, buccal cells; Geller and Potter, 1999; Migliore et al., 1999; Thomas
and Fenech, 2008), which could be contributed to several environmental
aneugens and not related to Aβ-mediated chromosome mis-segregation.
Analysis of brain extracts of the mice fed different cholesterol diets in this
study with ELISA (enzyme-linked immunosorbent assay) and immunoblotting for
Aβ40 and Aβ42 levels, and for the expression of APP, phospho-tau and ApoE,
respectively yielded inconclusive results (data not shown).

However, no

difference in Aβ42 levels between the dietary groups was detected (ranged from
22.3 to 23.4 pg/ml, p > 0.2), and similar performance on the task of spatial
memory and learning utilizing a modified version of the Morris water maze
(Nunez, 2008) over 12 consecutive trials (data not shown). The diets in this
study were not energy adjusted, and the caloric intake and weight gain between
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the groups was statistically significant (Table 2), which influenced animals’
behavior and performance during cognitive testing (e.g., mice with more adipose
tissue floated better and were less stressed; observational data), but may also
have affected the aneuploidy result. Future study with the middle aged animals
(5-6 months) should be conducted with cholesterol and regular diets of similar
digestible energy and controlled intake, and mice cognitive performance
assessed with other hippocampus-based memory test such as object recognition
(Clark et al., 2000).

POSSIBLE MECHANISMS OF ANEUPLOIDY INDUCTION

The Role of Cholesterol in Biological Membrane

Lipids are essential for membrane integrity, structure and function. The plasma
membrane is organized into two main domains, the exofacial (outer) and
cytofacial (inner) leaflet, which differ in cholesterol and phospholipids content,
ordering (cohesion and packing of e.g., acyl chains), fluidity, electric charge,
location of microdomains (e.g., lipid rafts and calveolae), and the functioning of
associated enzymes, receptors and proteins (Ikonen, 2008; Wood et al., 2002).
Lateral and transbilayer distribution of the cholesterol within the plasma
membrane is believed to be essential for several membrane functions such as:
(1) permeability of ions and maintenance of solute concentrations on each side of
the membrane; (2) anchoring and diffusion of the proteins; (3) vesicle formation;
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and (4) organization of signaling transduction (Maxfield and Tabas, 2005).
Membrane lipid domains and asymmetry in lipid distribution are not stationary
and could be affected by aging (Schroeder, 1988), chemical treatments (e.g.,
ethanol, MβCD; Christian et al., 1997; Rubin and Rottenberg, 1982), and
neuropathological conditions such as Alzheimer’s, Niemann-Pick, and Tangier
disease (Eckert et al., 2000; Lee et al., 1998; Koike et al., 1998; Mori et al.,
2001; Mukherjee and Maxfield, 1999; Orsό et al., 2000; Wood et al., 2002).
Manipulation of the cholesterol content in the leaflets results in changed
membrane fluidity which, for example, in the nervous system may affect the
functioning of the membrane-bound neuronal receptors and modulate the binding
of ligand molecules. Several techniques have been developed to detect the
difference and change in leaflet fluidity, including cationic and anionic
fluorescently labeled probes (Schroeder, 1985) such as Laurdan fluorescence
(Parasassi et al., 1990) or fluorescence quenching (Schroeder, 1985).

For

example, a spectrofluorometer measures the intensity of the fluorescence
polarization of Laurdan as a function of the change in the dipole moment of the
fluorophore after excitation (Mukherjee and Chattopadhyay, 2005).
The experiments of this dissertation have shown that human cells treated
with the MβCD:cholesterol complex, which serves as an acceptor of hydrophobic
cholesterol and aids its delivery into the plasma membrane by inserting it into a
central nonpolar cavity (Härtel et al., 1998), develop aneuploidy within 48 hours
(Figures 16A, B; 17B). This biological effect could be a consequence of the
rigidifying effect of cholesterol in which cholesterol-enriched, more ordered
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membranes fail to properly align and attach MT-bound chromosomes prior to
anaphase, resulting in aneuploid progeny.

To determine whether changed

membrane fluidity could be a mechanistic link between cholesterol exposure and
chromosome mis-segregation, the change in membrane ordering prior and after
cholesterol treatment could be measured by generalized polarization (GE) of
Laurdan fluorescent probe (Parasassi et al., 1990).
Early studies by Schroeder et al. (1988) and Wood et al. (1989) utilizing
fluorescent quenching to measure the synaptic membrane fluidity upon treatment
with 25mM of ethanol determined that the disordering (fluidizing) effect of this
molecule affected primarily the exofacial leaflet.

The mechanism by which

ethanol changes membrane fluidity has been ascribed to several processes, one
being the change in the order and packing of acyl chains, which in rigid
membranes are elongated and tight. Upon ethanol exposure, the chains become
disordered and loose, which allows for water and other small molecule to easily
enter the bilayer space (Marques et al., 2011; Mukherjee and Maxfield, 2004). It
could be hypothesized that membrane rigidifying effect of cholesterol could be
counteracted by membrane fluidizing action of ethanol, which should result in
attenuation of lipid-induced aneuploidy (Figure 21A, B).

Whether lower

concentrations and different pre-incubation times also have membrane-fluidizing
effects, and whether lipoprotein-induced aneuploidy could be counteracted by
ethanol in the dose-response manner over different time points is worthwhile to
investigate, especially in cells directly involved in the atherosclerotic process. A
moderate red-wine consumption has been associated with the reduced incidence
145

of CVD in consumers of a typical French diet high in saturated fats and
cholesterol (‘French Paradox’) (reviewed Lippi et al., 2010).

Alcohol and

polyphenols (e.g., resveratrol) in red wine may act synergistically and increase
the cholesterol efflux from blood vessel walls, decrease oxidative stress and lipid
peroxidation, and prevent downstream atherosclerotic events such as foam-cell
formation, but may also change membrane fluidity and reduce the aneugenic
effect of dietary cholesterol as another mechanism of atherogenesis.

The Role of Calcium in Aβ and LDL-Induced Aneuploidy

Findings from this and a recent study (Granic et al., 2010) suggest that both LDLcholesterol and Aβ-induced chromosome mis-segregation could be attenuated by
chelation of extracellular calcium (Figure 20A-E).

Whereas Aβ-mediated

aneuploidy depends on functional APP and Tau genes, lipid-induced
aneugenesis is independent of APP, but requires a functional LDL receptor. Tau
is essential for Aβ-induced neurotoxicity (Rapoport et al., 2002), and the calciumdependent protease calpain is activated by Aβ and generates neurotoxic tau
fragments leading to neurodegeneration (Park and Ferreira, 2005). Increased
membrane cholesterol regulates the calcium influx (Bialecki et al., 1991), and
increases the susceptibility of mature neurons to Aβ-induced calpain activation
and production of 17kDa neurotoxic tau fragment. A recent study by Abramov et
al. (2011) showed that a higher cholesterol content in the plasma membrane
increased Aβ-induced calcium signaling and apoptosis in both astrocytes and
146

neurons. Whereas Nicolson and Ferreira (2009) were the first to propose a role
for plasma cholesterol in a tau-Aβ-calcium mediated neurotoxicity pathway, the
data presented here indicate that restoring calcium homeostasis and therefore,
de-activating calpain-mediated tau cleavage and destabilization of microtubules
may attenuate LDL-cholesterol induced chromosome mis-segregation in vitro
(Figure 22).

Figure 22. Possible Pathways Involving Calcium Homeostasis, Aβ and LDLcholesterol-induced Aneuploidy in Pathogenesis of AD
Multiple interrelated pathways may be involved in the complex etiology of familial (FAD) and sporadic AD
(SAD). Both Aβ and LDL induce chromosome mis-segregation in vitro within 48 hr. Removal of extracellular
calcium decreased both Aβ and LDL-mediated aneuploidy. Elevated cholesterol changes plasma
membrane fluidity (Weber et al., 2006) and increases Aβ-induced calcium signaling (Abramov et al., 2011),
which in turn may increase the susceptibility of neurons to Aβ-dependent calpain activation, tau cleavage
into neurotoxic fragments and apoptosis (Nicholson and Ferreira, 2009). Calcium chelation may attenuate
both Aβ and LDL-induced mitotic defects by restoring calcium homeostasis and de-activate calpain, and,
consequently, preventing tau cleavage and destabilization of microtubules.
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IMPLICATIONS OF CHROMOSOME MIS-SEGREGATION IN AD AND CVD
FOR DIAGNOSIS AND THERAPY

The mechanistic implication of the results presented in this dissertation is that
disruption in cholesterol homeostasis may contribute to Alzheimer’s disease
pathogenesis by inducing genomic instability and chromosome mis-segregation,
and thus contributing to disease progression. AD as the most common type of
dementia in old age, currently affects 35.6 million people in either genetic
(familial) or sporadic form, and that prevalence is expected to quadruple
worldwide by the mid of the 21st century (Ferri et al., 2005). Whereas genetic or
early-onset AD accounts for only 5% of all cases (Cummings, 2004), 95% of
sporadic or late-onset AD is attributed to the interaction of a number of factors
such as advancing age, environmental insults, and to several risk-enhancing
genetic

polymorphisms

(Bertram

and

Tanzi,

2004).

Likewise,

CVD

(atherosclerosis) is the most prevalent disorder and the number one killer in
developed countries (Daviglus et al., 2006).
The search for more effective diagnoses and therapy for AD and CVD
should take into account mitotic defects in peripheral and central tissues of
individuals at risk, especially those whose genetic predispositions and lifestyle
factors (e.g., high-fat diet) increases the odds of developing both diseases.
Chromosome analysis and detection of low levels of aneuploid cells utilizing
FISH or spectral karyotyping in skin fibroblasts or buccal cells in patients at risk
for cardiovascular events during the pre-clinical phase of dementia could be a
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potential diagnostic tool. Another implication of the data presented above that
cholesterol-induced genomic instability in AD may be the initiating event in
disease pathogenesis also suggests new approaches to prevention and
treatments (Potter, 2004). For example, elevated total and LDL-cholesterol as
risk factors for AD and atherosclerosis in midlife should be treated early both as
an atherogenic and aneugenic agent. Molecules that would restore the mitotic
defects and strengthen the fidelity of mitotic machinery could be searched for and
used as a prophylactic measure. Furthermore, other aneugenic environmental
agents aside from high cholesterol that cause chromosome instability could be
identified and countered with drugs that restore genomic homeostasis.
Alternatively, a more difficult but still effective approach to therapy would be to
identify and remove mis-segregated cells from the body by utilizing their unique
cell biology and/or gene profile.
To summarize, the results from this dissertation and several other
laboratories over the past twenty years have shown that AD patients are
susceptible to genomic instability, accumulating elevated levels of aneuploid
including trisomy 21 cells throughout the body compared to age matched healthy
controls. Whether the patients suffering from CVD (atherosclerosis) are at higher
risk for AD because of disturbed genomic homeostasis may be important to
investigate.

The precise mechanism by which abnormal cells arise in the

periphery (e.g., skin and arterial walls) and especially in the brain during the life
of an individual and how or whether they contribute to disease initiation and
progression warrant future investigation.
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The better understanding of these

novel findings has the potential to contribute to the development of future
diagnoses and therapies for AD and CVD.

CONCLUDING REMARKS

This dissertation presented several novel findings, the main being that
Alzheimer’s disease and CVD (atherosclerosis) may be mechanistically related
through a cytogenetic pathway. While dysfunction of cholesterol homeostasis
may contribute to AD pathology via systemic and cerebral atherosclerosis
causing cerebral hypoperfusion, disrupted communication between neurons and
vascular cells at the BBB, inflammation, impaired cerebral Aβ clearance and
consequent CAA, and compromised BBB (Vascular Hypothesis), other
mechanisms may also be involved. Altered cholesterol homeostasis within the
brain and plasma membrane may promote or inhibit amyloid production and
clearance (Amyloid Cascade Hypothesis) leading to neurodegeneration. Finally,
this dissertation presents evidence that a unique common cytogenetic
mechanism may underlie both AD and CVD (atherosclerosis).

Specifically,

disturbed cholesterol homeostasis may interfere with the cytogenetic property of
mitotic cells in the periphery and brain by changing their ability to properly
segregate their chromosomes, similar to development of mis-segregated,
including HSA21 aneuploid cells in blood, skin, mucosa and brain of AD patients
(Chromosome Mis-segregation Hypothesis), further perpetuating the pathology.
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Another novel finding of this dissertation suggests an association between
disturbed intracellular cholesterol homeostasis and differential distribution of
lipids between cell compartments and aneuploidy, as observed in the NPC1
cells.

The mechanism by which impaired cholesterol trafficking and storage

leads to accumulation of neurofibrillary tangles and neurodegeneration in the
brains of NPC1 patients is obscure (Karten et al., 2009), but understanding the
correlation between the aneugenesis and dysfunction in cholesterol homeostasis
may provide new insights into the pathogenic pathways of both AD and NPC.
This study had several limitations including: (1) mis-segregation of only a
few of chromosomes was tested and the extent of chromosome-specific
aneuploidy is not known; (2) the role of the more or less neuroprotective APOE
variants in genomic instability and aneugenesis in conjunction with lipids is
undetermined; (3) the extent of lipoprotein-induced aneuploidy in the brain cells
has not been investigated; (4) mice on a high cholesterol diet gained significantly
more weight compared to the mice in other dietary groups, which may have
biased the results; and (5) the known fluidizing effect of ethanol in vitro has been
hypothesized as a possible mechanism for the reduction in aneuploidy in the
cells co-incubated with lipids and alcohol—however, the membrane fluidity has
not been measured.
In summary, the fact that several age-related diseases (e.g., Alzheimer’s,
cancer, atherosclerosis, and FTD) share a common cytogenic trait—genomic
instability and chromosome mis-segregation—opens new avenues for the
research and therapeutic approaches.
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GLOSSARY

acrocentric chromosome: a chromosome with a very short p (small) arm and
centromere (a region of the chromosome where sister chromatids are in close
contact) positioned towards its end. Observed in human chromosomes 13, 14,
15, 21, and 22.
anaphase: the stage of mitosis when sister chromatids are separated by mitotic
spindle.
aneugen: process, agent or molecule that induces improper segregation of the
chromosomes during the cell division.
aneuploidy: a numerical abnormality of chromosomes compared to normal
genome (e.g., normal human somatic cells contains 46 chromosomes or 22 pair
of autosomes and one pair of sex chromosomes).
apoptosis: programmed cell death.
BAC (bacterial artificial chromosome): an artificially constructed cloning
plasmid in which a DNA sequence of interest could be inserted and transformed
into bacteria to generate identical clones resistant to a specific antibiotic.
calpain: a calcium-dependent protein expressed ubiquitously in mammalian
cells.
cerebral amyloid angiopathy (CAA): accumulation of amyloid-β protein in blood
vessels of the central nervous system.
cerebral hypoperfusion: decrease blood flow in cerebral vasculature especially
in microvessels.
chelator: an organic compound that serves as a ligand to other molecules via
formation of a single central atom bond.
chiasma (pl. chiasmata): a X-shaped chromosomal structure and the site of
cross-over (a reciprocal exchange of DNA) between homologous chromosomes
during meiosis.
chromogenic in situ hybridization (CISH): an alternative cytogenetic method
to FISH that employs enzymatic reactions and the brightfield microscopy to
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assess gene alternations, aneuploidy and other chromosomal aberrations in
formalin fixed or paraffin-embedded tissue slices.
clonal proliferation: division of identical cells derived from the same original
cell.
cholesteryl esters: highly hydrophobic esterified form of cholesterol.
circle of Willis: a circle of arteries that supply the blood to the brain.
colcemid: microtubule toxin, a drug that inactivates spindle formation and arrests
the cells in metaphase.
cyclodextrines: a family of organic compounds composed of several sugar
molecules in a ring structure able to form stable aqueous complexes with other
molecules.
cytokinesis: a process of division of the mother cell into two daughters.
cytosol: intracellular fluid-filled space of the cell divided into compartments by
membranes.
diploid: containing two copies or homologs of each chromosome (one inherited
from one parent and one from the other). Most somatic cells are diploid.
dynein: a microtubule (MT) motor protein complex that transports various
cellular cargo along MT toward its minus-end and centrosomes.
efflux: any exit of ions or molecules from the cell into extracellular space.
endocytosis: a process of ingestion of molecules in which plasma membrane
folds inwards to form an intracellular vesicle.
endoplasmic reticulum (ER): an organelle in eukaryotic cell composed of
interconnected network of membranes responsible for transport, production,
metabolism and regulation of different proteins, lipids, ions and other molecules.
endosome: membrane-associated vesicle inside the cell that transports
molecules for further processing to other organelles or back to the plasma
membrane.
euploid: containing normal chromosome compliments for the species (opposite
of aneuploid).
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fluorescence-activated cell sorting (FACS): a technique that uses modified
flow cytometer (an instrument that counts and differentiates different types of
cells based on intensity of fluorescent dye) to sort cell into different containers.
fluorescence in situ hybridization (FISH): a cytogenetic technique in which a
specific DNA sequence labeled with a fluorescent dye binds to complimentary
DNA of a target cell of specimen.
fluorophore (chromophore): a compound that bound to other molecule causes
fluorescence (e.g., DAPI, fluorescein isothiocyanate, SpectrumOrange).
G-banding: a classic cytogenetic technique in which metaphase chromosomes
are enzymatically treated (trypsin) and stained with the Giemsa stain to obtain
unique chromosomal bands (light and dark).
Golgi network (apparatus): a membrane structure in the cell responsible for
processing and packing of the proteins before secretion.
hepatic steatosis: fatty liver, accumulation of neutral lipids in hepatocytes.
hyperploid: containing more than diploid chromosome compliment.
hypoploid: containing less than diploid chromosome compliment.
influx: flux of ions and molecules into the cell or subcellular organelles.
in vitro: (Latin ‘within glass’) studies in cellular biology done in the cells isolated
from tissues and organs.
in vivo: studies done in an intact living organisms.
karyotype: a set of condensed chromosomes in metaphase stained or otherwise
prepared in order to detect the unique features of each chromosome pair.
kinase: proteins that transfer phospho groups onto other molecules and thus
regulate different cellular processes.
kinetochore: a protein complex located at the centromere (a region of the
chromosome), where the microtubules are attached during mitosis.
ligand: (Latin ‘binding’) a biomolecule that forms a bond (e.g., ionic bonds) with
other substance or molecule to perform certain biological function.
loss of heterozygosity: loss of function of one allele of the gene in which the
other one is already non-active.
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lysosome: (Greek lysis [to separate] and soma [body]) an organelle in the cell
filled with digestive enzymes that break down proteins, sugars, nucleic acids and
cellular debris.
meiosis: a specialized nuclear division in formation of the gametes in which
each cell contains haploid nuclei with a single homolog of each chromosome
(e.g., 23 chromosomes in humans).
microtubule (MT): a straw-like hollow structure composed of tubulin subunits
that supports cell cytoskeleton in interphase and forms mitotic spindle during
mitosis.
mitochondria: cell energy plant that converts complex sugars into energy
packets, the adenosine triphosphate (ATP) via glycolysis or Kreb’s cycle.
mitosis: a process of division in which the duplicated chromosomes are
separated via mitotic spindle.
mitogen: an agent that stimulates the proliferation of the cells.
mosaicism: the presence of the euploid and aneuploid cell population in one
organ or organism.
nuclear envelope (NE): the inner cellular membrane that surrounds and protects
nucleus from various insults and damage.
PCR (polymerase chain reaction): a molecular biology technique used to
amplify a specific DNA sequences and fragments.
retrograde immunocytochemistry: a combination of protein staining and
tracing technique used to identify, for example, neuronal projections.
separase: a protein that initiates the separation of sister chromatids.
sister chromatids: a duplicated set of chromosomes.
spectral karyotyping (SKY): a cytogenetic technique that allows for
visualization of all chromosomes in metaphase by using different fluorescent
probe for each.
telomerase: a specialized enzyme that synthetizes the repetitive sequence of
DNA at the end of the chromosomes, the telomeres that maintain their integrity
and regulate the number of cell divisions.
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tetraploid: containing four copies (or homologs) of each chromosome as a result
of failed cytokinesis.
Xenopus cell extract: cells prepared from frog oocytes.
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